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 The use of transcranial Doppler (TCD) ultrasound for the assessment of cerebral 
blood flow velocity (CBFV) provides an indication of cerebral blood flow assuming the 
diameter of the insonated vessel remains constant. Studies using TCD have traditionally 
described cerebrovascular hemodynamics with respect to CBFV and cerebrovascular 
resistance (CVRi); however, a more complete assessment of the cerebral circulation can be 
gleaned from the analysis of within beat characteristic of the TCD velocity waveform for the 
determination of cerebrovascular tone. Therefore, the general purpose of the presented 
studies was to assess CBFV responses and within beat characteristic for the description of 
cerebrovascular hemodynamics after long duration spaceflight, with sustained orthostasis, in 
response to changes in the partial pressure of end tidal carbon dioxide (PETCO2), and with 
NG stimulation. After long duration spaceflight, cerebrovascular autoregulation was found to 
be impaired along with a reduction in cerebrovascular CO2 reactivity (Study 1). Additionally, 
critical closing pressure (CrCP) was found to be increased suggesting potential remodelling 
of the cerebrovasculature contributing to an increase in cerebrovascular tone (Study 2). With 
sustained orthostasis, CBFV was found to progressively decrease and to be related to 
reductions in PETCO2 and increases in CrCP suggesting the contribution of changes in 
cerebrovascular tone leading to the development of syncope (Study 4). The CBFV reduction 
with the progression towards syncope was also associated with changes in waveform 
morphology such that the dicrotic notch point was less than the end diastolic value (Study 3). 
Mathematical modelling (RCKL) was used to further assess changes in cerebrovascular 
hemodynamics for physiological interpretation of changes in CBFV waveform morphology 
and found that the amplitude of the dicrotic notch and the calculation of the augmentation 
index were both significantly related to vascular compliance before and after stimulation with 
NG (Study 5). The use of quantitative assessments of common carotid artery (CCA) blood 
flow as an indicator of cerebral blood flow suggested the dilation of the middle cerebral 
artery (MCA) with NG (Study 5 and 6) and changes in MCA diameter with acute alterations 
in PETCO2 (Study 6). CCA and MCA velocity wave morphology were assessed showing that 
with changes in PETCO2, changes in CBFV velocity wave were not reflected in the CCA 
 
 iv 
trace (Study 7). In addition, further assessment of the CBFV velocity trace and the 
calculation of CrCP and the augmentation index suggested that with changes in PETCO2 
cerebrovascular compliance and cerebrovascular tension, both thought to be components of 
cerebrovascular tone, change independently (Study 7). Combined, the results of the presented 
studies suggest that changes in cerebrovascular hemodynamics can be determined from 
alterations in the CBFV velocity waveform morphology. However, further work is required 
to determine how these variations relate to specific components of cerebrovascular tone, 
including alterations in cerebrovascular compliance and vascular tension, and how these 
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before and after HDBR (symbols as in Figure C.1). The assessment of NG effects are 
shown as differences from time = 0 (*, p<0.05). No HDBR effects were found with 
either CBFV or CVRi; however, post-HDBR, RI was significantly reduced (#, 
p<0.05). CON n=6, EX n=7 197 
Figure C.4: Femoral artery responses to NG  
Responses of superficial femoral artery flow (A), conductance (B), and diameter (C) 
in response to NG pre-HDBR (solid bars) and post-HDBR (hatched bars) for EX 
(grey) and CON (white). All variables showed a significant effect of NG (*, p<0.05). 
No HDBR effects were found for femoral flow, conductance, or diameter. CON n=5, 
EX n=6. 198 
Figure C.5: Representative femoral blood flow trace  
Representative tracings of the waveforms for a single subject of femoral blood flow 
(product of measured instantaneous velocity and vessel cross-sectional area) at 
baseline (A) and after NG stimulation (B). Mean flow, shown by dashed horizontal 
lines, was greater at baseline (56.1 mL/min) than after NG (30.1 mL/min) primarily 
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 Adequate cerebral blood flow (CBF) is critical to brain function as CBF provides the 
means of delivery of oxygen (O2) and glucose to cerebral tissue and the removal of carbon 
dioxide (CO2). Inadequate CBF has been shown to produce cognitive impairment (Poels et 
al., 2008) with further declines leading to loss of consciousness (Bondar et al., 1995) and 
potentially death. With human populations, the use of non-invasive methods for the 
assessment of CBF regulation is essential for clinical application and many experimental 
situations. Analysis methods have been developed for use with these non-invasive measures 
which allow for some information to be gleaned about the cerebral circulation; however, in 
the words of R. Panerai: “...efforts must be made to improve the amount of information that 
can be extracted from existing measurement techniques,” (Panerai, 2003). 
 A quick review of the literature will show the assessment of CBF under a wide 
variety of conditions and disease states including responses to spaceflight. Exposure to 
microgravity has been shown to promote cephalic fluid shifts (Hargens & Watenpaugh, 
1996) which may contribute to remodeling of the cerebrovasculature and affect the regulation 
of cerebral blood flow. Recently the National Aeronautics and Space Administration (NASA) 
has identified idiopathic intracranial hypertension and its resultant consequences as a serious 
health concern for long duration spaceflight (Fogarty, 2011). In addition to change in 
intracranial pressure with exposure to microgravity, atmospheric conditions aboard 
spacecraft may also influence CBF as aboard the International Space Station (ISS) the partial 
pressure of CO2, a known vasodilator of cerebral blood vessels, is greater than normal Earth 
atmospheric levels. 
 The use of transcranial Doppler ultrasound (TCD) has allowed for the assessment of 
cerebral blood flow velocity (CBFV) in humans. In addition to conventional assessments of 
CBFV, analysis of the blood velocity profile may provide additional information about the 
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cerebral hemodynamic environment and the consequences of long duration spaceflight on 
CBF and CBF regulation. The following sections will provide an overview of the assessment 
of CBF and the use of TCD, factors affecting cerebral hemodynamics, assessment of Doppler 
waveform morphology, assessment of functional cerebral hemodynamics, the influence of 
nitric oxide in CBF regulation including responses to changes in CO2 and nitroglycerin 
stimulation, and current understanding of CBF responses to spaceflight and spaceflight 
analogue studies. 
1.2 Assessment of Cerebral Blood Flow and Transcranial Doppler 
Ultrasound 
 Over the years, the assessment of CBF has taken many forms for both clinical and 
research applications. Initial work required the use of invasive techniques, primarily 
involving patient populations undergoing cranial surgery and utilizing flow probes for the 
direct assessment of cerebral arteries (Nornes & Wikeby, 1977) and carotid arteries 
(Lindegaard et al., 1987). Some information about cerebral blood flow responses can be 
determined from this type of study; however, conclusions are generally limited to the 
anesthetized patient population. As such, these methods are generally not practical for wide 
spread research or clinical applications. 
 The development of non-invasive methods of determining CBF has led to a greater 
understanding of cerebral hemodynamics in both health and disease. Several techniques have 
involved the use of tracer molecules as in stable xenon-enhanced computed tomography 
(Nariai et al., 1995) or inhalation of xenon-133 for use with single-photon emission 
computed tomography (SPECT). In addition to SPECT, positron emission tomography (PET) 
has been commonly used in the assessment of CBF. Both SPECT and PET methods require 
the administration of a radioactive isotope which is then monitored by detection equipment 
for the assessment of total and/or regional CBF (Wintermark et al., 2005). Unlike SPECT, 
PET measurements involve the use of metabolic tracers which allow for the determination of 
oxygen extraction which can then be used as an indicator of cerebral metabolism 
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(Wintermark et al., 2005; Powers, 1991). PET has been frequently used to validate other 
methods of determining CBF (Nariai et al., 1995; Poeppel et al., 2007); however the use of 
radioactive material among other technical considerations limit the applications of these 
methods for determining CBF. 
 Functional magnetic resonance imaging (fMRI) capitalizes on the different signals 
produced by oxygenated versus deoxygenated haemoglobin which can be used as an 
indicator of CBF without the administration of radioactive material. When subjected to a 
magnetic field, the free lone pair on deoxygenated haemoglobin produces a different 
magnetic signature in the surrounding tissue allowing for blood oxygen level dependent 
(BOLD) imaging (Brown, Perthen, Liu, & Buxton, 2007; Forster et al., 1998). BOLD signal 
increases with the presence of oxygenated haemoglobin allowing for the relative change in 
signal intensity to be determined (Brown et al., 2007; Forster et al., 1998). As BOLD gives 
an indication of oxygen levels, observed changes in BOLD signal can be the result of either a 
change in CBF, a change in blood volume, or a change in the oxygen utilization of cerebral 
tissue. The limitations inherent in BOLD imaging have led to a refined fMRI technique 
known as arterial spin labeling (ASL).  
 With ASL, a perpendicular magnetic field is applied to a “tagging” region of the body 
which serves to align the spins of water molecules in that region (Brown et al., 2007). Images 
are then recorded in an “imaging” region where the appearance of the spin oriented water 
molecules in blood are recorded (Brown et al., 2007). ASL provides a quantitative method 
for determining CBF in steady state situations and fMRI imaging techniques appear to be 
very promising with respect to the non-invasive determination of CBF; however, they do 
possess the limitations of size of measurement equipment required, length of time for 
assessment, and restricted application in the assessment of dynamic changes in CBF.  
 In 1982, Aaslid et al. (Aaslid, Markwalder, & Nornes, 1982) described the use of 
TCD as a non-invasive method for the assessment of CBF. TCD uses the principles of 
Doppler ultrasound to determine the velocity of red blood cells travelling towards or away 
from the Doppler probe. Briefly, and ultrasound wave of known frequency is transmitted 
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from the probe towards a vessel of interest, traditionally the middle cerebral artery (MCA). 
Sound waves are reflected off particles back towards the probe with the frequency of 
returning sound waves depended on the velocity of the particle from which it was reflected. 
Therefore, by determining the frequency shift and knowing the angle of insonation, the 
velocity of the moving particles, primarily red blood cells, can be determined using the 
Doppler Shift Equation (A): 
(A)   
    
        
 
Where V is the velocity of the moving particle, fd is the Doppler shift frequency, C is the 
velocity of the sound wave through tissue, ft is the transmitted ultrasound frequency, and θ is 
the angle of insonation (Hoskins, 1990). A schematic of Doppler ultrasound measurement is 
presented in Figure 1.1 drawn from information discussed in Reneman et al. (Reneman, 





Figure 1.1: Schematic of Doppler ultrasound measurement 
The ultrasound probe sends out a sound wave of known frequency that is reflected off particles back 
towards the probe. The frequency of the returning sound wave can be described using the Doppler 
shift equation (A) and is dependent on the transmitted frequency, the velocity of the particle reflected 
off, and the angle between the direction of the ultrasound beam and the direction of the moving 
particle (angle of insonation). 
 It should be highlighted that TCD provides measures of cerebral blood velocity and 
not flow. As such, TCD measures are commonly expressed as cerebral blood flow velocity 
(CBFV) with the assumptions made that the angle of insonation and the diameter of the 
MCA both remain constant with testing and, therefore, velocity measures are reflective of 
CBF. TCD validation studies have shown that measures of CBFV track well with changes in 
CBF (Poeppel et al., 2007; Dahl et al., 1992; Bishop, Powell, Rutt, & Browse, 1986; Muller, 
Voges, Piepgras, & Schimrigk, 1995; Ulrich, Becker, & Kempski, 1995) suggesting that the 
assumptions involved with the use of TCD for the assessment of CBF are valid. Studies have 
shown no changes in MCA diameter during experimental manipulations such as orthostatic 
stress and changes in arterial CO2, when measured during cranial surgery (Giller et al., 1993), 
angiography (Djurberg et al., 1998), assessing the power of the TCD Doppler spectrum 
(Poulin & Robbins, 1996), or through the use magnetic resonance imaging (Serrador, Picot, 
Rutt, Shoemaker, & Bondar, 2000; Schreiber, Gottschalk, Weih, Villringer, & Valdueza, 
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2000; Valdueza et al., 1997). However, other work has suggested that the MCA is not a static 
vessel and, therefore, care needs to be taken when interpreting CBFV as CBF. 
 Work by Hansen et al. (Hansen et al., 2007) has shown using MRI imaging that the 
MCA does dilate with nitroglycerin stimulation. In another study, Valdueza et al. (Valdueza, 
Draganski, Hoffmann, Dirnagl, & Einhaupl, 1999) used venous outflow measures in 
comparison to MCA velocity measures to suggest the dilation of the MCA with hypercapnia. 
In addition, a more recent paper showed that changes in CBFV underestimated changes in 
cerebral blood flow with hypercapnia and hypocapnia suggesting the possible dilation of the 
MCA (Willie et al., 2012). Methodological considerations have also raised questions as to the 
accuracy of the observation of no changes in MCA diameter. Bondar et al. (Bondar et al., 
1990), who used the Doppler spectrum power method to assess MCA diameter during 
parabolic flight cautioned that the values may have been affected by slight changes in the 
relative positions of the MCA and the ultrasound probe during the protocol thus changing the 
amount of ultrasound signal scattered by surrounding tissue and, therefore, altering the 
reflected spectrum power independent of changes in vessel diameter. Work published by 
Serrador et al. (Serrador et al., 2000) has frequently been used as support for the assumption 
that the diameter of the MCA does not change. However, the paper states that the resolution 
of the images analyzed in this study was unclear. The authors believed that the resolution was 
higher than the single pixel size of 0.47mm but this was not known. Assuming that the 
resolution of the images in this paper was improved to 0.25mm, this is still 10% of the 
diameter of an average MCA. Therefore, it is possible that this study was not able to detect 
small changes in MCA diameter that may have a significant influence on cerebral blood 
flow. To date, no studies have been conducted with improved MRI image resolution to verify 
results of this study. 
 In addition to assumptions made about MCA diameter, equation (A) shows that 
absolute values of CBFV are also dependent on the cosine of the angle of insonation. 
Therefore, as the angle of insonation approaches zero, the cosine of the angle approaches one 
and the accuracy of the velocity measurement increases. Conversely, as shown in Figure 1.2, 
as the angle of insonation becomes greater than 60°, where the error is 100%, the error of 
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recorded velocities increases such that small change in angle produce large errors in the 
calculation of velocity. 
 
Figure 1.2: Relationship between angle of insonation and resultant calculated velocity 
Using a starting velocity value of 1cm/s at an angle of 0°, this figure has been adapted from the 
Doppler shift equation where the calculated velocity is proportional to 1/cosθ. From the curve it can 
be seen that changes in the angle of insonation (θ) produce much smaller changes in velocity with 
angles approaching 0°. 
 When using TCD to assess blood flow in the MCA, the probe is placed over the 
temporal window where the skull bone allows for the transmission of ultrasound waves 
towards the cerebral blood vessels. The use of this site for ultrasound allows for an angle of 
insonation with the MCA approaching zero; thus decreasing potential error in the calculation 
of blood velocity. At least one group has attempted to use ultrasound imaging to determine 
the angle of insonation for the MCA, suggesting an angle of insonation for the right MCA of 
30±16 degrees (Krejza et al., 2007). Assuming an angle of 30% would account for an error of 
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approximately 15%. Therefore, as it is not possible to measure the exact angle of insonation 
using TCD, care needs to be taken in the placement of the probe to ensure that the angle of 
insonation remains as consistent as possible. 
 In addition to being a relatively simple method for the assessment of cerebral blood 
flow velocity with the use of equipment that is potentially very portable allowing for the use 
in a wide variety of settings, TCD is able to generate continuous, beat-by-beat mean 
measures of CBFV and a velocity trace throughout the cardiac cycle. When determining 
blood flow during a ‘steady state’ condition, flow can be explained through the relationship 
of pressure and vascular resistance. However, a true steady state condition is never achieved 
as fluctuations in blood flow are known to occur within a cardiac cycle and on a beat-by-beat 
basis. Therefore, analysis of the beat-by-beat and within cardiac cycle variation of the TCD 
velocity recording may provide additional information about other factors affecting cerebral 
blood flow in dynamic conditions. 
1.3 Factors Affecting Cerebral Blood Flow 
 The assessment of cerebral hemodynamics primarily requires an understanding of 
factors that affect blood flow. Overall blood flow is affected by a number of variables and is 
generally simplified to use the principles of Newtonian fluids flowing through rigid tubes. 
Using this simplification, hemodynamics can be explained by Poiseuille’s law (B). 
(B)   
     
   
 
By examining equation (B), it can be seen that flow (Q) is directly proportional to the 
pressure change across the system (ΔP) and the radius of the tube (r) to the fourth power. As 
well, flow is inversely proportional to the viscosity of the fluid (μ) and the length of the tube 
(L). With respect to acute changes in blood flow, it is assumed that the length of the system 
and the viscosity of blood do not change acutely. Therefore, flow is then described with 
respect to the pressure drop across the system and vascular radius, or vascular resistance such 
that flow is equal to the pressure gradient divided by resistance. 
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1.3.1 Vascular Resistance 
 To date, much of the research with respect to cerebral blood flow has focused on the 
pressure, flow, and resistance relationships. It is well known that not all blood cells within a 
vessel are moving at the same velocity. For simplification, it is generally assumed that blood 
flow is laminar with a parabolic flow profile such that faster moving particles are in the 
centre of the artery and slower moving particles near the wall (Ku, 1997). The different red 
blood cell velocities are evident in the Doppler spectrum as the intensity of the Doppler 
spectrum is dependent on the number of particles moving at a particular velocity. 
Traditionally, measures of CBFV using TCD have used the outer envelope of the Doppler 
spectrum representing the maximal velocity of particles within the vessel. The use of the 
peak envelope may not completely reflect changes in blood velocity within the vessel; 
however, assuming the central portion of the vessel is included in the sampling volume, it 
does provide a very repeatable and reproducible measure that is not artificially affected by 
slight shifts in probe placement or changes in vessel diameter. 
 The influence of blood pressure on cerebral blood flow is generally determined using 
a peripheral measure of arterial blood pressure (ABP). With participants resting in a supine 
position, pressure is thought to be equalized throughout the body; therefore, measures of 
ABP are used to represent cerebral perfusion pressure. Upon assuming an upright posture, 
pressure measures are adjusted to the height level of the TCD probe to provide an indication 
of pressure at the level of the brain. 
 Using the measures of ABP corrected to the level of the TCD probe (BPMCA) and 
CBFV, an index of cerebrovascular resistance can be calculated as: 
(C)      
     
    
 
Where the cerebrovascular resistance index (CVRi) is equal to the ratio of arterial blood 
pressure at the level of the TCD and CBFV. Describing cerebral blood flow regulation with 
respect to CBFV and CVRi does provide some information; however, this method also 
presents several limitations. As with the use of CBFV as an indicator of CBF, the use of 
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CVRi as an indication of resistance is dependent on the assumption that the diameter of the 
MCA remains constant and that BPMCA accurately reflects the pressure change across the 
cerebral circulation (perfusion pressure). In addition, the use of CVRi also assumes that flow 
though cerebral vessels will continue to 0mmHg, which may not be accurate as seen by the 
concept of critical closing pressure (Burton, 1951).  
1.3.2 Cerebral Perfusion Pressure 
 Cerebral perfusion pressure (CPP) is the pressure promoting blood flow to the brain 
or, with respect to equation (B), the ΔP of the system. This value is dependent on arterial 
pressure, intracranial pressure (ICP), and the venous pressure exiting the cerebral circulation 
(Mathew, 1996; Paulson, Waldemar, Schmidt, & Strandgaard, 1989; Zhang, 2001). The 
venous component of CPP is generally ignored, as it is thought that the venous system 
provides minimal resistance to venous outflow, and that the veins are not producing a siphon 
effect on the cranium (Carey, Manktelow, Panerai, & Potter, 2001). It is also thought that 
intracranial pressure remains constant under most conditions (Carey et al., 2001; Mathew, 
1996; Zhang, 2001), therefore, mean arterial pressure at the level of the brain is often used as 
a substitute for CPP measurements. 
 Work has been conducted looking at the changes in cerebral spinal fluid pressure 
dynamics which could influence ICP and, therefore, CPP (Haubrich et al., 2007; Hu, Alwan, 
Rubinstein, & Bergsneider, 2006). Studies examining ICP have primarily looked at 
individuals with head injuries; however, it does present a precedent for situations where CPP 
may be changing due to changes in ICP (Portella et al., 2005). Questions still remain on how 
changes in cerebral spinal fluid dynamics affect ICP, if these changes occur on an acute 
basis, and what exact influences these changes may have on CBF. 
1.3.3 Vascular Impedance 
 The use of the pressure and resistance relationship to describe blood flow may be 
adequate over long periods of time; however, the dynamic and pulsatile nature of blood flow 
suggests the use of vascular impedance. In addition to vascular resistance, impedance also 
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incorporates in the influences of the inertia of blood and vascular elasticity or vascular 
compliance (Zhu, Tseng, Shibata, Levine, & Zhang, 2011; Zamir, 2005). 
 Static vascular compliance can be defined as the slope of the pressure-volume curve 
or dV/dP where dV is the change in volume for the change in pressure dP and has been 
shown to be affected by several variables including vascular wall composition and vascular 
tone (Klabunde, 2007). Several studies have attempted to examine cerebrovascular tone 
using the concept of critical closing pressure (CrCP). First introduced in 1951 by Burton 
(Burton, 1951), CrCP is defined at the pressure level where blood flow is ceased due to the 
theoretical collapse of small vessels. Based on the principles of Laplace’s Law, Burton 
showed that CrCP would be dependent on both the active tension of the blood vessel, and the 
unstretched radius of the vessel. In the study of human cerebral circulation, direct assessment 
of the critical closing pressure is not possible; however, several methods have been 
developed that provide indications of CrCP (Panerai, Salinet, Brodie, & Robinson, 2011). 
Calculation of CrCP also allows for the determination of the resistance area product (RAP) 
described by Evans et al. (Evans, Levene, Shortland, & Archer, 1988). Calculated as the 
inverse of the pressure-velocity slope, RAP provides an indication of cerebrovascular 
resistance accounting for the influence of CrCP (Carey, Eames, Panerai, & Potter, 2001; 
Panerai, 2003). 
 In the study of CrCP, changes have been seen with alterations in CO2 such that an 
increase in CO2 produces a reduction in CrCP and an a reduction in CO2 increases CrCP 
(Panerai, Deverson, Mahony, Hayes, & Evans, 1999; Ainslie, Celi, McGrattan, Peebles, & 
Ogoh, 2008; Panerai, 2003). Interestingly, these studies also showed no changes in RAP 
suggesting that alterations in cerebral blood flow with CO2 are primarily affected by change 
in vascular tension and vessel radius and not necessarily vascular resistance (Panerai et al., 
1999). Work by Ogoh et al. (Ogoh, Brothers, Jeschke, Secher, & Raven, 2010) showed an 
increase in CrCP with heavy exercise which they suggested was related to an increase in 
plasma norepinephrine in addition to a reduction in the partial pressure of CO2 (PCO2). With 
the progression towards syncope, Carey et al. (Carey et al., 2001) have also shown increases 
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in CrCP and reductions in RAP suggesting that changes in cerebrovascular tone and 
resistance interact in the regulation of cerebral blood flow with approaching syncope. 
 The influence of cerebrovascular tone in the regulation of cerebral blood flow has 
been studied more recently with work assessing cerebrovascular autoregulation with respect 
to a Windkessel model including the components of both resistance and compliance. In 2009, 
Zhang et al. (Zhang, Behbehani, & Levine, 2009) showed, using a three-element Windkessel 
model, that steady state values of cerebrovascular resistance and/or compliance may 
influence dynamic cerebrovascular autoregulation. These results were later supported by 
Chan et al. (Chan et al., 2011) using a two-element Windkessel model. In a more recent 
paper, Zhu et al. (Zhu et al., 2011) have suggested that transfer function analysis of pressure 
and CBFV recordings can be used to determine cerebrovascular impedance in the frequency 
domain and that alterations in cerebrovascular impedance occur with age. The results of these 
studies suggest that values and changes in vascular tone, cerebrovascular compliance, and in 
general, cerebrovascular impedance cannot be ignored in the dynamic assessment of cerebral 
blood flow regulation. In addition, work has shown that, in peripheral vessels, a reduction in 
vascular compliance has been associated with an increase in risk of vascular injury and the 
progression of cardiovascular disease (Seals, 2003). Therefore, the assessment of 
cerebrovascular tone may be important in both clinical and research settings. 
1.4 TCD Waveform Analysis 
 Waveform analysis is not a new concept in the study of blood flow dynamics, but in 
some ways it is a topic that is rarely studied. It is well known that pulsatile flow will result in 
a waveform profile that is dependent on a number of contributing factors including driving 
pressure, vessel diameter, and vessel compliance. Therefore, through the assessment of TCD 
waveform morphology it may be possible to glean additional information about changes in 
cerebrovascular hemodynamics.  
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1.4.1 Doppler Resistance Indices 
 Many researchers have looked to the shape of Doppler velocity waveforms as a 
means of determining downstream vascular resistance. Several Doppler resistance indices 
have been developed for use in different situations. In a simple form, researchers have looked 
at the relationship between the maximum velocity point and minimum velocity point as 
shown in Figure 1.3. The ratio between systolic and diastolic, maximum and minimum 
velocity, has been used; however, some work has shown that this relationship does not 
adequately reflect changes in resistance (Adamson, Morrow, Langille, Bull, & Ritchie, 
1990). This is especially true in high resistance vascular beds where the minimum velocity 
point approaches zero or is negative (Figure 1.3, panel B). In this case, researchers have 
suggested that the ratio be reversed to diastolic to systolic, or minimum to maximum 





Figure 1.3: Velocity points for Doppler resistance indices 
Adapted from Arbeille et al. (Arbeille et al., 1995), this figure shows a schematic of a velocity trace 
for a low resistance vascular bed (panel A) and a high resistance vascular bed (panel B). The figure 
shows a dashed horizontal line showing the mean of the velocity signals, and arrows pointing to the 
systolic (Sys) and diastolic (Dia) points that are used for the calculation of the Doppler resistance 
indices. 
 For use with low resistance vascular beds such as cerebral circulation, the resistivity 
index (RI) was developed based on the theory that as downstream resistance changes, the 
amplitude of the diastolic component of the wave will also change (Donald & Levi, 1976). 
Calculated as: 
(D)    
               
       
 
RI calculates the proportion of the wave that is diastolic, or the minimum point (CBFVdia) 
with relation to the systolic, or maximum point (CBFVsys). As resistance increases, the wave 
becomes sharper with larger pulse amplitude (CBFVsys – CBFVdia). Therefore, the 
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contribution of the diastolic component of the wave is very small, increasing the RI. As 
resistance decreases, the contribution of the diastolic component of the wave increases 
thereby decreasing RI. 
 RI provides an indication of resistance based on two points on the Doppler waveform 
and the observation that the diastolic point of a velocity wave will change with changes in 
downstream vascular resistance. First described in 1969, the Gosling pulsatility index (PI) 
relates the amplitude of the velocity waveform to the mean of the wave (Hoskins, 1990). 
Therefore, PI is calculated as: 
(E)    
               
        
 
In contrast to RI, PI appears to provide a more robust estimate of resistance as it incorporates 
the entire waveform and is not as heavily reliant on two points. Both RI and PI have been 
validated experimentally and appear to track well with changes in vascular resistance 
(Adamson et al., 1990). However, it is thought that changes in CPP may influence RI and PI 
independently of changes in vascular resistance (Zwiebel & Pellerito, 2005). In addition, a 
recent study has suggested that PI is a more complex variable reflecting multiple 
cerebrovascular characteristics (de Riva et al., 2012). Therefore, care needs to be taken with 
the interpretation of PI as factors other than cerebrovascular resistance may be influencing 
this value.  
 Other work has started to question the exact points of the velocity wave that are to be 
used in the calculation of the Doppler resistance indices. Traditionally, CBFVsys has been 
considered the maximum point of the CBFV waveform; however, Kurji et al. (Kurji et al., 
2006) and Robertson et al. (Robertson, Debert, Frayne, & Poulin, 2008) have both shown 
CBFV waveforms that exhibit a distinct second peak which is higher than the observed first 
peak which the authors suggest is a wave augmentation and should not be considered as 
CBFVsys. Further work is required to assess this statement and to determine which points 
most accurately reflect downstream vascular resistance.  
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1.4.2 MCA Velocity Wave Inflection Points 
 Several studies considering the entire velocity wave over a cardiac cycle have looked 
to simplify the MCA velocity waveform and characterize it based on several key points 
(Kurji et al., 2006; Aggarwal, Brooks, Kang, Linden, & Patzer, 2008; Robertson et al., 2008; 
Lockhart et al., 2006). As shown in Figure 1.4, the MCA velocity wave can be characterized 
by several peaks (P1, P2, and P3) and troughs (T1, T2, and T3). Interpretation of the velocity 
wave inflection points has mainly attempted to link the observed velocity wave profile to that 
of the arterial pressure wave (Aggarwal et al., 2008; Robertson et al., 2008). Therefore, the 
first inflection point, labeled T1, represents the end diastolic value just before the start of the 
systolic portion of the wave. P1 represents the systolic peak and is commonly the maximum 
velocity point of the wave; however, studies have shown that under certain conditions P2 is 
greater than P1 (Kurji et al., 2006; Robertson et al., 2008). Associating the velocity wave 
with recordings of arterial pressure waves, P2 is thought to be the result of constructive 
interference from a reflected velocity wave (Nichols et al., 2008; Robertson et al., 2008). T3 
is the dicrotic notch which corresponds to the closing of the aortic valve and is used as the 
dividing point for the portion of the wave that is influenced by systole and the diastolic 
component primarily influenced by downstream vascular properties (Aggarwal et al., 2008). 
Some work has primarily focused on the systolic portion of the wave (Aggarwal et al., 2008; 
Kurji et al., 2006; Robertson et al., 2008) whereas others have looked to the diastolic portion 
as an indicator of the vascular environment (Lockhart et al., 2006). However, by looking at 





Figure 1.4: MCA velocity wave inflection points 
Adapted from several sources (Kurji et al., 2006; Aggarwal et al., 2008; Robertson et al., 2008; 
Lockhart et al., 2006), this figure depicts a schematic of a MCA blood velocity waveform with key 
inflection points labeled.  
 In 2006, Kurji et al. (Kurji et al., 2006) used this simplified model of the MCA 
velocity wave to assess changes with age and increased partial pressure of end tidal CO2 
(PETCO2). In this study, the group was able to demonstrate that CBFV waveforms change 
with alterations in PETCO2 and with age such that both age and increased PETCO2 showed 
increased P2 values. However, it is still unclear what physiological variables contribute to the 
observed changes in the TCD waveform. 
 Work by McVeigh et al. (McVeigh et al., 1999) has looked at the diastolic decay 
portion of a peripheral arterial blood pressure waveform to give an indication of large and 
small artery compliance. In another paper, this same group used the principles of the blood 
pressure wave analysis to assess cerebral blood velocity waves at rest and with nitroglycerin 
(NG) stimulation with particular focus on the points shown in Figure 1.4 (Lockhart et al., 
2006). The results of this study showed waveform changes with no change being seen in P1, 
but significant reductions in P2, P3, T1, T2, and T3.with NG stimulation; however, again, 
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there was limited discussion as to what the changes in waveform morphology mean 
physiologically. 
 Aggarwal et al. (Aggarwal et al., 2008) used the points of the MCA velocity wave 
presented in Figure 1.4 to create a linear model of the MCA velocity wave. Point values, 
slopes of lines between points, and timing of points were then all assessed for velocity data 
collected from patient population and compared to measures of ICP from a sensor that had 
been inserted into the epidural space and calculated CPP. MCA waveform features were then 
used to discriminate between subjects separated into high, medium, and low ICP and CCP 
groups. The results of this study suggest that the assessment of MCA velocity wave 
characteristics might provide a method for determining changes in ICP or CPP. 
 Work by Robertson et al. (Robertson et al., 2008), similar to the paper by Kurji et al. 
(Kurji et al., 2006), also looked at changes in the MCA velocity wave with increased PETCO2 
and identified the P2 point on the CBFV velocity trace which they termed the reflected 
component of the velocity wave. By likening this reflected velocity wave point to the work 
presented by Nichols et al. (Nichols et al., 2008) with central aortic pressure waves, 
Robertson et al. calculated an augmentation index and suggested that the observed changes in 
the velocity wave were the result of alterations in cerebrovascular compliance.  
 In general, the studies mentioned above all demonstrated the malleability of the MCA 
blood velocity wave. The work by Aggarwal et al. (Aggarwal et al., 2008) showed potential 
links between waveform characteristics, ICP and CPP, where the work by Robertson et al. 
(Robertson et al., 2008) suggested alterations in waveforms related to changes in 
cerebrovascular compliance. Additional work is still needed to determine how the velocity 
wave changes under various conditions and to determine how this relates to cerebrovascular 
hemodynamics. 
1.4.3 Carotid Artery Flow Profile 
 As the internal carotid artery (ICA) is the large conduit artery supplying the cerebral 
circulation, it follows that changes in cerebral blood velocity profile could be reflected in the 
ICA flow trace and potentially in the common carotid artery (CCA) which in turn supplies 
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the ICA. Some of the earliest TCD validation studies looked at the relationship between ICA 
flow and CBFV measures to verify that TCD measures were representative of changes in 
CBF (Lindegaard et al., 1987). Since the early TCD validation studies, other work has looked 
at CCA and ICA blood flow as indicators of changes in CBF (Eicke, Buss, Bahr, Hajak, & 
Paulus, 1999; Kleiser, Scholl, & Widder, 1995).  
1.4.3.1 Wave Intensity Analysis 
 Recently, “wave intensity” analysis of the CCA has been used as a potential indicator 
of cerebrovascular properties (Bleasdale et al., 2003). In this analysis, simultaneous pressure 
and flow waves are measured in the CCA and analyzed to for the calculation of the intensity 
of forward travelling waves, or waves travelling away from the heart, versus backwards 
travelling waves (Bleasdale et al., 2003; Rakebrandt et al., 2009; Zhang et al., 2010; Niki et 
al., 2002). In a study by Bleasdale et al. (Bleasdale et al., 2003) cerebrovascular resistance 
was manipulated by changes in arterial PCO2 and showed relations to the calculated reverse 
wave intensity of the CCA. This relationship led the authors to suggest that wave intensity 
may provide a non-invasive method for assessing cerebrovascular properties. 
1.4.3.2 RCKL Modelling 
 Another approach to waveform analysis involves the use of mathematical modelling. 
Models can use input variables measured in one segment of the arterial tree to determine 
downstream vascular responses in areas that cannot be easily measured non-invasively. In 
2007, Zamir et al. (Zamir, Goswami, Salzer, & Shoemaker, 2007) developed the RCKL 
model as a modification of the Windkessel model where resistance (R) and capacitance (C) 
were placed in parallel and viscoelastic resistance (K) and inertance (L) in series with C 
(Figure 1.5). If blood flow was a purely resistive system, the pressure wave would be 
identical to the flow wave (Zamir, 2005). As this is not the case, the RCKL model provides 
results for C, K, and L which are used to alter a modeled flow wave, based on the recorded 
pressure wave, so that the modeled wave matches the recorded flow wave. The R, C, K, and 
L parameters of this model therefore provide information about the total downstream 
vascular environment. This model has been successfully used with the peripheral vasculature 
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(Zamir et al., 2007) and may provide the opportunity to be used to assess cerebrovascular 
variables. 
 
Figure 1.5: RCKL Model 
Electrical circuit schematic of the RCKL model in which the resistor R is place in parallel with the 
capacitor C which is in series with a second resistor K and the inductor L.  
 
 The RCKL modelling approach requires the continuous assessment of blood flow and 
pressure within the artery of interest over a cardiac cycle. The skull provides a challenge for 
acquiring data non-invasively for use with this model; therefore, data must be collected from 
arteries supplying the cerebral circulation. In research involving cerebral blood flow, the 
internal carotid artery (ICA) is ideally used. However, again, the non-invasive assessment of 
pressure within this artery is generally not possible due to the anatomical arrangement of the 
vessel. Therefore, assessment of the common carotid artery (CCA) may provide adequate 
input for the model for the assessment of cerebral circulation. Preliminary work with this 
method and the CCA has been conducted with young and elderly participants with the results 
of this work suggesting that RCKL modeling is able to detect large changes in vascular 
properties with aging (Robertson, Zuj, Zamir, Hughson, & Shoemaker, 2008). However, care 
should be taken when interpreting these results, as the CCA is influenced by both intracranial 
and extracranial circulation. Further work is required with the RCKL model to determine the 
repeatability and validity of this model with use of CCA measures. As well, additional work 
needs to be conducted to help differentiate between cerebral circulation and extracranial flow 






1.5 Cerebrovascular Autoregulation 
 The assessment of cerebral hemodynamics under resting conditions only provides a 
small amount of information. Cerebral blood flow regulation is a dynamic process where, in 
some situations, alterations in cerebrovascular properties may only be evident with changes 
in the regulation of cerebral blood flow.  
 Cerebrovascular autoregulation (CA) is the term used for the process in which 
vascular resistance is regulated to maintain CBF in the face of changing CPP (Panerai, 1998; 
Strandgaard & Paulson, 1984; Paulson, Strandgaard, & Edvinsson, 1990). With an increase 
in CPP a stretch is placed on the cerebral resistance vessels resulting in a vasoconstrictor 
response (Davis & Hill, 1999). This effectively serves to increase cerebrovascular resistance 
and maintain CBF. The opposite is also true in that a decrease in CPP will elicit a 
vasodilatory response, reducing vascular resistance and maintaining flow. CA has been 
shown to act rapidly within 2-5 seconds of changes in CPP and maintain CBF for perfusion 
pressures between 50 and 150mmHg (Panerai, 1998). 
 In the literature, two types of CA are frequently referred to. Static CA refers to the 
maintenance of CBF when faced with a constant change in CPP. Contrasted to this, dynamic 
CA looks at the process of regulating CBF when faced with constantly varying or acute 
changes in CPP values. As beat-by-beat variation is evident in most, if not all, cardiovascular 
variables, quantification of dynamic CA is often considered as being potentially the most 
physiologically relevant. 
 Many different tests have been proposed for the assessment of dynamic cerebral 
autoregulation. In 1989, Aaslid et al. (Aaslid, Lindegaard, Sorteberg, & Nornes, 1989), 
presented the thigh cuff method to assess dynamic CA. Using this method, cuffs were placed 
around the upper thigh and inflated to pressure above systolic blood pressure effectively 
occluding blood flow to the legs for two to three minutes. Upon cuff release the resultant 
reactive hyperemia to the legs serves to cause a transient decrease in ABP which is then 
recovered through baroreflex mechanisms. At the same time, the decrease in ABP produces a 
reduction in CBF which is corrected for initially through autoregulatory mechanisms. By 
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characterizing the decline and recovery of CBF, dynamic CA can be described and 
quantified. More recently, work has looked to changes in posture as an alternate method of 
assessing dynamic CA. Sorond et al. (Sorond, Serrador, Jones, Shaffer, & Lipsitz, 2009) have 
proposed the use of a sit to stand test as a method to assess CA for use with a wider 
population and as a test that more accurately represented challenges of day to day life. The 
study by this group showed similar results between the posture change method and the use of 
thigh cuffs (Sorond et al., 2009). 
 Both the thigh cuff method and posture change are based on a transient reduction in 
ABP resulting in changes in CBF that are then corrected through autoregulatory mechanisms. 
It is this relationship between ABP and CBF that has led some researchers to examine CBF 
with respect to spontaneous fluctuations in ABP (Zhang, Zukerman, Giller, & Levine, 1998; 
Edwards, Shoemaker, & Hughson, 2002; Iwasaki et al., 2007; Zhang, Zuckerman, 
Pawelczyk, & Levine, 1997). Analysing data within the frequency domain, cross-spectral 
analysis using ABP as the input and CBFV as the output variable is able to provide transfer 
function estimates of phase, gain, and coherence of the data with results traditionally broken 
down into three frequency ranges; very low frequency (VLF; 0.03-0.07Hz), low frequency 
(LF; 0.07-0.2Hz), and high frequency (HF; 0.2-0.3Hz) (Zhang et al., 1998). The coherence 
provides an indication of the linear relationship between ABP and CBFV with values greater 
than 0.5 being used as an indicator of linearity (Zhang et al., 1998). If coherence is above 0.5, 
the gain can be examined as an indicator of cerebrovascular autoregulation with higher gain 
values indicating an inability of cerebrovascular autoregulatory processes to dampen 
fluctuations in CBFV with changes in ABP. Finally, the phase provides an indication of the 
time relationship between the two variables with results consistently showing CBFV leading 
ABP (Zhang et al., 1998; Edwards et al., 2002; Zhang et al., 1997). Interestingly, the positive 
phase seen with this analysis suggests that changes in CBFV occur before changes in ABP 
which would be contradictory to the concept of CA correcting for changes in ABP. In the 
paper by Hughson et al. (Hughson, Edwards, O'Leary, & Shoemaker, 2001) the phase lead 
was examined and suggested to be a mathematical issue and a consequence of the phase lag 
of CVRi. This was similarly reported by Edwards et al. (Edwards et al., 2002) with both 
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papers showing the expected phase lag in the cross spectral analysis of the ABPCVRi 
response. As the action of CA is to change cerebrovascular resistance in response to a change 
in pressure, assessment of the ABPCVRi transfer function may provide a better indication 
of CA. 
1.6 Cerebral Blood Flow and Carbon Dioxide 
 The pressure/flow relationships described in the assessment of CA primarily address 
the mechanical component of CBF regulation. Generally, these methods of assessing CBF 
regulation have ignored the influence of fluctuation in the partial pressure of arterial carbon 
dioxide (PaCO2). Therefore, other methods of assessing cerebrovascular function have 
looked at metabolic contributions to CBF control with response to CO2. Cerebral blood 
vessels have been shown to be very sensitive to changes in the partial pressure of arterial CO2 
with increases and decreases in the partial pressure of arterial CO2 being shown to produce 
increases and decreases in CBF respectively (Bishop et al., 1986; Dahl et al., 1992; Dahl, 
Russell, Nyberghansen, Rootwelt, & Mowinckel, 1994; Muller et al., 1995; Poeppel et al., 
2007; Ulrich et al., 1995). Many studies have used this reaction to arterial CO2 as a method 
of assessing cerebrovascular reactivity often using modifications in breathing patterns or 
changes in respired gases as methods for altering end tidal CO2 which in turn reflects 
changes in arterial CO2 (Kirkham et al., 1986). Changes in CBFV have been related to the 
changes in CO2 as an indication of cerebrovascular reactivity to CO2 presenting vasomotor 
reactivity as a percent change in CBFV for a 1mmHg change in CO2 with studies showing 
values ranging from 1.45%/mmHg to 5.28%/mmHg (Valdueza et al., 1999; Poulin, Liang, & 
Robbins, 1996; Hida et al., 1996; Ide, Eliasziw, & Poulin, 2003; Pandit, Mohan, Paterson, & 
Poulin, 2007; Ainslie et al., 2007; Clivati, Ciofetti, Cavestri, & Longhini, 1992; Claassen, 
Zhang, Fu, Witkowski, & Levine, 2007). 
 Several factors contribute to the differences in cerebral reactivity values seen. In a 
paper by Clivati et al. (Clivati et al., 1992) patients with chronic obstructive lung disease 
were compared to healthy controls showing that the patient population had a significantly 
reduced CO2 reactivity which may have been related to chronic hypercapnia. In a separate 
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study, Ainslie et al. (Ainslie et al., 2007) showed differences in cerebral reactivity measured 
in the morning versus the afternoon. Ide et al. (Ide et al., 2003) looked at the relationship of 
CBFV to end tidal CO2 and demonstrated a non-linear relationship with reduced 
cerebrovascular CO2 reactivity in the hypocapnic range and increased sensitivity with 
hypercapnia. Therefore, the methodology used to assess cerebrovascular CO2 reactivity may 
influence absolute values. 
 Another potentially confounding influence in the assessment of cerebrovascular CO2 
reactivity is the possibility of changes in ABP during CO2 manipulations (Hetzel, Braune, 
Guschlbauer, & Dohms, 1999; Dumville, Panerai, Lennard, Naylor, & Evans, 1998). Recent 
work by Battisti-Charbonney et al. (Battisti-Charbonney, Fisher, & Duffin, 2011) suggested 
thresholds for changes in ABP with changes in PCO2 and that alterations in CBF within these 
threshold points were due to change in CO2 and beyond the threshold changes in CBF were 
due to alteration in ABP. This interpretation does present some concern as assessment of 
cerebrovascular autoregulation has consistently shown alterations in CBF with spontaneous 
fluctuations in ABP (Zhang et al., 1998; Iwasaki et al., 2007; Edwards et al., 2002; Hughson 
et al., 2001; Zhang et al., 1997). Regardless of the existence of a threshold value for large 
alterations in ABP with changes in PCO2, CBF regulation is dependent on minor fluctuations 
in both ABP and CO2 and neither variable can be ignored in the assessment of cerebral blood 
flow. 
 In 2003, Edwards et al. (Edwards, Topor, & Hughson, 2003) presented data in which 
autoregressive moving average (ARMA) analysis was utilized to determine independent 
contributions of CO2 and ABP on CBFV. Through the use of ARMA analysis Edwards et al. 
showed modeled responses of CBFV and CVRi to a theoretical 1mmHg impulse and 
sustained increase in ABP and CO2 (Edwards et al., 2003; Edwards, Devitt, & Hughson, 
2004). Results from the Edwards et al. (Edwards et al., 2004) study suggested an increased 
CO2CVRi step response with hypocapnia and a reduced response with hypercapnia. At 
first glance this appears to be contrary to the results presented by Ide et al. (Ide et al., 2003); 
however the results from the Ide et al. study showed differences in cerebrovascular CO2 
reactivity when looking at either an increase or decrease in CO2 whereas the Edwards et al. 
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paper only looked at an increase in CO2 assuming the change in CBFV would be the same 
for either an increase or decrease in CO2. Therefore, care must be taken when interpreting 
results as it appears that cerebrovascular CO2 reactivity is dependent not only on starting CO2 
levels, but also on the direction of CO2 change applied. 
 Recent studies have shown the potential involvement of nitric oxide (NO) and the NO 
system with cerebrovascular CO2 reactivity (Lavi, Egbarya, Lavi, & Jacob, 2003; 
Schmetterer et al., 1997; Zimmermann & Haberl, 2003). Therefore, assessment of 
cerebrovascular responses to exogenous sources of NO may help in determining if changes in 
cerebrovascular CO2 reactivity are due to alterations NO availability, or the vascular 
sensitivity to NO. 
1.7 Cerebrovascular Responses to Nitroglycerin 
 As an NO donor, nitroglycerin (NG) is commonly used in clinical settings, alleviating 
symptoms of angina by reducing the work of the heart though venodilation and vasodilation 
of coronary arteries (Abrams, 1985; Abrams, 1996). In research settings, NG has been used 
as a means to determining maximal vasodilation responses to nitric oxide (Bleeker et al., 
2005), as a method for expediting orthostatic tolerance tests (Raviele et al., 1994), and as a 
model of migraine headache (Bednarczyk et al., 2002). Several studies have looked to 
determine cerebral blood velocity responses to NG consistently showing reductions in 
velocity (Borisenko & Vlasenko, 1992; Dahl, Russell, Nyberghansen, & Rootwelt, 1989; 
Dahl, Russell, Nyberghansen, & Rootwelt, 1990; Micieli et al., 1997; Siepmann & Kirch, 
2000; White et al., 2000). However, studies using PET and SPECT methods of determining 
cerebral blood flow have consistently shown no changes with NG stimulation suggesting that 
the observed reduction in CBFV is the results of MCA vasodilation with constant blood flow 
(Dahl et al., 1989; Borisenko & Vlasenko, 1992; White et al., 2000; Dahl et al., 1990). In 
2007, Hansen et al. used MRI to measure the diameter of the MCA confirming that it does 




 The observation of constant cerebral blood flow with dilation of the MCA has lead at 
least one group to suggest the use or sublingual NG as a method for determining 
cerebrovascular reactivity to NO (Borisenko & Vlasenko, 1992). Assuming that cerebral 
blood flow remains constant with the administration of NG and that NG works through an 
NO mechanism, measurement of CBFV in the MCA allows for the calculation of diameter 
change of the MCA. It is possible that impairments in cerebrovascular responsiveness to NO 
would be evident as reduced dilation responses to NG. Work has suggested the involvement 
of NO and the NO system in the regulation of cerebral blood flow (Lavi et al., 2003; 
Schmetterer et al., 1997; Zimmermann & Haberl, 2003). Therefore, the use of NG as an 
exogenous source of NO might provide a useful tool for determining cerebrovascular 
changes in cerebrovascular function.  
 Blood flow is the product of blood velocity and vessel cross-sectional area. As such 
blood flow through the MCA can be calculated as: 
(F)          




         
Rearranging the equation the MCA diameter then becomes equal to: 
(G)              
   
     
   
The percent change in diameter can be calculated as: 
(H)    
     
  
      
When equation (F) is used to substitute values for d1 and d2, the percent change in MCA 
diameter is then calculated as: 
(I)      
    
     
 
     
    
        
In the case of NG stimulation where CBF is believed to remain constant, it follows that the 
following equation can then be used in the calculation of percent diameter change: 
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(J)      
     
     
        
Using this equation to calculate MCA diameter change, Dahl et al. (Dahl et al., 1989) showed 
a 15% increase in diameter administration of 1mg of NG where Borisenko and Vlasenko 
(Borisenko & Vlasenko, 1992) showed a 7.2% increase with administration of 0.25mg NG. 
To date limited work has been conducted to determine the usefulness of NG as a method for 
assessing cerebrovascular NO reactivity. 
1.8 Cerebrovascular Responses to Spaceflight 
 Over the past century, the human drive for exploration has resulted in spaceflight. 
Since the first flight of Yuri Gagarin, time spent in space by astronauts has steadily increased 
and has emphasized the need to study the physiological effects of microgravity exposure. On 
Earth, the force of gravity produces a gravitational vector which draws blood and fluid 
towards the feet when in an upright posture. This generates a pressure gradient throughout 
the body such that a mean pressure of 100mmHg at heart level would translate to a pressure 
of approximately 200mmHg at the feet and 70mHg at the level of the brain (Hargens & 
Watenpaugh, 1996). In space, the gravity induced pressure gradient is eliminated and 
pressure is equalized effectively reducing pressure in the lower limbs and increasing pressure 
at the level of the brain (Hargens & Watenpaugh, 1996). In addition, exposure to 
microgravity results in cephalic fluid shifts (Frey, Mader, Bagian, Charles, & Meehan, 1993) 
which could contribute to an increase in ICP. Recently, NASA released the Human Research 
Roadmap in which idiopathic intracranial hypertension and its resulting effects were 
identified as major health risk factors associated with long duration spaceflight (Fogarty, 
2011). Two recent studies have noted structural changes in the eye and optic nerve after long 
duration spaceflight which could result from a sustained increase in intracranial pressure 
(Kramer, Sargsyan, Hasan, Polk, & Hamilton, 2012; Mader et al., 2011). However, little 
information is known as to how idiopathic intracranial hypertension with microgravity 
exposure affects cerebrovascular structure or function.  
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 Several studies have looked at orthostatic tolerance noting a high incidence of 
intolerance post-flight. Buckey et al. (Buckey et al., 1996) studied 14 astronauts before and 
after short duration spaceflight. They noted that before flight, all astronauts were able to 
complete a 10 minute stand test; however, after flight 9 of the 14 could no longer complete 
the test. In a separate study, Waters et al. (Waters, Ziegler, & Meck, 2002) also showed 
orthostatic intolerance post-flight with 11 of 35 unable to complete a 10 minute stand test 
post flight. It was also noted that orthostatic intolerance was more prevalent in female 
astronauts (100%) and mission specialists (7 of 16). This high incidence of orthostatic 
intolerance has led some researchers to study cerebrovascular responses to spaceflight. 
Development of pre-syncope or syncope in response to orthostasis is in essence the result of 
reduced cerebral blood flow (Hainsworth, 2004); therefore, the high incidence of orthostatic 
intolerance could be the result of altered cerebral hemodynamics with spaceflight. 
 Surprisingly, very limited work has been published looking at the effects of 
spaceflight on cerebral blood flow. In 1991, Bagian and Hackett (Bagian & Hackett, 1991) 
published their work using TCD to assess cerebral blood velocity during shuttle flights. This 
paper presented individual results from astronauts early in flight and showed no change in 
CBFV. Cerebral blood velocity data recorded during the Neurolab mission (STS-70) were 
presented in 2007 by Iwasaki et al. (Iwasaki et al., 2007) also showing no in-flight changes in 
CBFV. This can be contrasted to work presented by Arbeille et al. (Arbeille et al., 2001) who 
showed an initial increase in CBFV and values returning to pre-flight levels after 1 week and 
3 months in space. This initial increase in CBFV was also accompanied by an increase in 
CCA blood flow which suggests that CBF is increased at the start of flight, but returns back 
to pre-flight levels after one week in space.  
 Upon return to Earth’s gravitational environment, Iwasaki et al. (Iwasaki et al., 2007) 
again showed no change in supine resting CBFV measures. Although it appears that CBF is 
well maintained during and after spaceflight, it is possible that the cerebrovasculature has 
adapted to microgravity in such a way to potentially affect the regulation of CBF when faced 
with conditions such as orthostatic stress. Iwasaki et al. attempted to address this issue and 
interestingly found that reductions in CBFV in response to head up tilt were smaller after 
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spaceflight (Iwasaki et al., 2007). Additionally, spectral analysis results from this study 
showed changes that were consistent with improvements in dynamic cerebral autoregulation 
(Iwasaki et al., 2007). This provides an interesting result when considering the marked 
increase in orthostatic intolerance that has been demonstrated post spaceflight (Buckey et al., 
1996). However, when considering the astronauts used in the study by Iwasaki et al. (Iwasaki 
et al., 2007), it should be noted that none of these astronauts developed orthostatic 
intolerance post flight; therefore it is unclear if the results from this study accurately reflect 
potential adaptations of astronauts who do develop orthostatic intolerance post spaceflight.  
 In a more recently published study of the effects of spaceflight on cerebrovascular 
autoregulation, Blaber et al. (Blaber, Goswami, Bondar, & Kassam, 2011) looked at 
cerebrovascular responses of 27 astronauts after short duration spaceflight. In this study, 
astronauts were separated into those who could complete a 10 minute stand test post flight 
and those who could not. The results suggested impairments in cerebrovascular 
autoregulation on landing day for only those astronauts who could not complete the 10 
minutes of stand showing orthostatic intolerance. These results suggest that after short 
duration spaceflight, impairments in cerebrovascular autoregulation may contribute to 
reduced orthostatic tolerance.  
 One difficulty with any spaceflight research relates to the small number of people 
who have actually flown in space. As such, ground based analogue systems are often 
employed to further understanding of the physiological effects of microgravity exposure. 
Parabolic flight has been used as a method to examine responses during brief periods of 
weightlessness. A study by Bondar et al. (Bondar et al., 1990) showed an increase in CBFV 
with this exposure to microgravity in parabolic flight. However, the parabolic flight model 
presents several limitations. First, this study addressed changes in CBFV with exposures to 
microgravity only lasting up to 40s. Also, the microgravity sections of the flight pattern occur 
after exposure to a +2 Gz hypergravity session which may present confounding influences. 




 Elimination of the head to foot gravitational vector with exposure to microgravity is 
associated with fluid shifts towards the head (Hargens & Watenpaugh, 1996). These fluid 
shifts can be mimicked in humans through the use of head down tilt bed rest (HDBR) (Frey 
et al., 1993). Cerebral blood velocity responses to HDBR have been mixed with studies 
showing increases (Kawai et al., 1993), decreases (Arbeille et al., 2001; Hirayanagi et al., 
2005; Sun et al., 2005; Frey et al., 1993), and no changes in resting supine CBFV (Arbeille et 
al., 2001; Pavy-Le Traon et al., 2002; Zhang et al., 1997). One of the reasons for the 
differences in results could be related to the duration of the bed rest. In a short HDBR study, 
Kawai et al. (Kawai et al., 1993) demonstrated an increase in CBFV within the first nine 
hours of HDBR. Frey et al. (Frey et al., 1993) looked at two days of HDBR and showed 
reductions in CBFV. Similarly, Arbeille et al. showed reductions in CBFV and increased 
cerebral RI with four to five days of bed rest (Arbeille et al., 1998; Arbeille et al., 2001). 
However, Arbeille et al. also demonstrated that resting CBFV did not differ from baseline 
after longer periods of bed rest which has been confirmed in other studies (Arbeille et al., 
2001; Zhang et al., 1997; Pavy-Le Traon et al., 2002). 
 Cerebral blood velocity responses to stresses have also been mixed post HDBR. After 
24 hours of bed rest, Kawai et al. (Kawai et al., 1993) showed a significant reduction in 
CBFV when participants were returned to an upright posture. Similarly, Zhang et al. (Zhang 
et al., 1997) showed a greater reduction in CBFV with LBNP after 18 days of HDBR. 
However, these results are contrasted to those of Pavy-Le Traon et al. (Pavy-Le Traon et al., 
2002) who showed no changes in CBFV responses to thigh cuff deflation after seven days of 
HDBR and the results of Arbeille et al. (Arbeille et al., 1998) who showed no changes in 
CBFV responses to head up tilt after 4 days of HDBR. The variability in published CBFV 
responses to HDBR greatly reduces the ability to draw conclusions as to how the 
cerebrovasculature adapts to microgravity exposure. 
 In an attempt to gain further insight into cerebrovascular adaptations to microgravity, 
animal models are also employed. Hind-limb unloading models (HLU) have been developed 
in which rats are suspended by their tails placing them in a head down tilt position. Fluid 
shifts are then theoretically similar to those experienced in spaceflight and response of 
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cerebral vessels can be examined. Studies of cerebral arteries in rats have shown increased 
basal tone (Geary, Krause, Purdy, & Duckles, 1998; Wilkerson et al., 2005) and increased 
vasoconstriction response after HLU (Zhang, Zhang, & Ma, 2001). This is associated with a 
decrease in lumen diameter and increased wall thickness indicating vascular hypertrophy 
(Prisby et al., 2006; Wilkerson, Muller-Delp, Colleran, & Delp, 1999). Wilkerson et al. 
(Wilkerson, Colleran, & Delp, 2002) also showed that observed changes in cerebral vessel 
morphology were associated with regionally specific reductions in cerebral blood flow. In 
1998, Geary et al. (Geary et al., 1998) demonstrated that resting vessel diameter differences 
with HLU were abolished with L-NAME indicating the contribution of NO in the 
maintenance of vessel diameter. Therefore, it would appear that either a reduction in the 
bioavailability of NO or a reduction in the vascular smooth muscle responsiveness to NO 
contributed to the smaller cerebral vessel diameter after HLU.  
 Animal data suggests that cerebral blood vessel morphology changes with exposure 
to simulated microgravity. However, variability in the results of published human spaceflight 
and HDBR data still makes it unclear what the exact cerebrovascular responses are to 
spaceflight and how these compare and contrast to those of bed rest. 
1.9 General Purpose of Thesis 
 The general purpose of this thesis was to determine cerebrovascular responses to real 
and simulated microgravity exposure and to determine what further information can be 
gained about cerebrovascular hemodynamics from the examination of the cerebral blood 
velocity Doppler wave profile. Cerebrovascular properties were determined after long 
duration spaceflight, after five days of HDBR with and without an artificial gravity 
countermeasure, during head up tilt and the progression towards presyncope, and under 
conditions that might induce changes in cerebrovascular properties including a change in 
PETCO2 and administration of sublingual NG. 
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1.9.1 General Chapter Hypotheses 
 The first research chapter (Chapter 2) examines the cerebrovascular responses to long 
duration spaceflight. Based on animal data and results from HDBR studies, it was 
hypothesized that long duration spaceflight would result in alteration of cerebrovascular 
structure and function such that there would be greater reduction in CBFV with the 
application of a simulated orthostatic stress using lower body negative pressure and a 
blunting of cerebrovascular CO2 reactivity due to changes in the nitric oxide system as 
previously observed in animal studies (Prisby et al., 2006; Lin et al., 2009; Wilkerson et al., 
2005). However, as only CBFV was measured, no changes in supine resting values of CBFV 
were expected as a combination of a reduced vessel luminal diameter (Wilkerson et al., 1999; 
Geary et al., 1998) and reduced cerebral blood flow (Wilkerson et al., 2002) were expected to 
allow for the maintenance of CBFV. 
 The second chapter (Chapter 3) is an extension of the analysis from the study 
presented in Chapter 2. This section focuses on potential changes in cerebrovascular tone 
with exposure to long duration spaceflight. Animal studies have suggested an increase in 
myogenic tone of cerebral vessels after exposure to simulated microgravity (Wilkerson et al., 
2005; Geary et al., 1998; Lin et al., 2009). Therefore, it was hypothesized that after long 
duration spaceflight there would be an increase in cerebrovascular tone and that this increase 
would be reflected in alterations of the MCA Doppler spectrum morphology. 
 Due to logistical restraints associated with human spaceflight research, head down 
bed rest (HDBR) is often used as an Earth-based analogue of microgravity exposure. 
Therefore, the following three chapters present data from 12 men who completed five days of 
HDBR with and without an artificial gravity countermeasure. Cerebrovascular responses to 
head up tilt and the progression towards syncope are presented in Chapter 4 and Chapter 5. In 
these chapters, it was hypothesized that after HDBR there would be alterations in the 
regulation of cerebral blood flow such that greater reductions in CBFV would be seen with 
tilt. Similar to the results of Blaber et al. (Blaber et al., 2011) individuals who develop 
orthostatic intolerance, as defined as the inability to complete 10 minutes of tilt post HDBR, 
were hypothesized to show impairments in cerebrovascular autoregulation. This work also 
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looked at the MCA velocity waveform profile with approaching syncope. Previous studies 
have shown a reduction in the dicrotic notch point of the velocity wave in patients with 
neurocardiogenic syncope (Albina et al., 2004) and an increase in CrCP with approaching 
syncope (Carey et al., 2001). Therefore, it was hypothesized that similar variation would be 
seen with the MCA velocity wave which will be reflective of alterations in cerebrovascular 
tone and related to indices of dynamic cerebrovascular autoregulation.  
 Assessment of the MCA velocity wave profile continues in Chapter 6 with 
cerebrovascular responses to sublingual nitroglycerin. Using simultaneous assessments of 
CCA pressure and flow, RCKL modeling was used to determine downstream vascular 
resistance, compliance, viscoelastic resistance, and inertance. RCKL model results were 
hypothesized to be related to MCA velocity waveform characteristics both before and after 
NG thereby allow for the physiological interpretation of changes in the MCA velocity 
waveform. In response to NG, it was hypothesized that the RCKL model would show an 
increase in cerebrovascular compliance as suggested by the response of peripheral vessels 
(Smulyan, Mookherjee, & Warner, 1986; Bank & Kaiser, 1998) and the calculation of CrCP 
(Moppett, Sherman, Wild, Latter, & Mahajan, 2008). With respect to the HDBR, it was 
hypothesized that at rest the RCKL model would show increased resistance and decreased 
vascular compliance. However, it was hypothesized that the response to NG would be 
consistent after HDBR as was previously shown with women after 56 days of HDBR (Zuj et 
al., 2012b).  
 The final two chapters focus on the relationships between MCA blood velocity and 
CCA blood flow with alterations in PETCO2 and NG stimulation. In Chapter 7, CCA flow 
was used as a quantitative measure of cerebral blood flow to assess potential changes in 
MCA diameter with sublingual NG and acute changes in PETCO2. It was hypothesized that 
with NG there would be a reduction in CBFV but no change in CCA flow indicating dilation 
of the MCA. With alterations in PETCO2, it was hypothesized that the relationship between 
CCA flow and CBFV would be non-linear indicating diameter changes of the MCA.  
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 In the final research chapter (Chapter 8) comparisons were made between the CCA 
and MCA blood velocity waves with changes in PETCO2. In this section, it was hypothesized 
that the MCA velocity wave profile would show alterations in key inflection points 
suggesting change in cerebrovascular tone. It was also hypothesized that the changes in the 
MCA velocity wave would be reflected in the CCA velocity wave suggesting that CCA 
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 Long duration habitation on the International Space Station (ISS) is associated with 
chronic elevations in arterial blood pressure in the brain compared to normal upright posture 
on Earth, and elevated inspired CO2. Although results from short duration spaceflights 
suggested possibly improved cerebrovascular autoregulation, animal models provided 
evidence of structural and functional changes in cerebral vessels that might negatively impact 
autoregulation with longer periods in microgravity. Seven astronauts (1 woman) spent 
147±49 days on ISS. Pre-flight testing (30-60 days before launch) was compared to post-
flight testing on landing day (n=4) or the morning 1 (n=2) or 2 days (n=1) after return to 
Earth. Arterial blood pressure at the level of the middle cerebral artery (BPMCA) and expired 
CO2 were monitored along with transcranial Doppler ultrasound assessment of middle 
cerebral artery blood flow velocity (CBFV). Cerebrovascular resistance index was calculated 
as CVRi=BPMCA/CBFV. Cerebrovascular autoregulation and CO2 reactivity were assessed 
from an autoregressive moving average (ARMA) model of data obtained during a test where, 
in a supine position, two breaths of 10% CO2 were given 4 times during a 5min period. 
CBFV and Doppler pulsatility index were reduced during -20 mmHg lower body negative 
pressure, with no differences pre- to post-flight. The post-flight indicator of dynamic 
autoregulation from the ARMA model revealed reduced gain for the CVRi response to 
BPMCA (P=0.047). The post-flight responses to CO2 were reduced for CBFV (P=0.056) and 
CVRi (P=0.017). These results indicate that long duration missions on the ISS impaired 





 The microgravity environment, which causes cephalic fluid shifts with increased 
arterial pressure at the level of the brain relative to normal daily life on Earth (Hargens & 
Watenpaugh, 1996), might cause alterations in cerebrovascular structure and function. The 
impact of microgravity on human cerebrovascular function has primarily been examined 
during and after short duration spaceflights (Bagian & Hackett, 1991; Iwasaki et al., 2007; 
Blaber et al., 2011; Arbeille et al., 2001) with only a few measurements of cerebral blood 
flow velocity (CBFV) during or after long duration flights (Arbeille et al., 2001; Tobal, 
Roumy, Herault, Fomina, & Arbeille, 2001). During spaceflight, only modest changes in 
CBFV have been reported (Arbeille et al., 2001; Bagian & Hackett, 1991) with small 
increases in cerebrovascular resistance after months in space that were speculated to reflect 
increased sympathetic vasoconstriction (Arbeille et al., 2001). Post-flight CBFV in the supine 
posture was unchanged or slightly elevated from pre-flight (Blaber et al., 2011; Iwasaki et al., 
2007). Post-flight measurements of dynamic cerebrovascular autoregulatory indices, 
reflecting vascular smooth muscle responses to changes in arterial blood pressure, were 
slightly enhanced in one group of astronauts (Iwasaki et al., 2007) but were reduced in 
astronauts with reduced post-flight orthostatic tolerance (Blaber et al., 2011). 
 Results from Earth-based analogs of spaceflight using head down bed rest (HDBR) 
have revealed increases (Kawai et al., 1993), decreases (Arbeille et al., 1998; Arbeille et al., 
2001; Sun et al., 2005; Frey et al., 1993; Hirayanagi et al., 2005), or no changes (Arbeille, 
Kerbeci, Mattar, Shoemaker, & Hughson, 2008; Pavy-Le Traon et al., 2002; Zhang et al., 
1997; Arbeille et al., 2001) in supine CBFV. After HDBR, some studies have shown a 
greater reduction in CBFV with lower body negative pressure (LBNP) (Zhang et al., 1997) or 
assuming an upright posture (Kawai et al., 1993) suggesting an impairment in the ability to 
regulate cerebral blood flow when faced with an orthostatic stress. However, other research 
has found no difference in cerebrovascular responses to tilt or LBNP (Arbeille et al., 1998; 
Arbeille et al., 2008) or with rapid deflation of leg cuffs (Pavy-Le Traon et al., 2002).  
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 Animal models of spaceflight using hind limb suspension have provided convincing 
evidence of cerebrovascular structural and functional changes. Cerebral arteries from 
suspended rats have demonstrated vascular smooth muscle hypertrophy (Wilkerson et al., 
1999; Lin et al., 2009; Zhang et al., 2001; Wilkerson et al., 2002) with a smaller luminal 
cross-sectional area (Wilkerson et al., 1999) and increased basal myogenic tone (Wilkerson 
et al., 2005; Geary et al., 1998; Lin et al., 2009). Further work has also shown that these 
changes are associated with reduced cerebral blood flow (Wilkerson et al., 2002; Wilkerson 
et al., 2005) and greater vasoconstrictor responses possibly acting through nitric oxide-
dependent (Prisby et al., 2006; Lin et al., 2009; Wilkerson et al., 2005) or renin-angiotensin 
system-dependent mechanisms (Bao, Zhang, & Ma, 2007). 
 To date, there have been no investigations of the cerebrovascular response to carbon 
dioxide (CO2) after spaceflight. Cerebrovascular CO2 reactivity reflects endothelial function 
through activation of the nitric oxide system (Lavi et al., 2003; Schmetterer et al., 1997; Lavi, 
Gaitini, Milloul, & Jacob, 2006) that was impaired in animals by hind limb suspension (Lin 
et al., 2009; Prisby et al., 2006; Wilkerson et al., 2005). In addition, cerebrovascular CO2 
reactivity might also be altered as a consequence of elevated partial pressure of CO2 in the 
ambient air on the International Space Station (ISS) that could chronically influence arterial 
CO2 (PaCO2) and cerebral acid-base balance. 
 We hypothesized in the current study that resting CBFV would be unchanged 
following long duration spaceflight but there would be greater decreases with LBNP. Further, 
we hypothesized that post-flight cerebrovascular autoregulation would be impaired and CO2 
reactivity would be blunted as a consequence of chronic effects of the ISS environment. 
2.3 Methods 
 Cerebral hemodynamic data from long duration spaceflight were collected as a part of 
the Cardiovascular and Cerebrovascular Control on Return from the International Space 
Station (CCISS) project. Methods and procedures were reviewed and approved by the Office 
of Research Ethics at the University of Waterloo and the Committee for the Protection of 
 
 39 
Human Subjects at Johnson Space Center. Each volunteer signed an approved consent form 
after receiving full verbal and written details of the experiment. The experiment conformed 
to the guidelines in the Declaration of Helsinki. 
 Seven astronauts (1 woman) with an average age of 48±4 years participated. Pre-
flight data were collected 36±22 days prior to launch. Post-flight data were collected from 
astronauts returning via the space shuttle within 3-4 hours of landing (R+0, n=4) and, for 
astronauts returning via the Russian Soyuz spacecraft, the morning after landing (R+1, n=2) 
or two mornings after landing (R+2, n=1) for an astronaut whose return was delayed by 
weather. For R+0 testing, the astronauts landed on the shuttle in a supine posture and 
remained in that posture for transportation to the research facility and until the experiment 
was completed. Experiments on days R+1 and R+2 were conducted first thing in the 
morning. The astronauts did not assume upright posture on test day before being transported 
to the laboratory in a supine posture in an attempt to minimize the effects of re-adaptation to 
Earth’s gravitational environment. The astronauts spent an average of 147±49 days in space 
ranging from 58 days to 199 days with all but one spending greater than 100 days on orbit.  
2.3.1 Experimental Protocol and Instrumentation 
 Pre-flight testing for the shuttle-launched astronauts and one Soyuz-launched 
astronaut took place at Johnson Space Center (JSC, Houston, TX). Three of the four shuttle 
astronauts completed post-flight testing at Kennedy Space Center (KSC, Cape Canaveral, 
FL) with the other at Dryden Flight Research Center (Dryden, Edwards, CA). Pre-flight 
testing for two Soyuz launched astronauts and all post-flight testing was completed at the 
Gagarin Cosmonaut Training Center (GCTC, Star City, Russia). Due to logistics of each 
location, slightly different equipment was used at each of the experimental sites. 
 Throughout the testing periods, astronauts were equipped with a standard three lead 
electrocardiogram (Finometer ECG Module (JSC, KSC, Dryden), Finapres Medical, 
Amsterdam, the Netherlands; Hewlett-Packard (GCTC)) for the assessment of heart rate 
(HR). Arterial blood pressure (ABP) was continuously determined using finger 
photoplethysmography (Finometer (KSC, JSC, and Dryden), Portapres (JSC n=1), and 
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Finapres (GCTC), Finapres Medical, Amsterdam, the Netherlands) and height-corrected to 
heart level. The participants were also equipped with a nasal cannula for monitoring of 
expired CO2 (Ohmeda 5200 CO2 Monitor (JSC, KSC, and GCTC); ADInstruments CO2 
analyzer (Dryden)). End-tidal CO2 values were converted to mmHg based on atmospheric 
temperature and pressure (PETCO2). Transcranial Doppler ultrasound (Multigon Industries, 
New York, NY (JSC); EZDop, DWL, Compumedics, Germany (KSC); MultiFlow, DWL 
GmbH, Sipplingen, Germany (Dryden); CardioLab, European Space Agency (GCTC)), was 
used for the assessment of CBFV in the middle cerebral artery (MCA). In all locations TCD 
measures were conducted using a 2MHz pulsed Doppler probe that was placed over the right 
temporal window to allow for the insonation of the M1 segment of the MCA and the 
assumption of a 0° angle of insonation. Throughout the testing, the probe was held in place 
using a headband. 
 Testing that occurred at JSC, KSC, and Dryden utilized Chart software 
(ADInstruments Ltd.) for the continuous recording of ECG, ABP, CO2, and TCD signals. 
Data recorded at GCTC also utilized Chart software for the recording of ECG, ABP, and 
CO2. TCD data at GCTC were recorded on a separate system using CardioMed software 
(European Space Agency). Chart data were digitized at 1000Hz and CardioMed data at 
100Hz. Beat-by-beat data from the CardioMed system were aligned with Chart data by 
introducing a common marker signal, and by pattern matching the between beat intervals 
from R-waves and TCD waves. 
2.3.2 CO2 and LBNP tests 
 Cerebral blood flow was assessed under two different conditions: lower body 
negative pressure (LBNP), and a CO2 challenge using the “two-breath” test of Edwards et al. 
(Edwards et al., 2003). All testing took place with astronauts resting in a supine position. 
Two low levels of LBNP, -10 and -20 mmHg, were applied for approximately 2 min at each 
level while the astronauts were sealed at the waist into an airtight box. Vacuum was applied 




 The “two-breath” method (Edwards et al., 2003) was used to assess both 
cerebrovascular autoregulation and cerebrovascular CO2 reactivity. During this test, the nasal 
cannula was removed and a mask was held in place over the nose and mouth. A valve was 
turned to control whether the astronaut inspired room air or a gas mixture consisting of 10% 
CO2, 21% O2, balance N2. Two breaths of the CO2 gas mixture were inspired every minute 
for a five minute period. 
2.3.3 Data Analysis 
 The outer envelope of the TCD Doppler spectrum was averaged over each cardiac 
cycle to determine mean CBFV. Similarly, arterial blood pressure tracings were averaged 
over a cardiac cycle to provide an indication of beat-by-beat blood pressure at the level of the 
MCA (BPMCA). Mean CBFV and BPMCA were then used to calculate an index of 
cerebrovascular resistance (CVRi) as CVRi = BPMCA / CBFV. As an additional assessment of 
cerebrovascular resistance the Gosling Pulsatility index was calculated as PI = (CBFVsys-
CBFVdia)/CBFVmean (Beasley, Blau, & Gosling, 1979). 
 During the LBNP section of the protocol, 30s averages of cerebrovascular variables 
were taken starting 40s before the end of each stage for the steady state assessment at rest, -
10mmHg, and -20mmHg. The two-breath protocol was analyzed using autoregressive 
moving average (ARMA) analysis on the beat-by-beat data set as previously described 
(Edwards et al., 2003). PCO2 was determined for each heart beat by taking the point on the 
linear interpolation for end-tidal PCO2 corresponding to each R-wave on the 
electrocardiogram. Based on the best fit ARMA model parameters, step gains were 
calculated as the values of CBFV and CVRi 45s after the introduction of nominal inputs of 1 
mmHg change in BPMCA and 1 mmHg change in PCO2 as previously described by Edwards 
et al. (Edwards et al., 2003). 
2.3.4 Technical Issues 
 Technical problems reduced the sample size for certain comparisons. A CO2 analyzer 
did not function during one post-flight test so the CO2 responses of this astronaut could not 
be included in the ARMA analysis. In one astronaut the mean value of the TCD signal 
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differed by more than physiologically acceptable limits for pre- to post-flight comparisons 
suggesting possible differences in equipment or vessel investigation. Even so, the variability 
of the signals appeared to be appropriate so this astronaut’s data were included when the 
mean values were eliminated (e.g. ARMA analysis of CBFV) but were excluded when the 
absolute values were important (e.g. calculation of CVRi and its subsequent analysis by 
ARMA). The data set of one astronaut with a very low cardiac frequency would not solve 
with the ARMA algorithm. This data set was linearly interpolated to double the mean 
sampling frequency before analysis. Testing this approach on other data sets indicated no 
impact on model solution. 
2.3.5 Statistical Analysis 
 A two-way repeated measures analysis of variance was used to test pre- to post-flight 
effects of LBNP (SigmaStat 3.5, Systat Software Inc., Chicago, IL). The magnitudes of the 
impulse and step responses from the ARMA analysis were compared using a one-way 
repeated measures analysis of variance for pre- to post-flight effects. Statistical significance 
was set at p<0.05. 
2.4 Results 
 There were no differences in resting CBFV, CVRi, or PI from pre- to post-spaceflight 
during the LBNP phase of the study (Figure 2.1). In response to LBNP, CBFV (Figure 2.1, 
panel A) and PI (Figure 2.1, panel C) were reduced at -20mmHg with no changes in CVRi 
(Figure 2.1, panel B). BPMCA was not different (P=0.142) from pre- to post-flight at rest 
(92.9±15.0 and 99.9±8.4 mmHg) or at -20 mmHg of LBNP (92.2±13.4 and 97.4±8.8 
mmHg). Also, there were no differences in PETCO2 (P=0.737) at rest from pre-flight 
(42.3±2.5 mmHg) to post-flight (42.7±1.2 mmHg), or at -20 mmHg LBNP from pre-flight 


















































Figure 2.1: LBNP responses 
The mean values (± SD, n=7) for CBFV (A), CVRi (B) and PI (C) in response to LBNP are shown for 
pre-flight (black) and post-flight (open). P values for the main effect of LBNP are shown on each 
panel. No statistical differences were seen with respect to spaceflight. 
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 The BPMCA and cerebrovascular responses to the two-breath test with intermittent 
increases of inspired CO2 are displayed for a typical subject in Figure 2.2. The transient 
elevation in PCO2 reduced CVRi and resulted in increases in CBFV while BPMCA maintained 
spontaneous variations without obvious effect of PCO2. 
 Group mean responses from the ARMA analyses are displayed as the time course of 
change to a unit input in BPMCA and PCO2 in Figure 2.3 and individual step responses in 
Figure 2.4. When BPMCA was considered as the input signal the averaged gain value for 
BPMCACBFV was not different pre- to post-flight (-0.225±0.453 vs. 0.069±0.119 
cm/s/mmHg BPMCA, P=0.13, Figure 2.3 A and Figure 2.4 A), but the BPMCACVRi gain 
was reduced 17% after spaceflight (0.035±0.007 vs. 0.029±0.005 units/mmHg BPMCA, 
P=0.047, Figure 2.3 C and Figure 2.4 C). The indicators of CO2 reactivity from the responses 
of CBFV and CVRi revealed a strong trend for reduced CBFV response from pre- to post-
flight (2.113±1.228 vs. 1.300±0.595 cm/s/mmHg PCO2, P=0.056, Figure 2.3 B and Figure 
2.4 B) and a reduction in the CVRi response (-0.038±0.018 vs. -0.027±0.012 units/mmHg 












































































Figure 2.2: Representative "two-breath" test data set 
Data set of one subject from the “two-breath” protocol. Tracing shows that, as expected, two breaths 
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BPMCA + PCO2 --> CVRiBPMCA + PCO2 --> CVRi






Figure 2.3:Group ARMA step responses 
The group mean ARMA analysis step responses are shown as a function of time for pre- (solid line) 
and post-spaceflight (dashed line). The ARMA model incorporates two inputs (BPMCA and PCO2) 
acting on a single output (CBFV or CVRi). The extracted solutions are shown for BPMCACBFV (A, 
n=6), PCO2CBFV (B, n=6), BPMCACVRi (C, n=5), and PCO2CVRi (D, n=5). * P<0.05 
between the 45s plateau value pre- to post-flight, see Figure 2.4 for exact P-values. 
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Figure 2.4: Individual ARMA step responses 
Each astronaut’s pre- and post-spaceflight gain values computed at 45s from the step responses of 
the ARMA analysis are shown for BPMCACBFV (A, n=6), PCO2CBFV (B, n=6), BPMCACVRi 
(C, n=5), and PCO2CVRi (D, n=5). Solid lines and symbols connect pre- to post-spaceflight values 
for shuttle landed astronauts, open symbols and dashed lines show the Soyuz landed astronauts. P-




 The major findings of this study showed that long duration spaceflight was associated 
with reductions in the indices of cerebrovascular dynamic autoregulation and CO2 reactivity 
with no differences seen in resting CBFV or responses to low levels of LBNP. These 
findings, following long duration spaceflight on the ISS, were consistent with hypotheses that 
suggested cerebrovascular consequences from chronic elevation in cerebral blood pressure 
and chronic exposure to elevated atmospheric PCO2. Our results contrast with improved 
dynamic autoregulation after the short duration Neurolab spaceflight mission (Iwasaki et al., 
2007) but are similar to findings in astronauts who presented with orthostatic intolerance 
after spaceflight (Blaber et al., 2011).  
2.5.1 Cerebrovascular Indicators at Rest and During LBNP 
 We anticipated greater reduction in CBFV during LBNP after long duration 
spaceflight indicative of impaired cerebral blood flow regulation, but both at rest and during 
LBNP the CBFV, PI, and CVRi were unchanged from pre-flight. Resting CBFV is expected 
to reflect the metabolic demands of the brain (Aaslid et al., 1989; Panerai, Dineen, Brodie, & 
Robinson, 2010) as well as the constant influence of PaCO2 (Panerai et al., 2010; Mitsis, 
Poulin, Robbins, & Marmarelis, 2004). Our finding of no change in supine CBFV after 
spaceflight was consistent with other observations after short (Blaber et al., 2011; Iwasaki et 
al., 2007) and long duration flights (Tobal et al., 2001). The unchanged estimate of PaCO2 
taken from the end-tidal PCO2 made it unlikely that alterations in CO2 had an effect on 
resting cerebral blood flow. 
 The potential effects of long duration spaceflight on cerebrovascular structure and 
function have been inferred from HDBR studies with humans (Arbeille et al., 1998; Arbeille 
et al., 2008; Arbeille et al., 2001; Frey et al., 1993; Hirayanagi et al., 2005; Kawai et al., 
1993; Pavy-Le Traon et al., 2002; Sun et al., 2005; Zhang et al., 1997) and from animal 
models of hind limb suspension (Geary et al., 1998; Lin et al., 2009; Wilkerson et al., 1999; 
Wilkerson et al., 2002; Wilkerson et al., 2005; Zhang et al., 2001). The human HDBR studies 
reported variable results with increases, decreases and no change in CBFV. Animal models 
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have revealed reduced flow (Wilkerson et al., 2002; Wilkerson et al., 2005) accompanied by 
significant structural changes with increased thickness of vessel walls (Lin et al., 2009; 
Wilkerson et al., 1999; Wilkerson et al., 2002; Zhang et al., 2001) and reduced internal 
dimensions (Wilkerson et al., 1999). The animal models also suggested an involvement of 
renin-angiotensin system in structural modifications with hind limb suspension (Bao et al., 
2007; Gao et al., 2009). An up-regulation after 4-weeks, but not after 7-days, of proteins 
involved in the synthesis of angiotensinogen and of angiotensin-II type-1 receptors was 
observed in cerebral and carotid arteries, and these changes were associated with increased 
arterial wall thickness (Bao et al., 2007; Gao et al., 2009). Based on these results from animal 
models, it is possible that human cerebral arteries might also undergo structural change with 
prolonged exposure to microgravity. At the moment, it is not possible to rule out the 
possibility that, while CBFV was unchanged, cerebral blood flow might have been reduced 
as a function of a smaller middle cerebral artery. This can only be tested in future studies by 
quantitative measurements of cerebral blood flow or measures of middle cerebral artery 
dimensions. 
 In the current study, CBFV was reduced during -20 mmHg of LBNP but there was no 
difference in this response from pre- to post-flight. These results contrast with observations 
after the short duration Neurolab mission (Iwasaki et al., 2007) where there was a smaller 
reduction in CBFV during LBNP as well as during upright tilt compared to pre-flight. Our 
LBNP results after long duration spaceflight were consistent with observations from 
cosmonauts after 6-months in space; however, at greater levels of LBNP, cosmonauts 
showed a trend towards greater reductions in CBFV after flight (Tobal et al., 2001). In the 
current study, it is therefore possible that -20 mmHg LBNP was not sufficient to challenge 
cerebral blood flow regulation, as these same astronauts only showed small changes in post-
flight baroreflex function in the seated posture (Hughson et al., 2011); therefore, it is still 
possible that changes in CBFV might have occurred with greater levels of LBNP or in 
assuming an upright posture. Reduced PI during LBNP reflected a relative reduction in 
cerebrovascular resistance (Beasley et al., 1979), but there were no apparent pre- to post-
flight differences in this indicator of static cerebrovascular autoregulation. 
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2.5.2 Dynamic Cerebrovascular Autoregulation 
 Dynamic cerebrovascular autoregulation, in contrast to static autoregulation (Aaslid 
et al., 1989; Panerai, Dawson, & Potter, 1999), is an index of the rapid responses of the 
cerebrovascular system to acute changes in BPMCA (Panerai et al., 1999). An inverse 
relationship exists between the dynamic autoregulatory index and PCO2 (Edwards et al., 
2004); therefore, it was important that resting PCO2 was not different from pre- to post-flight 
and further that the simultaneous effects of BPMCA and PCO2 were accounted for by the 
ARMA model. The reduction in gain for CVRi relative to the change in BPMCA provided an 
index of impaired dynamic cerebrovascular autoregulation after spaceflight. Similarly, there 
was a trend towards a reduced CBFV response to a change in BPMCA (P=0.128). Reduced 
cerebrovascular dynamic autoregulation after long duration spaceflight was consistent with 
some (Zhang et al., 1997) but not all (Pavy-Le Traon et al., 2002) findings after HDBR, and 
with astronauts who had orthostatic intolerance after short duration spaceflights (Blaber et 
al., 2011). Altered post-flight cerebrovascular control might reflect the structural and 
functional changes observed in the animal models of spaceflight (Lin et al., 2009; Wilkerson 
et al., 1999; Wilkerson et al., 2002; Zhang et al., 2001). 
2.5.3 Cerebrovascular Reactivity to CO2 
 No previous investigation has examined cerebrovascular CO2 reactivity after 
spaceflight. Animal studies showing reductions in nitric oxide-dependent dilation of cerebral 
arteries after hind limb suspension (Lin et al., 2009; Prisby et al., 2006; Wilkerson et al., 
2005) suggested that the CO2 response might be altered due to the link between CO2 induced 
dilation of human cerebral arteries and nitric oxide-dependent mechanisms (Lavi et al., 2006; 
Fathi et al., 2011; Schmetterer et al., 1997). CO2 reactivity was investigated in the current 
study by the “two-breath” method (Edwards et al., 2003) which accounts for the spontaneous 
variability in PCO2 that can complicate interpretation of cerebrovascular responses (Panerai 
et al., 2010; Edwards et al., 2003). The reduced gain for the CBFV and CVRi responses 
computed with respect to the input of PCO2 support the hypothesis that the nitric oxide-
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dependent dilatory mechanisms of the cerebrovascular system might be impaired by long 
duration spaceflight.  
 The environment of ISS had an average inspired PCO2 of 3.34mmHg during the 
experiments described in this study. This value is over 10-fold greater than ambient 
conditions on Earth. Patients with chronic hypercapnia have blunted cerebrovascular CO2 
reactivity (Clivati et al., 1992); however it is unclear if chronic exposure to increased 
atmospheric PCO2, as seen on ISS, produces reductions in cerebrovascular CO2 reactivity in 
a healthy population. Slightly elevated inspired CO2 might have had a chronic effect on 
PaCO2 and arterial acid-base which could in turn affect cerebrovascular resistance. To date, 
no arterial blood samples have been taken on ISS to determine if changes in PaCO2 have 
occurred.  
2.5.4 Individual Variability and Potential Implications 
 The responses of dynamic autoregulation and CO2 reactivity, and the pre- to post-
flight differences varied between astronauts. Finding a range of pre-flight baseline CBFV and 
CVRi responses to the input of BPMCA (Figure 2.4 A and C) is similar to previous 
observations (Edwards et al., 2003). Likewise, differences between subjects in CO2 reactivity 
(Figure 2.4 B and D) are expected and might be related to differences in nitric oxide-
dependent dilation, but this was not directly tested. Of interest in the current study is the 
magnitude of change following spaceflight. One individual (open triangle, Figure 2.4) had 
the largest change from pre- to post-flight in both CBFV and CVRi responses to BPMCA 
along with one of the larger changes in response to PCO2. The other astronauts had relatively 
consistent changes. The functional consequences of these changes cannot be identified from 
the current study; however, a recent study (Blaber et al., 2011) noted that reductions in 
dynamic cerebrovascular autoregulation were associated with orthostatic intolerance. No tilt 
tolerance tests were performed by the astronauts in the current study. 
 Implications of individual variability in the changes in cerebrovascular dynamic 
autoregulation and CO2 reactivity beyond orthostatic tolerance are not known. However, 
NASA has recently identified idiopathic intracranial hypertension as a risk factor for post-
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flight visual problems (Fogarty, 2011; Mader et al., 2011). The current data showing a range 
of changes in post-flight cerebrovascular responses might provide impetus to investigate the 
potential for transcranial Doppler measurements to yield information on risk for these visual 
problems. 
2.5.5 Limitations 
 The sample size in the current study was small. We had 7 astronauts participate in the 
study but technical limitations reduced our main comparison of CVRi responses to n=5. CO2 
was not available in one astronaut (this astronaut’s data were eliminated from all ARMA 
analyses but were included in the LBNP portion of the study), and there were marked 
differences between pre- and post-flight CBFV in another astronaut suggesting that different 
arteries might have been investigated (this astronaut’s data were eliminated from CVRi 
results but maintained for CBFV as the delta response was assumed similar independent of 
artery). Further, it is acknowledged that with data collection in several different locations, 
different equipment was used for data collection possibly contributing to variability in the 
results. However, the consistent pattern of response between astronauts suggests that 
equipment did not influence the main findings of this study. 
There were also differences in the timing of the post-flight testing. Figure 2.4 indicates the 
individual astronauts according to their landing site which dictated whether tests were 
conducted on R+0 (all shuttle landings, n=3 for this figure) or were on R+1 or R+2 (Soyuz 
landings). For shuttle landings, all astronauts were tested within 3-4h of landing and they had 
not been in an upright position for more than a few seconds during transitions between the 
shuttle and crew transport vehicle. For Soyuz landings, crew were upright at some times on 
landing day during their return to Star City, but were transported the morning after their 
arrival to the laboratory without assuming an upright posture for longer than toilet 
requirements. This provided a situation as similar as possible to the shuttle crew. These 




 The current study has shown a consistent impairment of dynamic cerebrovascular 
autoregulation and CO2 reactivity in astronauts following long duration spaceflight; however, 
there were between person differences in the magnitude of impairment. It is unclear at the 
moment whether these changes have pathophysiological significance associated with the 
complications in vision attributed to idiopathic intracranial hypertension (Fogarty, 2011; 
Mader et al., 2011). Future studies should investigate pre- to post-flight changes in 
transcranial Doppler indices of cerebral blood flow and CO2 reactivity to determine if they 






Assessment of middle cerebral artery Doppler waveform 
morphology for the determination of cerebrovascular tone 






 Microgravity exposure results in cephalic fluid shifts and increased intracranial 
pressure that may result in remodelling of the cerebrovasculature. The purpose of this study 
was to examine the cerebral blood flow velocity (CBFV) waveform morphology for the 
determination of cerebrovascular tone before and after long duration spaceflight. Data were 
collected from 7 astronauts who spent a minimum of 58 days on orbit. CBFV waveform 
morphology was assessed based on key inflection points referring to the overall pulse 
amplitude of the signal, the amplitude of the reflected peak, and the amplitude of the dicrotic 
notch. Critical closing pressure (CrCP) and resistance area product (RAP) were calculated 
using a two point method involving mean and diastolic values of CBFV and arterial pressure. 
Waveform morphology and CrCP were assessed before and after flight at rest, after two 
breaths of 10% CO2, and at -20mmHg lower body negative pressure (LBNP). The amplitudes 
of waveform points were increased with CO2 and decreased with LBNP, but were not 
different after spaceflight. RAP was not different with CO2, LBNP, or spaceflight. In 
contrast, CrCP was decreased with CO2 and significantly increased in all three conditions 
after spaceflight. These results suggest that long duration spaceflight results in 





 Exposure to microgravity is associated with cephalic fluid shifts (Hargens & 
Watenpaugh, 1996) that may promote cerebrovascular remodelling. Cerebral arteries from 
animal models of microgravity exposure have shown evidence of vascular smooth muscle 
hypertrophy (Wilkerson et al., 1999; Lin et al., 2009; Zhang et al., 2001; Wilkerson et al., 
2002) associated with increased myogenic tone (Wilkerson et al., 2005; Geary et al., 1998; 
Lin et al., 2009), a reduction in lumen cross-sectional area (Wilkerson et al., 1999), and 
reduced cerebral blood flow (Wilkerson et al., 2002; Wilkerson et al., 2005).  
 Work with humans after spaceflight or simulated microgravity exposure has shown 
no changes in resting cerebral blood flow velocity or cerebrovascular resistance (Blaber et 
al., 2011; Iwasaki et al., 2007; Arbeille et al., 2008; Pavy-Le Traon et al., 2002; Zhang et al., 
1997; Arbeille et al., 2001). However, these results are based on transcranial Doppler 
ultrasound (TCD) measures of cerebral blood flow velocity (CBFV) and are dependent on 
the diameter of the insonated vessel remaining constant after spaceflight or simulated 
microgravity. Currently it is unknown if this assumption is valid after spaceflight; however, 
additional information may be gleaned from the analysis of within beat characteristics of the 
CBFV trace with respect to changes in cerebrovascular tone. To date, no studies have been 
conducted examining potential changes in cerebrovascular tone after spaceflight. 
 Several methods have been proposed to assess vascular tone which could be applied 
to the cerebral circulation including alteration in key inflection points of the Doppler 
waveform (Kurji et al., 2006; Lockhart et al., 2006; Robertson et al., 2008) and the 
calculation of critical closing pressure (CrCP) (Moppett et al., 2008; Panerai et al., 2011; 
Panerai, 2003; Ogoh et al., 2010). The purpose of this study was to examine TCD recordings 
before and after long duration spaceflight to determine potential changes in cerebrovascular 
tone. It was hypothesized, that similar to results from animal models of microgravity 
exposure (Wilkerson et al., 2005; Geary et al., 1998; Lin et al., 2009) long duration 





 Data for this study were collected as a part of the Cardiovascular and Cerebrovascular 
control on return from the International Space Station (CCISS) project with the general 
method, including instrumentation and experimental protocol having been presented in 
Chapter 2.  
3.3.1 Data Analysis 
 For the assessment of velocity waveform characteristics and cerebrovascular tone, 10 
cardiac cycles were averaged to produce a representative waveform at rest before the 
application of LBNP, at the end of -20mmHg LBNP, and after the two breaths of CO2 at the 
point where the increase in CBFV was greatest. Key inflection points on the CBFV 
waveform were then determined as shown in Figure 3.1 and assessed with respect to the end 
diastolic velocity value, T1, as P1-T1, T2-T1, P2-T1, T3-T1, and P3-T1. As previously 
described (Robertson et al., 2008; Kurji et al., 2006), the peaks P1 and P2 of the velocity 
wave were used with the end diastolic value T1 for the calculation of an augmentation index 
as AI = (P2-T1) / (P1-T1) x 100%.  
 Critical closing pressure (CrCP) and the resistance area product (RAP) were 
calculated using a two point method previously described (Panerai et al., 2011). Using this 
method, the slope of the relationship between ABP and CBFV was calculated as a = 
(CBFVmean – CBFVdia) / (ABPmean – ABPdia). RAP was calculated as RAP = 1 / a and 
CrCP calculated as CrCP = ABPmean – (CBFVmean / a). 
3.3.2 Statistical Analysis 
 A two-way repeated measures analysis of variance was used to test for the main effect 
of spaceflight and conditions; Resting, LBNP, and CO2 (SigmaStat 3.5, Systat Software Inc., 





 Analysis of MCA velocity wave inflection points, presented in Figure 3.2, showed 
that P1-T1 was increased with CO2 and decreased with LBNP. Similar directional changes 
were seen for P2-T1, P3-T1, T2-T1, T3-T1 and AI. No differences were seen in any of these 
measures after spaceflight. 
 The results for CrCP and RAP are shown in Figure 3.3. With CO2, CrCP was seen to 
decrease but was not changed with the application of -20mmHg LBNP. Post spaceflight, 
CrCP was increased in all three conditions. RAP was no different from baseline with either 
CO2 or LBNP; however, the RAP values were different between the CO2 and LBNP 
conditions. No differences in RAP were seen with spaceflight. 
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Figure 3.1: Representative velocity wave 
Key inflection points indicated as the three peaks (P1, P2, P3) and three troughs (T1, T2, T3). For 
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Condition P<0.001
Condition P=0.003Condition P=0.004
Condition P=0.003 Condition P<0.001
Condition P<0.001
 
Figure 3.2: Key inflection point analysis results 
Data show pre-flight (black bars) and post-flight (white bars) results for baseline rest, after the CO2 
stimulus, and with -20mmHg LBNP (conditions). P values show the main effects of condition. No 


































Figure 3.3: Results for calculation of CrCP and RAP 
CrCP (A) and RAP (B) results for pre-flight (black bars) and post-flight (white bars) for the three 
conditions; baseline rest, CO2, and -20mmHg LBNP. Statistical analysis showed the main effect of 
condition for both CrCP and RAP with post hoc testing indicating that for CrCP, CO2 values were 
different from baseline and that a difference existed in RAP values between CO2 and LBNP. 
Statistical analysis also found a main effect of spaceflight for CrCP indicating that CrCP was 



































Figure 3.4:Representative MCA waveforms 
Pre-flight (solid line) and post-flight (dashed line) representative MCA waveforms of two shuttle 
launched and landed astronauts. Pre to post spaceflight the MCA waveforms were altered, but the 
large amount of individual variability in the waveforms prevented any statistically significant 
difference.  
3.5 Discussion 
 The current study utilized the assessment of MCA velocity wave inflection points and 
the calculation of CrCP in an attempt to identify potential changes in cerebrovascular tone 
with spaceflight. Contrary to the first hypothesis, no differences were seen in the velocity 
wave inflection points after long duration spaceflight. However, in support of the hypothesis, 
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CrCP was seen to be increased after long duration spaceflight suggesting an increase in 
cerebrovascular tone potentially due to vascular remodelling. 
3.5.1 Cerebrovascular Remodelling with Spaceflight 
 To date, little information is known about the effects of long duration spaceflight on 
human cerebrovascular structure and function, but hypotheses have been developed (Hargens 
& Watenpaugh, 1996; Zhang, 2001) based on data from animal models of microgravity 
exposure. Cerebral arteries of rodents exposed to hind limb unloading have shown vascular 
smooth muscle cell hypertrophy (Wilkerson et al., 1999; Lin et al., 2009; Zhang et al., 2001; 
Wilkerson et al., 2002) with smaller luminal cross-sectional area (Wilkerson et al., 1999) and 
increased basal myogenic tone (Wilkerson et al., 2005; Geary et al., 1998; Lin et al., 2009). 
However, it is not known if similar adaptations occur with spaceflight, or if human arteries 
respond in the same fashion. 
 Of the studies that have attempted to assess changes in human arterial tone with 
microgravity exposure, the results have been mixed. In contrast to the results from animal 
studies, Eiken et al. (Eiken, Kolegard, & Mekjavic, 2008) showed an increased pressure 
distension of the tibial artery after five weeks of horizontal bed rest suggesting a reduction in 
vascular tone. However, Tuday et al. (Tuday, Meck, Nyhan, Shoukas, & Berkowitz, 2007) 
demonstrated an increase in aortic stiffness in astronauts who exhibited orthostatic 
intolerance after 5 to 18 days in space. Similarly, Baevsky et al. (Baevsky et al., 2007) found 
a reduction in pulse wave transit time during and after spaceflight which suggests an increase 
in vascular tone consistent with the results from animal studies.  
 This study is the first to examine potential changes in human cerebrovascular tone 
after long duration spaceflight. Based on the results from the animal studies, it was 
hypothesized that after long duration spaceflight, there would be cerebrovascular remodeling 
leading to an increase in cerebrovascular tone and that this increase in tone would be evident 
in changes in the MCA blood velocity waveform and changes in calculated CrCP. Consistent 
with this hypothesis and the results from animal data with simulated microgravity exposure, 
there was an increase in CrCP with long duration spaceflight suggesting an increase in 
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vascular tone. However, contrary to the hypothesis, there were no differences in the MCA 
velocity wave inflection points with respect to the end diastolic value (T1) or in the 
calculated augmentation index.  
 The lack of difference in waveform inflection points could be attributed to the small 
sample size of astronauts and potentially individual differences in results. Representative 
MCA velocity waveforms pre and post spaceflight of two male shuttle astronauts are 
presented in Figure 3.4. From this figure it can be seen that the velocity wave profile of 
individual astronauts was different pre to post flight with different directional responses for 
each individual.  
3.5.2 Responses to CO2 and LBNP 
 Results of the current study showed alterations in key inflection points of the MCA 
velocity wave, AI, and CrCP with CO2 and the application of -20mmHg LBNP. The response 
to CO2 was expected as previous work has shown a reduction in CrCP (Panerai et al., 1999; 
Panerai, 2003) and an increase in AI (Robertson et al., 2008; Kurji et al., 2006) with 
hypercapnia. In the current study, responses to CO2 and LBNP were used to determine if 
cerebrovascular tone responses differed after long duration spaceflight. Recently, a reduction 
in cerebrovascular CO2 reactivity and impaired cerebrovascular autoregulation has been 
observed in these astronauts (Zuj et al., 2012a). However, in the current study, no differences 
were found in the cerebrovascular tone responses to CO2 or LBNP. 
3.5.3 Limitations 
 The current study utilized transcranial Doppler measures of MCA velocity and 
arterial pressure measures recorded using finger photoplethysmography. When assessing 
MCA velocity using transcranial Doppler, care was taken to minimize any potential 
differences in the angle of insonation pre to post spaceflight. However, it is possible that 
slight differences in probe orientation may have resulted in variability in the analysis of 
MCA velocity wave inflection points. With respect to the calculation of CrCP, ABP recorded 
from the finger was used to represent cerebral perfusion pressure. However ABP measured 
from a peripheral site may not accurately reflect changes in pressure within the cerebral 
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circulation. One group has looked at the differences in CrCP calculated using finger 
plethysmography and carotid tonometry finding an increase in CrCP values and no negative 
CrCP values when tonometry and the linear regression method was used to calculated CrCP 
(Hsu et al., 2005). However, this paper also noted no differences between the mean and 
diastolic values of arterial pressure which were the points used to calculate CrCP in the 
current study. Therefore, it is unlikely that the site of the arterial pressure measurement 
would affect the calculation of CrCP with the method used in the current study. 
3.6 Conclusion 
 The current study was the first to look at cerebral blood velocity waveforms and the 
calculation of CrCP and RAP after long duration spaceflight for the assessment of 
cerebrovascular tone. Contrary to the hypothesis, no differences in MCA velocity waveform 
inflection points were found after spaceflight; however, this was likely due to large 
variability in individual responses. Conversely, in support of the hypothesis, CrCP was 
increased post flight suggesting an increase in cerebrovascular tone. This result suggests that 
cerebrovascular remodelling may be occurring with long duration exposure to microgravity 






Cerebrovascular and CO2 responses during the 








 Syncope from sustained orthostasis results from hypoperfusion of cerebral tissues and 
is normally associated with a reduction in arterial pressure at the level of the brain (BPMCA) 
and a reduction in end tidal carbon dioxide (PETCO2). In this study, it was hypothesized that 
cerebrovascular responses to head up tilt and the progression towards syncope, both before 
and after exposure to head down bed rest (HDBR), would be dominated by the reduction in 
PETCO2 prior to an effect of BPMCA. Twelve men (21-42 years of age) completed an 
orthostatic tolerance test consisting of head up tilt and progressive lower body negative 
pressure, before and after completing five days of continuous HDBR with and without an 
artificial gravity countermeasure. Cerebral blood velocity (CBFV), BPMCA, and PETCO2 were 
continuously recorded throughout the test. Cerebrovascular indicators: cerebrovascular 
resistance (CVRi), critical closing pressure (CrCP), and resistance area product (RAP) were 
calculated. Comparing from supine to 6-10min after the start of tilt there were reductions in 
CBFV (-6.3±3.7cm/s), PETCO2 (-4.2±3.5mmHg), and CrCP (-18.0±6.7mmHg), an increase in 
RAP (0.31±0.09mmHg/cm/s), and no change in CVRi. Changes in these variables progressed 
and were assessed in detail over the final 15min of the test to reveal that CBFV and CrCP 
were significantly related to changes in PETCO2 (r=0.688±0.169, and r=0.631±0.196 
respectively). BPMCA was not significantly reduced until the last minute of the test and was 
correlated with a reduction in RAP (r=0.913±0.091). No differences in responses were seen 
with HDBR. These results indicate that changes in PETCO2 with orthostasis make an 
important contribution to increases in cerebrovascular tone and the reduction in CBFV during 





 Syncope occurring with prolonged orthostasis results from a reduction in cerebral 
perfusion and is normally associated with a large, rapid reduction in arterial blood pressure at 
the level of the middle cerebral artery (BPMCA) (LeLorier et al., 2003; Lewis et al., 2010; 
Carey et al., 2001). A reduction in cerebral blood flow velocity (CBFV) with the progression 
towards syncope has been attributed by some researchers to a reduction in the partial pressure 
of arterial carbon dioxide (PaCO2) (Carey et al., 2001; Cencetti, Bandinelli, & Lagi, 1997; 
LeLorier et al., 2003). However, other work has suggested a poor relationship between 
PaCO2 and changes in CBFV at least during the early phase of orthostasis (Immink et al., 
2006; Serrador, Hughson, Kowalchuk, Bondar, & Gelb, 2006). Both BPMCA and PaCO2 have 
a major influence on CBFV, but many studies have looked at the effects of BPMCA and 
PaCO2 in isolation or did not address the influences of PaCO2 when looking at 
cerebrovascular responses to orthostasis thus preventing the identification of underlying 
mechanisms. 
 Assessment of cerebrovascular hemodynamics frequently relies on measurement of 
CBFV and calculation of cerebrovascular resistance or conductance, but these measures may 
not fully explain alterations in cerebrovascular properties. The calculations of critical closing 
pressure (CrCP) and resistance area product (RAP) have been used to further describe 
cerebral hemodynamic changes with exercise (Ogoh et al., 2010) and alterations in end-tidal 
PCO2 (PETCO2) (Ainslie et al., 2008; Panerai et al., 1999; Panerai, 2003). Carey et al. (Carey 
et al., 2001) showed changes in both CrCP and RAP with approaching syncope, but did not 
relate these changes directly to alterations in PETCO2. Further analysis of CrCP and RAP may 
help to better describe cerebrovascular hemodynamic responses to orthostasis since CrCP is 
taken to reflect changes in cerebrovascular tone, while RAP, as an index of cerebrovascular 
resistance, does not make the assumption that cerebral perfusion pressure gradient is 
referenced to 0mmHg (Evans et al., 1988; Panerai, 2003). 
 A reduction in orthostatic tolerance has been associated with cardiovascular 
deconditioning from exposure to real or simulated microgravity (Arbeille et al., 2008; 
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Buckey et al., 1996; Zhang et al., 1997). The potential contributions of change in PETCO2 and 
the cerebrovascular response to CO2 have not been investigated with respect to this reduction 
in tolerance. Animal models provided a basis to suspect change as the nitric oxide (NO) 
system, linked to cerebrovascular CO2 reactivity in humans (Lavi et al., 2003; Schmetterer et 
al., 1997; Lavi et al., 2006), is down-regulated with simulated microgravity (Prisby et al., 
2006; Lin et al., 2009; Wilkerson et al., 2005). Recent observations of reduced 
cerebrovascular CO2 reactivity in astronauts returning from long duration spaceflight (Zuj et 
al., 2012a) further suggest that these factors should be investigated following head-down bed 
rest (HDBR). To date, no studies have been conducted examining the relationship between 
blood pressure, PETCO2, and cerebral blood flow with the progression towards syncope 
before and after exposure to simulated microgravity. 
 The following study provided the opportunity to examine cerebrovascular responses 
to head up tilt and the progression towards syncope both before and after exposure to 
simulated microgravity with particular emphasis on the influences of changes in arterial 
pressure and PETCO2. It was hypothesized that with the progression towards syncope, there 
would be a reduction in CBFV that was related primarily to the change in PETCO2 and not 
BPMCA and that the reduction in CBFV would be associated with an increase in CrCP 
indicating increased cerebrovascular tone. Post-HDBR, it was hypothesized that these 
relationships would remain consistent but changes would occur sooner after tilt due to a 
reduction in orthostatic tolerance. 
4.3 Methods 
4.3.1 Experimental Protocol 
 Twelve, healthy men (21-42 years of age) completed five days of continuous 6° head 
down bed rest (HDBR) with and without an artificial gravity countermeasure. The study was 
designed so that all men participated in random order in both the control (CON) condition 
and the artificial gravity (AG) condition with each testing session separated by 30 days. All 
experimental procedures were approved by the Comité Consultatif de Protection des 
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Personnes dans la Recherche Biomédicale, Midi-Pyrenees (France), and local ethics 
committees, including the Office of Research Ethics, University of Waterloo. The entire 
protocol was in accordance with the declaration of Helsinki. Each subject signed a consent 
form after receiving full disclosure of the experimental protocol and was aware of his right to 
withdraw from the study for any reason without prejudice.  
 A short arm centrifuge was used to generate the AG countermeasure with a head to 
foot force vector of 1g at the centre of mass of the participant. The protocol consisted of 
intermittent application of force where five minutes of centrifugation was repeated six 
consecutive times for each of the five days of HDBR. 
 Orthostatic tolerance, tilt testing was conducted two days before the start of HDBR 
(pre-HDBR) and as the first transition to an upright posture after the five days of HDBR 
(post-HDBR). After five minutes of baseline data collection in the supine position, 
participants were passively tilted to an 80° head up position where they were required to 
stand quietly for 30 minutes. If signs of orthostatic intolerance did not occur within this time, 
lower body negative pressure (LBNP) was progressively applied with step decreases of -
10mmHg every three minutes. Testing continued until one or more of the following test 
termination criteria were met; systolic blood pressure <70mmHg, a sudden drop in HR (>15 
bpm), severe light headedness, nausea, or the request of the subject to terminate the test. 
 A standard three lead electrocardiogram (Roxon Medi-Tech Ltd., St. Leonard, QC, 
Canada) was used for the assessment of heart rate (HR). Finger photoplethysmography 
(Nexfin, BMEYE B.V., Amsterdam, Netherlands) was used for the continuous assessment of 
arterial blood pressure (ABP). Values recorded in the finger were corrected to heart level. 
Post processing of the blood pressure signal involved the correction of recorded values to a 
manual blood pressure measure, taken by a trained experimenter before the start of the tilt 
test with the subjects resting in a supine position. An additional height correction was also 
applied during post processing to determine arterial pressure at the level of the middle 
cerebral artery (BPMCA). Participants were equipped with a nasal cannula for monitoring of 
expired CO2 (Ohmeda 5200 CO2 Monitor, Madison, WI, USA). Values were recorded as 
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percent CO2 to be later converted to mmHg based on ambient temperature and barometric 
pressure. HR, BPMCA, and CO2 data were collected at 1000Hz using Chart software 
(ADInstruments Ltd., Colorado Springs, CO, USA). 
 Blood flow velocity in the middle cerebral artery (CBFV) was determined using 
transcranial Doppler ultrasound (TCD). A 2MHz pulsed Doppler probe was placed over the 
right temporal window which allowed for the insonation of the M1 segment of the right 
middle cerebral artery (MCA) and the assumption of 0° for the angle of insonation. A head 
band was used to hold the probe in place throughout the testing. Doppler signals were 
collected using CardioLab hardware (CNES device, European Space Agency, France) and 
were recorded at 100Hz using CardioMed software (CNES - European Space Agency, 
France). 
4.3.2 Cerebrovascular Variables 
 Mean CBFV values were calculated from the outer envelope of the Doppler spectrum 
over a cardiac cycle. The Doppler recording was also assessed to determine maximum 
(systolic) and minimum (end diastolic) values for each cardiac cycle. An index of 
cerebrovascular resistance (CVRi) was calculated as CVRi = BPMCA / CBFVmean. The 
Gosling Pulsatility index was also calculated as an additional assessment of cerebrovascular 
resistance as PI = (CBFVsys – CBFVdia) / CBFVmean (Beasley et al., 1979).  
 Further analysis was conducted with the CBFV waveform for the calculation of 
critical closing pressure (CrCP) and resistance area product (RAP). Following the methods 
described in a recent critical analysis (Panerai et al., 2011), CrCP was calculated for each 
beat using mean and diastolic values for CBFV and arterial blood pressure at the level of the 
MCA (BPMCA). The slope of the relationship between CBFV and BPMCA was calculated as a 
= (CBFVmean – CBFVdia) / (MAPMCA – DBPMCA). RAP was then calculated as RAP = 1 / a 
and CrCP calculated as CrCP = MAPMCA – (CBFVmean / a). Previous studies of head-up tilt 
and sustained orthostasis have used a linear regression method for assessing CrCP and RAP 
(Stewart et al., 2012; Carey et al., 2001). However, in this study, the two point method using 
mean and diastolic values of CBFV and BPMCA was chosen as it has recently been shown to 
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have greater repeatability and fewer instances of negative CrCP values being calculated 
(Panerai et al., 2011). 
4.3.3 Data Analysis 
 This study reports on data collected during the control and artificial gravity condition; 
however the original design of the study included two artificial gravity conditions with pre-
HDBR data collected three times for each subject. Post-HDBR data for the second artificial 
gravity condition were not included in the present analysis as only a small number of 
individuals completed the entire protocol. Previous work has demonstrated good 
reproducibility of tilt responses (LeLorier et al., 2003) and statistical analysis of these data 
(not shown) showed no differences between the pre-HDBR responses defined as the 
difference between a five minute average taken at supine baseline, a five minute average 
from minutes 6 to 10 of the tilt, and the last minute of the test. Therefore, for analysis 
purposes, pre-HDBR was considered as the average of all three pre-HDBR data collections. 
 Variables were assessed beat-by-beat then averaged every 10 seconds after the 
transition to the tilted position. PETCO2 values were linearly interpolated to determine values 
for each heart beat. Tilt responses were assessed as the difference between a five minute 
average taken during supine rest and a five minute average taken between minutes 6 and 10 
of the tilt. For some tests, following HDBR, the participant was unable to complete 10 
minutes of the stand test. Therefore, tilt values were taken as the average from five minutes 
post tilt excluding last minute of the test. 
4.3.4 Statistical Analysis 
 The analysis of cardiovascular responses to tilt was performed in several ways. First, 
a two-way repeated measures ANOVA (SigmaStat 3.5, Systat Software Inc., Chicago, IL) 
was used to compare supine baseline with early tilt defined as the average of values between 
minutes 6 and 10 of the tilt. Secondly, the end of tilt responses were assessed as percent 
changes over the final 15 minutes of the test with a one-way repeated measures analysis of 
variance being used to assess each minute value. Finally, linear regression analysis was used 
on data from each individual to explore possible interrelationships between different 
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variables. From the data in the final 15 minutes of the test, two distinct sections were 
identified based on the point at which BPMCA became different from the value at 15 minutes. 
BPMCA was not different until 1min before syncope; therefore, regressions were performed on 
data between minutes 15 and 2, and 2 and 0 separately to determine relationships between 
PETCO2, BPMCA, CBFV, CrCP, and RAP. Data for the linear regressions are presented as the 
Pearson product moment correlation (r). 
 All values are shown as mean ± standard deviation unless otherwise stated. 
Significance was set at P<0.05 for the repeated measures analysis of variance, P<0.001 for 
linear regression analysis between minutes 15 and 2, and P<0.01 for linear regression 
analysis between minutes 2 and 0.  
4.3.5 Analysis Limitations 
 Data were available for all twelve individuals pre-HDBR; however, post-HDBR some 
data were not available for the planned analyses. For the comparison of early tilt responses 
(average between 5 and 10 minutes post tilt), three individuals in the CON condition and one 
in the AG condition experienced syncope within five minutes of tilt, and one person had an 
unrelated medical complication. Therefore, only 7 of 12 individuals were included in the 
repeated measures analysis. The linear regression analysis was not attempted in the post-
HDBR tests as three additional tests were terminated due to a power outage, equipment 
failure, and a request by the participant to stop the test that was not related to the onset of 
presyncopal symptoms. 
4.4 Results 
 Analysis of the cerebrovascular responses to tilt, presented in Figure 4.1, show the 
difference from the five minute average taken during supine rest and minutes 6-10 after tilt. 
A reduction in CBFV (panel A), PETCO2 (panel B), BPMCA (panel D) and CrCP (panel E) 
were seen along with an increase in RAP (panel F) and no significant changes for CVRi 
(panel C) or PI (data not shown). No differences were found between pre-HDBR responses 
and post-HDBR for either the CON or AG condition.  
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 The changes in CBFV, PETCO2, and BPMCA during the last 15 minutes before syncope 
pre-HDBR are presented in Figure 4.2. CBFV and PETCO2 progressively decreased with 
significant reduction from the value at 15 minutes by 4min (-10.8±7.0%) and 5min (-
10.1±7.2%) before syncope respectively. Conversely BPMCA was only different 1 minute 
before and at syncope where BPMCA was reduced by -8.0±6.0% and -35.1±11.8% 
respectively. 
 Three separate indicators of cerebrovascular resistance were examined over the final 
15 minutes before syncope for the pre-HDBR tests (Figure 4.3). CVRi progressively 
increased and was statistically increased from minute 15 in the last minute before syncope 
with a sharp decrease to the end test value that was not statistically different from minute 15. 
Both RAP and PI were not significantly different until the last point of the test where there 
was a reduction in RAP, but a dramatic increase in PI. 
 Linear regression analysis results are presented in Table 4.1. Pre-HDBR, significant 
relationships were found between CBFV and BPMCA for only 4 of 12 people, while the 
relationship between CBFV and PETCO2 was significant in 10 of 12 people. This is in 
contrast to the last two minutes of the test where only 3 of 12 people had significant 
relationships between CBFV and PETCO2 whereas 9 of 12 had CBFV significantly related to 





Table 4.1: Correlation coefficients for the linear regression assessing the relationship between 
BPMCA and PETCO2 with CBFV, CrCP, and RAP during the last 15 minutes before syncope 
 Time = 15 to 2 minutes Time = 2 to 0 minutes 

























 Values are the Pearson product moment correlation (mean ± SD) for the individuals showing 
significant relationships. The number of individuals out of 12 with significant relationship is 
presented in parentheses.  
 
 A visual display of the interrelationships between PETCO2, BPMCA, CrCP, and RAP is 
shown in Figure 4.4 for pre-HDBR tests (note the inverted scale for CrCP). Linear 
regressions were performed on data pairs for these variables between 15 and 2 minutes 
before syncope for each individual. RAP-BPMCA was significant for 9 of 12 people whereas 
CrCP-BPMCA was significant for only 4 of 12 people (Table 4.1). RAP-PETCO2 was 
significant for 6 of 12 people and the relationship between CrCP-PETCO2 was significant for 
7 of the 12 subjects (Table 4.1). During the last two minutes of the test only RAP-BPMCA was 
























































































































Figure 4.1:Delta tilt responses 
The early tilt responses are shown as the difference from a five minute average taken during supine 
rest and a five minute average of minute six to ten of the tilt for individuals who completed greater 
than 5 minutes of tilt in both the CON and AG conditions (n=7): pre-HDBR (black bars), post-HDBR 
control (white bars), and post-HDBR artificial gravity (grey bars). Values are mean ± SD. No 
statistically significant differences were found between the conditions. P values indicate differences 

































Figure 4.2: Percent change CBFV, PETCO2, and BPMCA 
The percent change in CBFV (solid line, ○), BPMCA (dashed grey line, ■), and PETCO2 (dash-dotted 
line, ▼) over the last 15 minutes of the tilt test (presyncope at t=0) for pre-HDBR (n=12). Points on 
the line show mean values ± SD, with values that are significantly different from 15 minutes before 



























Figure 4.3: Percent change CVRi, RAP, and PI 
Three cerebrovascular resistance indicators are shown as percent change in CVRi (dashed grey line, 
■), PI (solid line, ○), and RAP (dashed-dotted line, ▼) over the last 15 minutes of the tilt test 
(presyncope at t=0) for pre-HDBR (n=12). Points on the line are mean values ± SD, with points 


















































































Figure 4.4: Progressions of BPMCA, RAP, PETCO2, and CrCP 
Interrelationships between variables for the last 15 minutes of the tilt tests for pre-HDBR (n=12). A. 




 This study provided an in depth look at cerebrovascular responses during the final 15 
minutes of an orthostatic challenge resulting in presyncopal symptoms. In support of the first 
hypothesis, it was observed that while BPMCA was unchanged until the final minute before 
syncope, CBFV and PETCO2 were significantly reduced earlier with 10 of 12 individuals 
having significant linear relationships between these variables. These findings are consistent 
with some previous research (Cencetti et al., 1997; Carey et al., 2001; LeLorier et al., 2003) 
but challenge the suggestion based on examination of the early phase of head-up tilt 
(Serrador et al., 2006) and standing (Immink et al., 2006) that changes in CBFV are 
independent of PETCO2. The results of the current study also supported the second hypothesis 
revealing an increase in CrCP that was linearly related to the reduction in PETCO2 suggesting 
a progressive increase in cerebrovascular tone that was coupled to the reduction in CBFV. In 
contrast, RAP, an indicator of cerebrovascular resistance, was unchanged until there was a 
large drop in BPMCA just prior to syncope. After HDBR, there were no differences in the 
cerebrovascular responses compared to pre-HDBR; but, 7 of 12 in the CON condition and 2 
of 12 in the AG condition experienced presyncopal symptoms in the first 10 minutes of tilt 
after HDBR. Potential benefits of the artificial gravity countermeasure were not observed 
with respect to the indicators of cerebrovascular function during tilt. 
4.5.1 Early Tilt Cerebrovascular Responses 
 The early responses to tilt were assessed by comparing supine resting values of 
cerebrovascular variables to an average taken between minutes 5 and 10 after tilt. Responses 
were consistent with other research observing reductions in BPMCA, CBFV, and PETCO2 after 
the transition to an upright posture (Immink et al., 2006; O'Leary et al., 2007; Cencetti et al., 
1997; Serrador et al., 2006). The absence of significant change in CVRi or PI was somewhat 
unexpected as BPMCA was reduced by ~20mmHg and autoregulatory processes were 
expected to reduce cerebrovascular resistance to maintain CBFV; however, the reduction in 
PETCO2 would have an opposite effect on cerebrovascular resistance as detected by an 
increase in RAP. The reduction in PETCO2 would also be expected to increase CrCP (Carey 
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et al., 2001), but a large decrease in CrCP occurred with the reduction in BPMCA during tilt 
potentially reducing vascular tone and minimizing the decrease in CBFV. 
 The observed increase in RAP and large reduction in CrCP in the current study during 
80° head-up tilt contrast with a recent report of no change in RAP and smaller changes in 
CrCP during an incremental tilt study up to 75° (Stewart et al., 2012). It might be that 
vascular tone (CrCP) and RAP contributed differently to cerebrovascular regulation with 80° 
head-up tilt compared to incremental tilt to 75°. However, the differences in calculation 
method for CrCP and RAP, with the two point method involving the mean and diastolic 
values in the current study as opposed to the linear regression method (Stewart et al., 2012), 
which has the potential for producing negative values for CrCP (Panerai et al., 2011), could 
account for these findings.  
4.5.2 Sustained Tilt Cerebrovascular Responses 
 Over the final 15 minutes of the tilt before syncope, BPMCA was well maintained until 
the last minute. In contrast, PETCO2 and CBFV were reduced 5 and 4 minutes before syncope 
respectively. We utilized the two regions based on unchanged versus changed BPMCA to 
further investigate relationships between variables. One set of regressions was computed for 
the period of constant BPMCA (15 to 2 minutes before syncope), the second set when BPMCA 
was changing (last two minutes of the test). These analyses confirmed distinct regions over 
which changes in PETCO2 or BPMCA were related to alterations in cerebral hemodynamics. 
From 15 to 2 minutes before syncope, the reduction in CBFV was primarily related to the 
decline in PETCO2, while in the final two minutes before syncope, the reduction in CBFV 
was associated with the decrease in BPMCA. 
 Changes in BPMCA and PETCO2 potentially impact CBFV through changes in vascular 
resistance and vascular tone. Three indications of cerebrovascular resistance, CVRi, RAP, 
and PI, were calculated in the current study. Through most of the final 15 minutes of tilt the 
resistance indicators were relatively stable but then presented slightly different patterns with 
the progression towards syncope. Previous studies, primarily looking at CVRi responses, 
have observed paradoxical increases in cerebrovascular resistance before syncope (Serrador 
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et al., 2006; Bondar et al., 1995; Levine, Giller, Lane, Buckey, & Blomqvist, 1994) with 
explanations including sympathetic nervous system mediated mechanisms (Bondar et al., 
1995; Serrador et al., 2006) and changes in arterial CO2 (Serrador et al., 2006; Blaber, 
Bondar, Moradshahi, Serrador, & Hughson, 2001). CVRi was increased only at 1 minute 
before syncope then decreased at syncope. However, the use of CVRi as an indicator of 
cerebrovascular resistance is dependent on CBFV being proportional to cerebral blood flow 
which may not be the case if the diameter of the insonated vessel is changing. Its calculation 
is also dependent on the assumption that the pressure gradient is referenced to 0 mmHg 
venous pressure. Therefore, two other independent indicators of vascular resistance were also 
assessed. With respect to the Doppler resistance index PI, it would appear that it is likely that 
values are only representative of cerebrovascular resistance until the last minute of the test 
where there is a marked reduction in arterial pressure and a large increase in PI. Conversely, 
the profile of RAP was consistent with what would be expected with functioning 
cerebrovascular autoregulation, in that there was only a marked reduction in resistance when 
arterial pressure was dropping, but this was independent of the impact of PCO2. This profile 
of RAP decreasing in the final minute before syncope is similar to the pattern described by 
Carey et al. (Carey et al., 2001). 
 The indication of cerebrovascular tone derived from the CrCP increased progressively 
over the final 15 minutes prior to syncope in direct proportion to the reduction in PETCO2. 
Although the direction of change was similar to that described by Carey et al. (Carey et al., 
2001), the timing and potential functional consequences were different as the data of Carey et 
al. (Carey et al., 2001) showed increases in CrCP only in the final 60 seconds of the test. 
Conversely, in the current study the progressive increase in CrCP was followed in the final 
minute before syncope by a reduction (see Figure 4.4 B, noting the inverted scale for CrCP). 
The increase in CrCP was associated with the reduction in PETCO2 whereas the final decrease 
in CrCP was associated with the rapid decline of BPMCA, and is consistent with the reduction 
in CrCP noted in the early phase of the tilt of the current experiment when BPMCA was 
reduced from the supine baseline. Previous work has shown increases in CrCP with 
reductions in CO2 (Panerai et al., 1999; Panerai, 2003; Ainslie et al., 2008); however this 
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study is the first to suggest that over the last 15 minutes before syncope increased 
cerebrovascular tone was associated with a reduction in PETCO2 which could contribute to 
reduced cerebral blood flow. The significance of the increase in CrCP with the approach of 
syncope is that there is a simultaneous reduction in diastolic blood pressure so that the 
closure of cerebral vessels could occur through part of the cardiac cycle reducing CBFV 
(Carey et al., 2001). 
4.5.3 Effects of HDBR and the Artificial Gravity Countermeasure 
 Contrary to the hypothesis that CBFV would show greater reductions post-HDBR, 
there were no differences in the early phase tilt responses compared to pre-HDBR for either 
CON or AG conditions. However, four of the individuals who were unable to complete 5 
minutes of tilt post-HDBR were excluded from the analysis. It is possible that these 
individuals did have impaired cerebral blood flow regulation post-HDBR, but it is unclear 
from the current analysis. Of the remaining subjects, tilt tolerance was reduced and analysis 
of relationships between variables was compromised due to the short data sets. For the 
individuals who sustained tilt for relatively longer periods of time post-HDBR, it would 
appear that changes in BPMCA dominated the responses potentially suggesting that 
cerebrovascular autoregulation was overriding any PCO2 effects with the shorter duration of 
tilt. 
4.5.4 Limitations 
 In the current, study PETCO2 was measured as a surrogate for PaCO2 with the 
progression towards syncope. The relationship between PETCO2 is altered during postural 
transitions, but it is unknown if the relationship then remains constant with sustained 
orthostasis (Immink et al., 2006; Serrador et al., 2006) since further changes in the ventilation 
perfusion ratio could occur as cardiac output is reduced with prolonged tilt (Guinet et al., 
2009).  
 The use of transcranial Doppler ultrasound for the assessment of cerebral blood flow 
is dependent on the diameter of the insonated vessel remaining constant. Studies have shown 
that the diameter of the middle cerebral artery remains constant with changes in PETCO2 and 
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the application of a mild orthostatic stress (Giller et al., 1993; Serrador et al., 2000). 
However, it is possible that prolonged orthostatic stress and reduced PCO2 could have 
reduced the MCA diameter so that measures of CBFV might underestimate the decrease in 
cerebral blood flow. The MCA diameter and cerebrovascular properties might also change 
with HDBR as seen in animal models of hindlimb suspension (Wilkerson et al., 1999; Lin et 
al., 2009), but this seems unlikely with 5 days of HDBR in humans. Regardless, these issues 
raise a need for caution in interpreting the observed changes in CBFV as alterations in 
cerebral blood flow. 
4.6 Conclusion 
 This study examined the cerebrovascular responses to head up tilt with particular 
emphasis on the contributions of changes in arterial blood pressure and PETCO2 both before 
and after exposure to five days of HDBR with and without an artificial gravity 
countermeasure. Analysis of data showed that the reductions in CBFV were strongly 
correlated to decreases in PETCO2 during the period from 15 to 2 minutes before the onset of 
syncope. The mechanism underlying the decrease in CBFV appeared to be related to a 
progressive increase in CrCP as indicators of cerebrovascular resistance obtained from CVRi, 
RAP and Doppler PI were unchanged over that similar period. In the final two minutes prior 
to syncope, RAP was the only cerebrovascular resistance indicator that reflected the 
anticipated decline in cerebrovascular resistance that occurred as BPMCA was reduced. These 
results suggested that the progressive reduction in PETCO2 with sustained orthostatic 
challenge reduced CBFV through an increase in cerebrovascular tone assessed by CrCP, and 
that RAP provides a valuable index of cerebrovascular resistance changes to counter the 
effects of changes in BPMCA. The increase in cerebrovascular tone rather than an increase in 






Middle cerebral and temporal artery Doppler spectrum 
morphology changes with orthostasis before and after five 






 A marked reduction in orthostatic tolerance has been noted with exposure head down 
bed rest (HDBR). As syncope from prolonged orthostasis ultimately results from cerebral 
hypoperfusion, examining cerebrovascular responses to tilt and the progression towards 
syncope may provide additional indications about the mechanisms involved in the reduction 
in orthostatic tolerance. Therefore, the purpose of this study was to assess cerebrovascular 
responses to tilt before and after HDBR with respect to potential changes in middle cerebral 
and temporal artery blood velocity traces with the progression towards syncope and indices 
of dynamic cerebrovascular autoregulation. Data for this study were collected from 12 men 
who completed an orthostatic tolerance test consisting of head up tilt and progressive lower 
body negative pressure before and after 5 days of HDBR with and without an artificial 
gravity countermeasure. Doppler ultrasound was used to assess middle cerebral artery 
(CBFV) and temporal artery blood velocity (VTEMP) with the velocity traces assessed for the 
appearance of a negative component in the VTEMP trace and the difference between the 
dicrotic notch and end diastolic values of CBFV. During supine rest indices of dynamic 
cerebrovascular autoregulation were determined using cross-spectral analysis for the input 
variable of arterial pressure and the output of CBFV and cerebrovascular resistance (CVRi). 
With tilt, VTEMP and CBFV decreased with no change in CVRi but an increase in temporal 
artery vascular resistance with no differences after HDBR. Both pre- and post-HDBR, within 
five minutes before syncope, a negative component of VTEMP appeared and the dicrotic notch 
point of the CBFV trace became less than the end diastolic value. No differences in dynamic 
cerebrovascular autoregulation were found with HDBR and values were not related to VTEMP 
or CBFV wave morphology. The minimum values of VTEMP was found to be related to 
vascular resistance, where the change in CBFV was not as strongly related to CVRi 






 In the assessment of blood flow, analysis of Doppler spectrum morphology may 
provide additional information about changes in cerebrovascular hemodynamics. Analysis of 
Doppler spectrum morphology could also be useful in the identification of potential 
indicators of approaching syncope which would assist in assessment in both clinical and 
research settings. Assessing orthostatic tolerance requires the use of tolerance tests in which 
an individual is subjected to orthostatic stress and tolerance quantified based on the duration 
and magnitude of exposure withstood by the subject. It has also been noted that 
cardiovascular changes during orthostasis mimic those of hemorrhage (Cooke, Ryan, & 
Convertino, 2004). Recently we have published work demonstrating changes in temporal 
artery Doppler spectrum morphology with the progression towards syncope (Arbeille, Zuj, 
Shoemaker, & Hughson, 2012). In this paper, it was found that in two thirds of cases, the 
temporal artery Doppler spectrum showed a change in morphology in which a negative 
component appeared and allowed for the early detection of approaching syncope. The 
purpose of the following paper was to further characterize changes in temporal artery 
Doppler spectrum morphology with the progression towards syncope both before and after 
exposure to five days of head down bed rest with and without an artificial gravity 
countermeasure. The second purpose of this study was to characterize changes in cerebral 
blood velocity Doppler spectrum morphology with relation to changes in the temporal artery 
Doppler spectrum morphology and indications of dynamic cerebrovascular autoregulation. 
 Exposure to real or simulated microgravity has been shown to be associated with 
cardiovascular deconditioning reduced orthostatic tolerance (Arbeille et al., 2008; Buckey et 
al., 1996; Zhang et al., 1997). Some studies have suggested that this change in orthostatic 
tolerance could be related to reductions in dynamic cerebrovascular autoregulation (Zhang et 
al., 1997; Blaber et al., 2011; Zuj et al., 2012a), where other work has suggested the 
contribution of impaired peripheral vasoconstriction responses (Buckey et al., 1996; Arbeille 
et al., 2008). To date, no studies have looked at alterations in middle cerebral or temporal 
artery Doppler waveform morphology with exposure to real or simulated microgravity, or 
how these variables might relate to changes in orthostatic tolerance. 
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 As syncope is ultimately the result of cerebral hypoperfusion, changes in the middle 
cerebral artery blood velocity waveform may be indicative of approaching syncope. In 2004, 
Albina et al. (Albina et al., 2004) published a paper in which the qualitative assessment of 
transcranial Doppler (TCD) waveforms during tilt testing. The results of this paper found that 
patients with a history of neurocardiogenic syncope consistently showed a deepening of the 
dicrotic notch in the Doppler waveform. However, no attempt was made to quantify this 
change, determine if it occurred at a consistent point before the onset of syncope, or relate 
this qualitative observation to quantitative assessments of cerebrovascular properties. 
 In the current paper, it was hypothesized that, similar to previously reported results 
(Arbeille et al., 2012), a negative component of the temporal artery Doppler velocity trace 
would appear approximately five minutes before the onset of syncope. It was also 
hypothesized that this change would be associated with a reduction in the dicrotic notch 
portion of the middle cerebral artery blood velocity trace. After exposure to five days of 
simulated microgravity, it was hypothesised that there would be a reduction in orthostatic 
tolerance associated with impaired dynamic cerebrovascular autoregulation. With respect to 
Doppler waveform morphology, it was hypothesized that the appearance of the negative 
component would appear closer to syncope in those individuals with reduced orthostatic 
tolerance, indicating an impairment of peripheral vasoconstriction during orthostasis. 
Conversely, it was also hypothesized that the alterations in the middle cerebral artery blood 
velocity trace would occur earlier in the orthostatic tolerance test and be associated with a 
greater reduction in cerebral blood flow velocity and impaired cerebrovascular 
autoregulation.   
5.3 Methods 
 Data for this study were collected as part of the same experiment described in Chapter 




5.3.1 Vascular Measures 
 Transcranial Doppler ultrasound (TCD) was used for the assessment of cerebral blood 
flow velocity (CBFV). A 2MHz pulsed Doppler probe was placed over the right temporal 
window which allowed for the insonation of the right middle cerebral artery (MCA). A head 
band was used to hold the probe in place throughout the testing. On the left side of the head, 
an 8MHz pulsed Doppler probe was attached to the TCD head set which allowed for the 
assessment of blood velocity in the temporal artery (VTEMP). Supplying extracranial tissues, 
the temporal artery is a branch of the facial artery that originates from the external carotid 
artery. Approximately 1cm above the mandible, anterior to the ear, the Doppler probe was 
oriented to maximize the VTEMP signal amplitude. Doppler signals were conducted using 
CardioLab hardware (CNES – European Space Agency device, France) and were recorded at 
100Hz using CardioMed software (CNES - European Space Agency, France). 
 For MCA and temporal artery Doppler recordings, mean velocity values (CBFV and 
VTEMP respectively) were calculated as the mean of the outer envelope of the Doppler 
spectrum over a cardiac cycle. For each of the Doppler recordings, maximum (systolic) and 
minimum (diastolic) values were determined for each cardiac cycle. In addition to the 
minimum value, the end diastolic value of the MCA trace was also determined. Vascular 
resistance was calculated as TEMPVR = MAPTEMP / VTEMP and CVRi = MAPMCA / CBFV for 
the temporal artery and MCA respectively where MAPTEMP and MAPMCA represent the mean 
arterial pressure height corrected to the levels of the temporal artery and MCA. The ratio of 
mean velocity values (CBFV / VTEMP) was used as a method of assessing the redistribution of 
cardiac output (Arbeille et al., 1998; Arbeille et al., 2008).  
5.3.2 Data Analysis 
 This study reports on data from the control condition and one artificial gravity 
condition; however, the original study design included two artificial gravity countermeasure 
protocols and, therefore, pre-HDBR data were collected for each subject three times. 
Previous work has demonstrated good reproducibility of tilt responses (LeLorier et al., 2003) 
and statistical analysis of this data (not shown) showed no differences between the pre-
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HDBR responses; therefore, for analysis purposes, pre-HDBR was considered as the average 
of all pre-HDBR data collections. 
 Variables were assessed beat-by-beat and then averaged for every minute during the 
test. To assess the responses to tilt averages were taken over the first five minutes of the test 
(Supine) and minutes 6-10 of the tilt (Tilt). For some test, participants were unable to remain 
standing for 10 minutes of tilt. For these individuals, the tilt value was taken as the average 
from minute 5 to a point before the last two minutes of the test. 
 Beat-by-beat data was also averaged every 10s of the test and used to assess timing of 
changes in hemodynamic variables with the progression towards syncope. This data was 
analyzed to determine the time point before presyncope where the temporal velocity trace 
showed a negative component and the point where the dicrotic notch of the MCA velocity 
wave was less than the end diastolic value with examples of these wave changes being shown 
in Figure 5.1. The time point for VTEMP was determined as the point in the VTEMP minimum 
data where three consecutive 10s averages showed values less than (more negative) -0.5cm/s 
and was not followed by a section of three or more 10s averages greater than -0.5cm/s. 
Similar criteria was used for determining the time point for CBFV with the point where the 
difference between CBFV minimum and CBFV end diastole (CBFVmin-dia) was greater 
than 0.75cm/s for three consecutive 10s averages and was not followed by 3 or more 10s 
averages with differences less than 0.75cm/s. The values of -0.25cm/s and 0.75cm/s were 




































Figure 5.1: Representative temporal artery and MCA velocity waves 
Figure shows tracings at rest (A and C) and near syncope (B and D). Both waves show similar 
morphological changes; however the temporal artery shows a negative component where the MCA is 
consistently positive with the dicrotic notch less than the end diastolic value. 
 Dynamic cerebrovascular autoregulation was assessed during the first five minutes of 
the test while participants rested in the supine position. For this analysis a transfer function 
method was used similar to previously reported (Edwards et al., 2002). Data for the five 
minutes of supine rest were assessed beat-by-beat then re-sampled at a frequency of 1Hz 
using linear interpolation. Linear trends were removed and cross-spectral analysis was 
performed for the input variable of MAP and the output of either CBFV or CVRi using 
Welch’s method (Matlab, Math Works, USA). Transfer function gain, coherence, and phase 
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were determined in three frequency regions; very low frequency (VLF: 0.03-0.07 Hz), low 
frequency (LF: 0.07-0.2 Hz), and high frequency (HF: 0.2-0.3 Hz). 
5.3.3 Statistical Analysis 
 Mean velocity, vascular resistance, and the velocity ratio were all assessed using a 
two way repeated measure analysis of variance (SigmaStat 3.5, Systat Software Inc., 
Chicago, IL). Alterations in the timing of the appearance of the temporal artery negative 
velocity and potential changes in the timing point where the dicrotic notch was less than the 
end diastolic velocity value of the MCA velocity trace were assessed using a one way 
repeated measures analysis of variance (SigmaStat 3.5, Systat Software Inc., Chicago, IL). 
VTEMP minimum and CBFVmin-dia were tested for potential relationships with arterial 
pressure, cardiac stroke volume, and vascular resistance using linear regression. Unless 
otherwise stated, all values show mean ± standard deviation. For all statistical analysis, 
significance was set at p<0.05. 
5.4 Results 
 Analysis of the velocity, resistance, and ratio responses to tilt showed that with tilt 
(average of minutes 6-10) there were significant reductions in CBFV (Figure 5.2 A) and 
VTEMP (Figure 5.2 B) with no changes in CVRi (Figure 5.2 C) and a significant increase in 
TEMPVR (Figure 5.2 D). The ratio of CBFV to VTEMP (Figure 5.2 E) was also significantly 
increased with tilt, indicating that although there were reductions in both CBFV and VTEMP, 
there was a greater reduction in VTEMP. No differences were seen between pre-HDBR 









































































































Figure 5.2: Responses to tilt 
Results (mean ± SD) for CBFV (A), VTEMP (B), CVRi (C), TEMPVR (D), the ratio between CBFV and 
VTEMP (E) at supine rest (baseline) and minutes 6-10 of the tilt (tilt) for pre HDBR (black bars), CON 
(white bars), and AG (grey bars) (n=7). Differences from supine values are denoted by * at p<0.05. 
No effects of HDBR were seen for any of the variables. 
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 Assessment of dynamic cerebrovascular autoregulation was conducted during the five 
minutes of supine rest before tilt. Results from this analysis, presented in Table 5.1 showed 
no effects of HDBR. Further analysis was conducted with respect to the CON condition. In 
this case, individuals were grouped based on those who were able to complete 10 minutes of 
tilt (tolerant) and those unable to complete 10 minutes of tilt (non-tolerant). Pre HDBR, all 
subjects were able to complete 10 minutes of tilt. Post HDBR in the CON condition, only 
five of the 12 subjects were able to complete more than 10 minutes of tilt. Data from these 
two groups are also presented in Table 5.1. Analysis showed no differences in pre HDBR 
versus post HDBR dynamic cerebrovascular autoregulation variables for either the tolerant or 
intolerant individuals.  
 On average, the negative component of temporal negative velocity occurred 
7.17±8.84 (n=12) minutes before the onset of presyncope. Post-HDBR the negative 
component appeared 9.85±13.67 (n=11) and 8.14±12.95 (n=7) minutes before presyncope for 
CON and AG respectively with no difference being seen between pre-HDBR, CON, and AG 
(p>0.05). However, it should be noted that these values included data from three subjects 
who showed negative velocity much earlier than 10 minutes before presyncope. When data 
from these individuals were excluded from the analysis, the negative component of VTEMP 
appeared 1.93±1.75 (n=8), 3.21±2.93 (n=7), and 3.53±4.74 (n=6) minutes before presyncope 
for pre-HDBR, CON, and AG respectively with no differences between pre-HDBR, CON, 
and AG. 
 Assessment of the difference between the dicrotic notch of the MCA velocity trace 
and the end diastolic values showed that with the progression towards syncope, the dicrotic 
notch became lower than the end diastolic value in 11 of 12 individuals. For these 11 
individuals, the MCA velocity wave dicrotic notch became less than the end diastolic value 
on average 5.7±4.2 minutes before presyncope pre-HDBR. Post-HDBR this wave profile was 
seen on average 5.8±6.2 minutes and 11.5±12.5 minutes for CON and AG respectively. It 
should be noted that in the AG condition this average included two individuals who showed 
the smaller dicrotic notch values at 21 and 36 minutes before presyncope. When these 
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individuals were removed from the average, it became 5.6±5.2 minutes before presyncope. 
No differences with HDBR were seen with these values. 
 Analysis of the 10s averages for the last 15 minutes of the test suggest a good 
agreement between the temporal artery diastolic velocity and temporal artery vascular 
resistance (Figure 5.3 A). The graph of the difference between the minimum MCA velocity 
and the end diastolic value showed values around 0 until the last five minutes of the test. At 
this point, the minimum value on the MCA velocity trace, corresponding to the dicrotic 
notch, was less than the end diastolic value. This value also appeared to be inversely related 
to CVRi (Figure 5.3 B) until the last minute of the test where the two signals diverged with a 
dramatic decrease in CVRi and the continual increase of CBFVmin-dia. (becoming more 
negative).  
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Table 5.1: Transfer function gain and phase for the MAP-->CBFV and MAP-->CVRi relationships 
     
Pre-HDBR Post-HDBR 
  PRE CON AG Tolerant Non-tolerant Tolerant Non-tolerant 






















































































































































































 Values are means ± SD with number of observations in superscript parentheses. Values are calculated for pre-HDBR (PRE), post-HDBR 
without countermeasures (CON), and post-HDBR with the artificial gravity countermeasure (AG). Values for PRE and CON are further separated 
into those individuals who in the CON condition could complete 10 minutes of tilt pre-HDBR and post-HDBR (Tolerant) and those who completed 


















































































Figure 5.3: VTEMP and CBFV in last 15 minutes 
Graphs showing last 15 minutes of the tests for all subjects pre-HDBR, where syncope occurred at 
time 0 on the graph. Changes in VTEMP minimum (A) and CBFVmin-dia (B) appeared to mirror those 
of TEMPVR CVRi (note the inverted scales of TEMPVR and CVRi). 
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 Linear regressions analysis was done for each subject to further examine the changes 
in the minimum value of the temporal velocity trace and CBFVmin-dia. A summary of 
average results are presented in Table 5.2 with average R
2
 values presented for subjects 
showing significant relationships (P<0.001). Briefly, regression analysis suggested that 
changes in the minimum VTEMP values were related to alterations in vascular resistance 
(TEMPVR), cardiac stroke volume (SV), and arterial pressure (BPMCA). Similarly, the 
difference between the dicrotic notch and end diastole of CBFV showed significant relations 
to alterations in SV and BPMCA with a weaker association with vascular resistance (CVRi). 
 
Table 5.2: Correlation coefficients for linear regressions assessing the relationships of VTEMP min 
and CBFVmin-dia with respect to BPMCA, vascular resistance (VR), and cardiac stroke volume 
(SV) 
 BPMCA VR SV 












 Values are the Pearson product moment correlation squared (mean ± SD) with the number of 
individuals out of 12 with significant relationships in parentheses. 
5.5 Discussion 
 This study provided the opportunity to examine morphological changes in the 
temporal artery and middle cerebral artery blood velocity wave profiles with the progression 
towards syncope and the comparison morphological changes to other measured 
hemodynamic variables both before and after exposure to five days of HDBR. The major 
finding of this study was that, in the majority of subjects, the Doppler spectrum morphology 
profiles of both the temporal artery and middle cerebral artery showed consistent alterations 
with the progression towards syncope with definitive changes occurring less than five 
minutes before the onset of syncope both before and after exposure to five days of 
continuous HDBR. Analysis also suggested that the alterations in the VTEMP velocity profile 
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were associated with changes in vascular resistance and arterial pressure, where alterations in 
the CBFV velocity profile were associated with change in cardiac stroke volume and arterial 
pressure. 
5.5.1 Doppler Spectrum Morphology 
 Previous work has suggested that the appearance of temporal artery negative velocity 
can be used as an indicator of approaching syncope (Arbeille et al., 2012). It has been 
previously demonstrated that in 66% of cases, negative temporal artery velocity appeared on 
average 5 minutes before the end of the test. This study emphasized that the negative velocity 
indicated increased vascular resistance in the final phase before the onset of presyncope and 
is a sign that is easily detectable in real time. In the current study, a more quantitative 
assessment of the appearance of temporal negative velocity in that three consecutive ten 
second averages were required with the minimum temporal velocity value less than 0.5cm/s. 
With the analysis used in this study, negative temporal artery velocity tended to appear 
earlier in the test when all individuals were considered. However, when three individuals 
who showed the appearance of temporal artery negative velocity early in the test were 
excluded from the analysis, similar to previously reported, the temporal negative velocity 
appeared much closer, approximately 2 minutes before the onset of syncope.  
 Several things could account for this discrepancy in results for the timing of the 
definitive morphological change of the temporal artery velocity profile. One of the primary 
issues is in the selection of the point where negative velocity appears. In the previous study, 
the negative velocity appearance was determined through quasi-qualitative assessment of the 
Doppler trace in order to determine if the appearance of temporal negative velocity could be 
used as a real time indicator for the onset of syncope. In this study, velocity was strictly 
quantitatively assessed; therefore, it is possible that in the analysis for this study, small 
variations in signal quality produced down spikes/noise in the VTEMP signal that could have 
produced 10 second averages less than -0.5cm/s or that oscillations in the velocity signal 
would show negative velocity in real time, but would average to a value greater than -
0.5cm/s and thus be excluded in the current analysis. With respect to the results from the 
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previous paper and this paper, it would appear that the appearance of negative temporal 
artery velocity is a good signal for use in real time during orthostatic tolerance testing, 
however, further work with recording of temporal artery blood velocity is required to 
determine the appropriate quantitative threshold to use when assessing temporal artery 
negative velocity and vascular resistance. 
 This study also showed that with the progression towards syncope, the MCA velocity 
waveform showed morphological alterations in which the value of the dicrotic notch of the 
signal became smaller than the end diastolic velocity value. Previous work has demonstrated 
this type of waveform alteration with respect to patients with a history of neurocardiogenic 
syncope (Albina et al., 2004); however, no work has been done to determine if this response 
is consistent with the approach of syncope in patient or non-patient populations, or how this 
change relates to other cerebrovascular variables. Figure 5.1 shows a representative velocity 
waveform from the temporal artery (top) and the middle cerebral artery (bottom) during 
supine rest (left) and during the last minute before syncope (right). At rest the two velocity 
waves show similar profiles with continuous positive velocity; however, with the approach to 
syncope, the temporal velocity wave shows a negative component corresponding to the 
dicrotic notch. Whereas, the MCA velocity wave continues to show positive velocity with the 
dicrotic notch less than the end diastolic value. Relating these two waveform profile changes 
would suggest that the deepening of the dicrotic notch of the MCA velocity and the negative 
component of the temporal artery velocity wave could be associated with changes in 
downstream vascular resistance.  
 Previous work with the Doppler resistance indices of vascular resistance and direct 
measures of vascular resistance have shown alterations in the diastolic component of the 
velocity waveform such that there is a reduced positive diastolic value with increasing 
resistance (Adamson et al., 1990), transitioning to a negative component in high resistance 
vascular beds (Arbeille et al., 1995). In the current study, changes in temporal artery 
minimum velocity seemed to track well with alteration in vascular resistance. Linear 
regression analysis conducted for each individual using 10s averages from the last 15min of 
the test showed significant relationships between changes in VTEMP minimum and TEMPVR. 
 
 100 
Conversely, although the alterations in the CBFV waveform were similar morphologically to 
the changes in VTEMP, changes in CBFV only showed week relations to alterations in CVRi 
suggesting that other variables, including absolute cerebral blood flow and changes in 
vascular tone, could have contributed to this observed change.  
 Part of this difference could be related to the influence of cerebrovascular 
autoregulation. Located at the same height above the heart, both the MCA and temporal 
artery are subjected to similar hydrostatic forces. However, blood flow in the MCA is also 
affected by the influences of cerebrovascular autoregulation serving to reduce vascular 
resistance with reductions in perfusion pressure thus allowing for the maintenance of cerebral 
blood flow. Whereas, blood flow in the temporal artery does not experience the protective 
effects of cerebrovascular autoregulation and is influenced by sympathetic vasoconstriction 
which serves to reduce blood flow in this vascular territory. In this case, where the changes in 
VTEMP morphology appear to be related to alterations in downstream vascular resistance, the 
changes in CBFV may be indicative of reduced total flow in an area of low vascular 
resistance with alterations in cerebrovascular tone. 
5.5.2 Cerebrovascular Autoregulation 
 In the present study, dynamic cerebrovascular autoregulation was determined using 
cross-spectral analysis. Contrary to our hypotheses, the results of this study showed no 
changes in autoregulation after five days of HDBR in either the CON or AG conditions. In 
addition, when subjects were grouped into those who could complete 10 minutes of tilt after 
5 days of HDBR in the CON condition (tolerant) and those who could not complete 10 
minutes of tilt (non-tolerant) there was again no differences in the effects of HDBR between 
the two groups.  
 Previous studies investigating cerebral blood flow responses before and after 
exposure to real or simulated microgravity have shown varied responses. In response to 
LBNP or assuming a head up posture, studies have found greater reductions in CBFV 
potential indicating an impaired ability to regulate cerebral blood flow (Kawai et al., 1993; 
Zhang et al., 1997). However, other work has shown no change in the CBFV response to tilt 
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or LBNP (Arbeille et al., 1998; Arbeille et al., 2008) or with rapid deflation of leg cuffs 
(Pavy-Le Traon et al., 2002). In the assessment of dynamic cerebral autoregulation, work by 
Zhang et al. (Zhang et al., 1997) showed a trend towards a higher coherence between MAP 
and CBFV post HDBR suggesting an impairment in autoregulation. This is in agreement 
with more recent studies which showed impaired dynamic cerebrovascular regulation after 
long duration spaceflight (Zuj et al., 2012a). However, studies looking at dynamic 
cerebrovascular autoregulation after short duration flight have shown no changes (Iwasaki et 
al., 2007), or impairments in only those astronauts who also showed orthostatic intolerance 
after flight (Blaber et al., 2011). Therefore, it was hypothesized that impairments in 
cerebrovascular autoregulation would also be seen in those individuals unable to complete 10 
minutes of stand post HDBR. Although 7 of 12 individuals were unable to complete 10 
minutes of stand in the CON condition, compared to 2 of 11 in the AG condition, the results 
of this study did not find any effects of HDBR on autoregulation in these groups. The 
reduced orthostatic tolerance with maintenance of cerebrovascular autoregulation seen in this 
study tends to suggest that although some previous work has demonstrated impairments post 
spaceflight and HDBR it does not appear to be a primary cause of the development of 
orthostatic intolerance. 
 As differences in orthostatic tolerance were seen in this study analysis was conducted 
to see if changes in tolerance were related to variation in the timing of Doppler spectrum 
morphology changes. Contrary to our hypothesis, no differences were seen in the timing of 
Doppler morphology changes with respect to the onset of syncope pre to post HDBR in 
either the CON or AG group. However, tests were shorter post HDBR with syncope 
occurring sooner after tilt, changes in Doppler morphology occurred earlier after tilt. Also 
contrary to the hypothesis, no differences in the timing of Doppler resistance indices were 
found between tolerant and non-tolerant individuals. These results would suggest that after 
five days of bed rest, alterations in cerebral blood flow did not contribute to reduced 
orthostatic tolerance. In addition, temporal artery vasoconstriction, indicative of peripheral 
vasoconstriction, also appeared to remain constant, again suggesting additional factors, 




 This study used recordings of middle cerebral artery and temporal artery blood 
velocity as indicators of blood flow in the vascular territories which in turn is used for the 
calculation of vascular resistance. As flow is the product of velocity and vessels cross-
sectional area, changes in the diameter of insonated vessels may confound the results of this 
study. Previous work has shown that the diameter of the MCA remains stable with changes in 
PETCO2 and mild orthostatic stress (Giller et al., 1993; Serrador et al., 2000); however no 
work has been done to determine if the diameter of the MCA changes after real or simulated 
microgravity in humans. Work with animal models suggests a reduction in MCA lumen 
diameter (Wilkerson et al., 1999) with vascular smooth muscle hypertrophy (Wilkerson et al., 
2002; Wilkerson et al., 1999; Lin et al., 2009; Zhang et al., 2001) and increased myogenic 
tone (Wilkerson et al., 2005; Geary et al., 1998; Lin et al., 2009). Therefore, it is possible that 
the lack of change in CBFV seen in the study is the result of reduced cerebral blood flow 
through a smaller middle cerebral artery. However, this is unlikely as the bed rest period was 
only 5 days. 
 It is unknown what effects tilt and the progressions towards syncope have on the 
diameter of the temporal artery. However, with the increased sympathetic activity associated 
with tilt (O'Leary, Kimmerly, Cechetto, & Shoemaker, 2003) vasoconstriction of the 
temporal artery would be expected. If this is the situation, then our assessments of reduced 
temporal artery blood flow and increased vascular resistance would be underestimating 
actual changes. Regardless, any potential changes in temporal artery diameter would not 
change the observation that the temporal artery velocity waveform develops a negative 
component approximately two minutes before the onset of syncope or that this change in 
velocity waveform morphology seems to be related to changes in vascular resistance. 
5.6 Conclusions 
 The results of this study found that both the temporal artery and middle cerebral 
artery Doppler spectrum morphologies showed consistent changes before the onset of 
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syncope and that these alterations were not different after exposure to five days of HDBR. 
Analysis of the temporal artery Doppler velocity waveform showed the appearance of a 
negative component on average two minutes before the onset of syncope and a change in the 
MCA velocity waveform such that the dicrotic notch point became less than the end diastolic 
value. Regression analysis suggested that the change in the temporal artery blood velocity 
waveform was related to alterations in vascular resistance, where the changes in the MCA 
velocity trace were more depended on blood flow. Although there was a reduction in 
orthostatic tolerance after five days of HDBR, there were no changes in either the indices of 
cerebrovascular autoregulation, CBFV and VTEMP responses to tilt, or the alteration in 
Doppler waveform morphology with the progression towards syncope. These results indicate 
that cerebral blood flow regulation is well maintained and does not contribute orthostatic 
intolerance after five days of HDBR. In addition, although both the MCA and temporal artery 
blood velocity profiles showed similar morphological changes, it would appear that VTEMP is 
influenced by vascular resistance, where CBFV is influenced by overall cerebral blood flow 





The calculation of cerebrovascular tone and changes in 
middle cerebral artery diameter with nitroglycerin before 






 Within beat characteristics of the middle cerebral artery (MCA) velocity trace may 
provide an indication of changes in cerebrovascular tone. However, little work has been 
conducted to determine how changes in the velocity trace relate to other indicators of 
cerebrovascular resistance and compliance especially in situations where the diameter of the 
MCA may be changing. The purpose of this study was to assess potential changes in the 
MCA velocity trace with nitroglycerin (NG) and head down bed rest (HDBR) in relation to 
change in the common carotid artery (CCA) velocity profile and calculated indicators of 
cerebrovascular resistance (R), compliance (C), viscoelastic resistance (K), and intertance 
(L). Before and after HDBR, MCA velocity, CCA velocity, CCA diameter, and CCA 
pressure were assessed at rest and after NG. R, C, K, and L were determined using a 
mathematical model (RCKL) with the inputs of CCA pressure and flow. Results showed that 
after 5 days of HDBR there were no changes in resting CCA or calculated MCA diameter. In 
response to NG, both the CCA and MCA were seen to dilate with no differences after 
HDBR. Results from the RCKL model showed a reduction in R and an increase in C with 
NG with no differences at rest or with NG after HDBR. Assessment of velocity waves 
showed that with NG, both the CCA and MCA velocity waves exhibited similar changes. 
Comparison to the RCKL model results, found that the augmentation index and the 
amplitude of the dicrotic notch of the MCA velocity wave were significantly related to C 
both before and after NG. The results of this study demonstrate that cerebrovascular tone and 
the diameter of the MCA are well maintained after 5 days of HDBR. In addition assessment 
of the MCA velocity trace and RCKL modeling suggest that NG results in an increase in 






 Transcranial Doppler (TCD) measurement of cerebral blood flow velocity (CBFV) is 
frequently used as a method for non-invasively assessing cerebrovascular hemodynamics. In 
addition to the calculation of mean CBFV, analysis of within beat changes of the CBFV 
waveform have been used to describe cerebrovascular resistance and tone. However, in 
situations where the insonated vessel is changing the relation of within beat characteristics to 
cerebrovascular tone may be altered. Therefore, the purpose of this study was to use 
measures of common carotid artery (CCA) blood flow and pressure to model the cerebral 
circulation and relate within beat variations in CBFV to the model outputs of cerebrovascular 
hemodynamics.  
 Previous work has shown a consistent drop in CBFV with nitroglycerin stimulation 
(Borisenko & Vlasenko, 1992; Dahl et al., 1989; Dahl et al., 1990; Micieli et al., 1997; 
Siepmann & Kirch, 2000; White et al., 2000) that has been shown to be due to a dilation of 
the middle cerebral artery (Hansen et al., 2007). In addition to changes in CBFV and 
diameter of the MCA, studies have also noted changes in the CBFV waveform (Lockhart et 
al., 2006) and reduction in critical closing pressure suggesting alterations in cerebrovascular 
tone (Moppett et al., 2008). Therefore, stimulation with NG presents an experimental model 
to assess changes in cerebrovascular tone with changes in MCA diameter. 
 Exposure to real and simulated microgravity is associated with cephalic fluid shifts 
(Hargens & Watenpaugh, 1996) that may alter the structure and function of cerebral blood 
vessels. Studies of humans have shown no change (Arbeille et al., 2008; Pavy-Le Traon et 
al., 2002; Zhang et al., 1997; Arbeille et al., 2001) increased (Kawai et al., 1993), and 
decreased (Arbeille et al., 1998; Arbeille et al., 2001; Sun et al., 2005; Frey et al., 1993; 
Hirayanagi et al., 2005) cerebral blood velocity measured by transcranial Doppler ultrasound 
following head-down bed rest (HDBR). However, measures of cerebral blood velocity may 
not accurately reflect cerebral blood flow if the diameter of the insonated artery changes. To 
date, no studies have been conducted in humans to quantitatively assess cerebral blood flow 
before and after HDBR. 
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 In 2007, Zamir et al. (Zamir et al., 2007) presented a mathematical model for the 
assessment peripheral vascular properties. Based on a modified Winkessel model, the RCKL 
model placed vascular resistance (R) in parallel with vascular compliance (C) which was in 
series with viscoelastic resistance (K) an inertance (L). In a pilot study, the RCKL model was 
used with measures of CCA blood flow and pressure to show changes in cerebrovascular 
properties with aging (Robertson et al., 2008). Therefore, this study utilized the RCKL model 
to assess change in cerebrovascular properties to NG and HDBR and related the model 
outputs to assessments of within beat CBFV properties. 
 In this study, it was hypothesized that NG would result in an increase in 
cerebrovascular compliance that would be reflected in both the MCA velocity and CCA flow 
profiles and with RCKL model outputs. Post HDBR, it was hypothesized that RCKL 
modeling would show an increase in vascular resistance and a reduction in vascular 
compliance, but no differences in the response to NG. 
6.3 Methods 
6.3.1 Experimental Protocol 
 Data for this study were collected from twelve healthy men 32±8 years of age (mean 
± SD). The men participated in the study which involved five consecutive days of 6° head 
down bed rest (HDBR) with and without an artificial gravity countermeasure. The study was 
a cross-over design in which each man completed HDBR without countermeasures (CON) 
and with the artificial gravity (AG) countermeasure in random order with each session 
separated by 30 days. All experimental procedures were approved by the Comité Consultatif 
de Protections des Personnes dans la Recherche Biomédicale, Midi-Pyrénées (France), and 
local ethics committees, including the Office of Research Ethics, University of Waterloo. 
After receiving full disclosure of the experimental protocol, each participant signed a consent 
form and was aware of his right to withdraw from the study for any reason without prejudice. 
The entire protocol was in accordance with the declaration of Helsinki. 
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 The AG countermeasure consisted of short arm centrifugation designed to create a 
head to foot force vector with a magnitude of 1g at the centre of mass of the participant. 
Centrifugation was applied for five minutes and repeated six times for a cumulative time of 
30 minutes of AG per day. Due to medical issues during the study, one participant did not 
complete the AG protocol; therefore, data were collected for all twelve individuals in CON 
and only eleven for AG. 
 All measures for the response to nitroglycerin (NG) were collected in a supine 
position. Baseline recordings were conducted after which 0.3mg of NG (Natispray, Proctor & 
Gamble Pharmaceuticals, France) was administered sublingually. Data were continuously 
collected for ten minutes after NG administration. 
6.3.2 Vascular Measures 
 Throughout the protocol, TCD (CardioLab, ESA-CNES device) was used for the 
assessment of CBFV. A 2MHz, pulsed Doppler probe was placed over the right temporal 
window allowing for the insonation of the M1 segment of the MCA. The probe was held in 
place throughout the test via the use of custom designed head gear. The outer envelope of the 
Doppler spectrum was determined and digitally recorded for later processing. Data were 
recorded using CardioMed (ESA-CNES, France) software and the outer envelope digitized at 
100Hz.  
 Echo Doppler ultrasound (ATL HDI 5000, Philips, France) was used for the 
assessment of CCA diameter. A linear transducer was placed over the right CCA and 
longitudinal B-mode images were obtained with simultaneous Doppler velocity. B-mode 
images, Doppler spectrum, and Doppler audio were recorded using digital video tape for later 
processing. 
 Blood pressure waveforms were obtained from the left CCA with the use of a hand 
held Millar pressure transducer. Arterial blood pressure was continuously monitored using 
finger photoplesthysmography (Nexfin, BMEYE B.V, Amsterdam, Netherlands). Due to 
variation in hold-down pressure with the use of the Millar pressure transducer, Millar 
diastolic pressure values were corrected to recorded finger diastolic pressure values.  
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6.3.3 Data Analysis 
 Mean arterial pressure (MAP) was determined as the mean over a cardiac cycle of the 
arterial blood pressure recorded at the finger. The outer envelope of the MCA and CCA 
velocity traces were individually averaged over a cardiac cycle to provide beat-by-beat 
CBFV and CCA velocity values. CCA blood flow was calculated from the resultant velocity 
and mean CCA diameter calculated from the recorded ultrasound video. For both the MCA 
and the CCA, vascular resistance was calculated as CVRi = MAP/CBFV and CCAVR = 
MAP/CCA flow respectively.  
 The change in MCA diameter with NG was calculated using two methods. First, the 
percent diameter change was calculated assuming cerebral blood flow remained constant 
with NG stimulation using the equation (Borisenko & Vlasenko, 1992): 
(Equation 1)        
     
     
        
Where CBFV1 is the mean resting CBFV value and CBFV2 is the mean CBFV value five 
minutes after the administration of NG. Values for CCA flow were also determined in this 
study and can be considered surrogate measures of cerebral blood flow. Therefore, changes 
in MCA diameter were also calculated by: 
(Equation 2)        
    
     
 
     
    
        
Where again, CBFV1 is the mean baseline CBFV value and CBFV2 is the mean CBFV value 
five minutes after the administration of NG. Similarly, CCA1 is the mean common carotid 
flow value during supine rest and CCA2 is the mean common carotid flow value five minutes 
after the administration of NG.  
 For the assessment of velocity wave characteristics of the MCA and CCA waveforms, 
10 to 20 consecutive cardiac cycles were averaged to produce a representative velocity 
waveform. The resultant representative waves were then assessed for potential variation in 
key inflection points (T1, P1, P2, T3, P3, Figure 6.2) with respect to the end diastolic 
velocity (T1). In addition, the augmentation index was calculated as previously described 
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(Kurji et al., 2006; Robertson et al., 2008) as AI = (P2-T1) / (P1-T1) x 100%. CrCP was 
calculated for each beat, as previously described (Panerai et al., 2011) using mean and 
diastolic values for CBFV and arterial blood pressure. The slope of the relationship between 
CBFV and arterial pressure was calculated as a = (CBFVmean – CBFVdia) / (MAP – DBP). 
RAP was then calculated as RAP = 1 / a and CrCP calculated as CrCP = MAP – 
(CBFVmean / a). 
 For the assessment of vascular properties downstream from the CCA, a mathematical 
model was used which was previously presented by Zamir et al. (Zamir et al., 2007) to 
describe characteristics of peripheral vessels. Briefly, in the current study simultaneous 
recordings of CCA pressure and flow were assessed at baseline and after NG stimulation and 
used as inputs to the RCKL model. Values for downstream vascular resistance (R), 
compliance (C), viscoelastic resistance (K), and inertance (L) were determined as model 
outputs. 
6.3.4 Statistical Analysis 
 Unless otherwise stated, values presented show the mean ± SD. Data were assessed 
using a two-way repeated measures analysis of variance for the main effects of HDBR and 
NG (SigmaStat 3.5, Systat Software Inc., Chicago, IL). The potential relationships of 
waveform inflection points, CrCP, and RAP with RCKL model outputs were assessed using 
linear regressions (SigmaStat 3.5, Systat Software Inc., Chicago, IL). For all tests, 
significance was set at P<0.05. 
6.3.5 Analysis Limitations 
 During this study, one individual did not complete the AG condition due to medical 
considerations. Therefore, two-way repeated measures ANOVA assessment of NG responses 
before and after HDBR, only 11 subjects were included. However, relationships between 





 In response to NG, CBFV was seen to decrease (Figure 6.1 B) with a corresponding 
increase in CVRi (Figure 6.1 D). Conversely, there was no change in CCA flow (Figure 6.1 
A) with a reduction in CCAVR (Figure 6.1 C) suggesting that the changes in CBFV and CVRi 
were due to changes in MCA diameter. With HDBR, there were no differences in resting 
values or responses to NG for any of these variables.  
 With HDBR, there were no changes in resting diameter of the CCA or MCA 
calculated with the assumption of constant CBF or using CCA flow as a surrogate of cerebral 
blood flow (Table 6.1). In response to NG, dilation was seen of the CCA with no changes 
after HDBR. Similarly, the MCA also showed dilation in response to NG with both 
calculation methods. Post HDBR, the dilation response of the MCA was larger in the CON 
condition when no change in cerebral blood flow was assumed with NG (P=0.016); however, 
no differences in the dilation response were seen when CCA flow was used as a quantitative 
indication of cerebral blood flow. 
 Changes were seen in both the CCA and MCA Doppler spectrum morphology with 
NG stimulation (Table 6.2). Waveforms presented in Figure 6.2 show data from one subject 
pre-HDBR with the baseline wave shift so that initial points at time 0 were equal. For both 
the CCA and MCA velocity waveforms, there were significant reductions in P1-T1, P2-T1, 
and T3-T1 with NG stimulation. For the MCA velocity trace P3-T1 was also reduced, but 
this did not reach significance with the CCA velocity trace (P=0.08). There was a significant 
reduction in AI for both the CCA and MCA with NG stimulation (Table 6.2). No differences 
at rest or with NG stimulation were seen after HDBR. The calculation of CrCP showed no 
changes with NG where RAP was seen to increase (Table 6.3). There were no effects of 
























































































Figure 6.1: Cerebral and carotid responses to NG 
Values at baseline and in response to NG for changes in CCA blood flow (A), CBFV (B), CCAVR (C), 
and CVRi (D). Bars represent PRE (black), CON (white), and AG (grey) (mean ± SD, n=11). 
Statistical analysis showed significant decreases in CCAVR and CBFV and an increase in CVRi with 




Table 6.1: Calculated percent change in vessel diameter with NG and HDBR 
 Condition CCA 
MCA 
(no change CBF) 
MCA 
(CCA Flow) 
% Change HDBR CON 0.56 ± 4.81 -0.68 ± 5.93 2.74 ± 6.86 
 AG -0.89 ± 3.82 -0.54 ± 7.14 0.21 ± 8.64 
% Change NG PRE 6.54 ± 3.28 12.37 ± 3.42  13.06 ± 5.49 
 CON 6.47 ± 4.06 16.41 ± 4.52* 16.66 ± 7.30 
 AG 8.56 ± 4.69 13.04 ± 2.98 17.28 ± 7.67 
 Values show the mean ± SD (n=11) for each calculated percent change in vessel diameter. 
Percent changes are presented for the CCA and the MCA diameter calculated assuming no changes 
in cerebral blood flow and using CCA flow as a surrogate for cerebral blood flow. No statistically 
significant changes in resting diameter were seen with HDBR. Diameter changes with NG that are 
statistically different from PRE are denoted by * (P<0.05). 
 
Table 6.2: Velocity wave inflection points with NG and HDBR 
   AI (%) P1-T1 (cm/s) P2-T1 (cm/s) T3-T1 (cm/s) P3-T1 (cm/s) 
MCA PRE Baseline 65.63±9.76 36.39±6.16 23.54±3.72 13.12±2.94 18.47±2.96 
  Nitro 44.79±9.76* 28.45±6.03* 12.44±2.61* 5.55±2.52* 11.50±2.75* 
 CON Baseline 66.46±12.55 37.00±7.56 24.15±4.94 14.48±3.84 18.97±3.51 
  Nitro 42.25±11.56* 27.53±4.14* 11.47±3.13* 5.30±2.30* 10.61±1.79* 
 AG Baseline 63.99±12.94 37.59±9.73 23.37±5.31 13.77±3.39 18.59±3.89 
  Nitro 43.16±13.49* 28.34±6.75* 11.95±4.25* 6.21±3.66* 11.77±2.39* 
CCA PRE Baseline 26.45±9.62 70.61±8.38 18.33±6.28 7.00±8.38 17.23±3.33 
  Nitro 10.78±12.26* 65.85±11.33* 6.06±8.74* -0.62±8.09* 15.56±3.96 
 CON Baseline 26.24±10.90 78.72±20.90 19.03±6.77 8.44±20.90 17.61±4.71 
  Nitro 9.90±13.15* 69.38±16.88* 5.24±9.22* -0.80±9.36* 16.25±5.44 
 AG Baseline 27.26±11.70 73.88±11.50 19.51±7.09 8.74±4.60 17.48±3.68 
  Nitro 10.91±11.95* 69.13±10.53* 6.64±8.13* 0.98±7.90* 16.38±4.18 
 Values show the mean ± SD (n-11) for the augmentation index (AI) and the differences 
between inflection points and the end diastolic value (T1). Values after NG stimulation that are 
statistically different from baseline are denoted by * (P<0.05). No statistically significant differences 

























































Figure 6.2:Representative MCA and CCA velocity traces 
Representative tracing from one individual of the Doppler velocity waves for the MCA (A) and the 
CCA (B) during resting baseline (black) and after NG stimulation (grey). Points on the waves 






















































































Figure 6.3: RCKL results with NG and HDBR 
Values at baseline and in response to NG for RCKL model outputs of resistance (R, panel A), 
compliance (C, panel B), viscoelastic resistance (K, panel C), inertance (L, panel D). Bars represent 
PRE (black), CON (white), and AG (grey) (mean ± SD, n=11). Statistical analysis showed significant 




Table 6.3: CrCP and RAP values with NG and HDBR 
  CrCP (mmHg) RAP 
PRE Baseline 24.90±5.63 1.70±0.30 
 Nitro 22.91±6.06 2.13±0.45* 
CON Baseline 27.36±10.32 1.64±0.38 
 Nitro 21.85±8.68 2.12±0.39* 
AG Baseline 23.03±6.40 1.78±0.45 
 Nitro 20.60±9.57 2.23±0.76* 
 Values show the mean ± SD (n-11) for the critical closing pressure (CrCP) and resistance 
area product (RAP). Values after NG stimulation that are statistically different from baseline are 
denoted by * (P<0.05). No statistically significant differences were seen with HDBR. 
 
 In response to NG, the RCKL model revealed a reduction in vascular resistance 
(Figure 6.3 A), an increase in vascular compliance (Figure 6.3 B), and no changes in either 
viscoelastic resistance (Figure 6.3 C) or inertance (Figure 6.3 D). No differences were seen 
with HDBR for any model output.  
 Pre-HDBR RCKL model outputs were compared to MCA velocity wave points, AI, 
CrCP and RAP using linear regressions both before and after NG stimulation. Results from 
the analysis showed a strong trend for RAP to be related to R at rest (P=0.058) and 
significantly related to R after NG. Similarly, P1-T1, or the pulse amplitude of the wave was 
significantly related to R at rest (P=0.05) and after NG (P=0.002). Results also showed that 
AI (Figure 6.4 A) and T3-T1 (amplitude of the dicrotic notch, Figure 6.4 B) were 
significantly related to C both before (P=0.001, and P=0.005 respectively) and after NG 
(P<0.001 and P=0.002 respectively). P2 was also significantly related to C after NG 
(P=0.013) with a trend towards the same relationship at baseline (P=0.082). After NG, K was 
related to RAP (P=0.049) and AI (P=0.015) with a trend towards being related to P1-T1 
(pulse amplitude, P=0.088) and T3-T1 (dicrotic notch amplitude, P=0.082). No significant 





































Figure 6.4: Linear regression results for AI and T3-T1 with C 
Linear regression results testing the relationship between pre-HDBR resting values (black circles) 
and NG values (grey circles) of AI (panel A), T3-T1 (the dicrotic notch, panel B) and C (vascular 
compliance). The results of this analysis showed significant linear relationships between C and both 




 The current study used quantitative measures of cerebral blood flow along with 
mathematical modeling and waveform inflection point analysis to determine cerebrovascular 
responses to NG before and after five days of HDBR. In support of the hypothesis, RCKL 
modeling and assessment of MCA velocity wave form inflection points suggested increased 
compliance of the cerebrovasculature. Similarly, the changes in MCA velocity waveform 
inflection points were mirrored in the CCA flow waveform suggesting that change in the 
CCA reflect alterations in cerebrovascular conditions with NG stimulation. In contrast to the 
hypothesis, no difference in any variable assessed was seen after HDBR in either the CON or 
AG conditions. 
6.5.1 Blood Flow, Resistance, and Cross-Sectional Area 
 The use of transcranial Doppler ultrasound allows for the assessment of cerebral 
blood velocity, but the interpretation of results with respect to cerebral blood flow is 
dependent on the diameter of the insonated vessel (normally the MCA) remaining constant. 
Studies have frequently shown reduction in CBFV with NG stimulation (Borisenko & 
Vlasenko, 1992; Dahl et al., 1989; Siepmann & Kirch, 2000; White et al., 2000) with 
quantitative assessments of cerebral blood flow showing no changes (Dahl et al., 1989; 
White et al., 2000; Borisenko & Vlasenko, 1992) and MRI measurements suggesting dilation 
of the MCA (Hansen et al., 2007). The results of the current study are in agreement with 
previous work in that reductions in CBFV were observed along with no changes in 
quantitative measures of cerebral blood flow indicating the dilation of the MCA. 
 The percent dilation of the MCA was assessed with HDBR and NG using CCA flow 
measures as a surrogate for cerebral blood flow. One study, which assessed cerebral blood 
flow with NG, suggested that a 15% dilation of the MCA was required to account for the 
reduction in velocity and observed measures of cerebral blood flow. Similar results were 
found with MRI assessments of the MCA after NG stimulation finding a 10-14% dilation of 
the MCA. The results of the current study were consistent with both of these studies, as a 
dilation of 13% was found with NG pre-HDBR, and dilations of 16% and 17% post-HDBR.   
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 No previous work has examined potential changes in MCA diameter with HDRB in 
humans. Animal studies of microgravity exposure have suggested structural changes in 
cerebral arteries (Wilkerson et al., 1999; Lin et al., 2009; Zhang et al., 2001; Wilkerson et al., 
2002) with a reduced lumen cross sectional area (Wilkerson et al., 1999). However, other 
work has demonstrated that these changes only occurred with simulated microgravity 
exposure lasting longer than 7 days (Bao et al., 2007; Gao et al., 2009). Therefore, it was 
unlikely that any structural change would be present after only 5 days of HDBR. The results 
of this study support this as no changes in calculated MCA diameter were found.  
 Assessment of vascular resistance showed opposite responses of CVRi and CCAVR to 
NG. An increase in CVRi was seen with NG; however, the calculation of CVRi is dependent 
on the assumption that CBFV represents cerebral blood flow. As the MCA was seen to dilate 
with NG stimulation, the observed increase in CVRi is due to the change in vessel diameter 
and not changes in cerebrovascular resistance. Conversely, there was a small but significant 
reduction in CCAVR that served of offset a slight reduction in arterial pressure (data not 
shown) to maintain CCA blood flow. As the diameter of the MCA is changing, these results 
highlight the need for caution in interpreting CBFV responses as reflective of cerebral 
hemodynamics. 
6.5.2 Cerebrovascular Tone 
 This study has demonstrated that the use of CCA blood flow as a quantitative 
assessment of cerebral blood flow revealed changes in the MCA diameter with NG 
stimulation. This study also used the quantitative assessment of CCA blood flow to examine 
potential changes in cerebrovascular tone through the use of waveform analysis and RCKL 
modelling. Previous work has noted alterations in ophthalmic artery Doppler wave 
morphology with NG stimulation (Lockhart et al., 2006). It has also been suggested that an 
augmentation index based on the peak systolic values (P1) and the reflected peak (P2) can be 
calculated that would be reflective of vascular compliance (Kurji et al., 2006; Robertson et 
al., 2008). Changes in the augmentation index of the MCA velocity wave have been noted 
with hypercapnia (Robertson et al., 2008) and aging (Kurji et al., 2006) with both situations 
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showing an increase in the index suggesting a reduction in cerebrovascular compliance. In 
the current study, alterations in key inflection points were noted with the MCA and, to a 
lesser extent, the CCA in that with NG there were reductions in the amplitudes of all 
inflection points with respect to the end diastolic value (Figure 4, Table 2). In addition, the 
augmentation index calculated for both the MCA and CCA velocity waves was reduced 
suggesting an increase in cerebrovascular compliance. These results support the hypothesis 
that the MCA velocity wave and CCA flow wave would show similar changes in NG and 
that NG would result in an increase in vascular compliance. 
 In contrast to the augmentation index results, the calculation of CrCP was not 
significantly different with NG. Previous work has shown a reduction in CrCP with NG 
(Moppett et al., 2008) which is in agreement with the augmentation index results suggesting 
a reduction in cerebrovascular tone with NG. With the current data set, a small but significant 
reduction in PETCO2 was noted with NG (data not show). Previous work has shown an 
increase in CrCP with a reduction in PETCO2 (Ainslie et al., 2008; Carey et al., 2001; Hsu et 
al., 2004). Therefore, in the current study the lack of a significant reduction in CrCP may be 
attributed to the confounding influence of the reduction in PETCO2.  
 Of additional consideration is the calculation method used in the current study to 
determine CrCP. Where previous work has used a linear regression between CBFV and 
arterial pressure to calculate CrCP (Moppett et al., 2008), the current study utilized a two 
point method which only involved the calculation of mean and diastolic CBFV and arterial 
pressure. This method has been shown to have good repeatability (Panerai et al., 2011); 
however, it may not be as sensitive in detecting changes in vascular tone with NG. The 
calculation method for CrCP used in this study may also explain the lack of relationship 
between CrCP and RCKL outputs before and after NG.  
 Mathematical modeling was used in an attempt to further explain the variation in 
MCA velocity waveforms with NG stimulation. The RCKL model has been previously used 
with the peripheral vasculature to show alterations in vascular compliance independent of 
vascular resistance (Zamir et al., 2007). The results from the current study showed an 
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increase in cerebrovascular compliance and a reduction in resistance with no changes in 
viscoeastic resistance or inertance with NG stimulation. The observed increase in 
cerebrovascular compliance is in agreement with previous investigations showing increased 
peripheral vascular compliance (Smulyan et al., 1986; Bank & Kaiser, 1998) and results 
showing a reduction in CrCP suggesting an increase in cerebrovascular compliance (Moppett 
et al., 2008).  
 Linear regressions were performed between RCKL model results and MCA velocity 
wave inflection points at rest pre-HDBR in an attempt to determine the how inflection points 
relate to cerebrovascular properties. Previous work has related the shape of the MCA velocity 
waveform for the interpretation of inflection points (Robertson et al., 2008; Aggarwal et al., 
2008) but no work has attempted to directly relate these variables to other assessments of 
cerebrovascular properties. Results of the current study found that the pulse amplitude (P1-
T1) of the velocity wave was related to vascular resistance which is consistent with the use of 
the Doppler resistance indices (Gosling, Lo, & Taylor, 1991) which relate the pulse 
amplitude of the velocity trace to either the mean velocity (PI) or the peak velocity (RI) to 
provide an indication of vascular resistance. Interestingly, the vascular compliance output 
from the RCKL model was significantly related to AI, P2-T1, and T3-T1. 
 The augmentation index of the velocity wave is based on the assessment of central 
pressure waves which identified a second systolic peak which was generated from a reflected 
pressure wave (Nichols et al., 2008). Work with the common carotid artery has demonstrated 
that the augmentation index calculated from the flow wave was linearly related to the 
augmentation index calculated from the pressure wave (Hirata, Yaginuma, O'Rourke, & 
Kawakami, 2006). Therefore, it was expected that AI calculated from the MCA velocity 
wave and the pulse amplitude of P2, which is due to the reflected wave, would be 
significantly related to the value of C from the RCKL model.  
 In addition to the augmentation index, the amplitude of the dicrotic notch was 
inversely related to vascular compliance. This too can be explained by the velocity of the 
reflected component of the wave as a greater P2 would serves to increase the pulse amplitude 
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to the dicrotic notch as a greater amount of the mean flow is occurring in the systolic portion 
of the velocity wave. Previous work has shown that an increase in the ratio of velocity in the 
systolic portion of the ophthalmic artery velocity wave to that in the diastolic portion is 
significantly related to central vascular compliance, such that an increase in the ratio was 
related to a decrease in central vascular compliance (Maruyoshi et al., 2010). It is unclear 
how the results presented in this chapter relate to central vascular properties, but they do 
highlight that changes in the augmentation index, the amplitude of the reflected peak, and the 
amplitude of the dicrotic notch are all related to changes in vascular compliance downstream 
from the CCA. 
 In response to HDBR, no differences in cerebral vascular tone were seen with either 
the RCKL model results or MCA velocity wave inflection points. Work with animal models 
of microgravity exposure has suggested increased myogenic tone of cerebral vessels 
(Wilkerson et al., 2005; Geary et al., 1998; Lin et al., 2009). In contrast, human studies have 
suggested both increased (Eiken et al., 2008) and decreased (Tuday et al., 2007; Baevsky et 
al., 2007) arterial compliance with microgravity, but no study has been published examining 
potential changes in human cerebrovascular tone. The results of the current study show that 
cerebrovascular tone is well maintained after exposure to 5 days of HDBR.  
6.5.3 Limitations 
 One of the major limitations with this study was with respect to the length of the 
HDBR period. As the study only involved 5 days of HDBR, it was unlikely that any 
structural changes in the cerebrovasculature occurred during this time. Animal studies have 
observed an upregulation of proteins involved in the synthesis of angiotensinogen and of 
angiotensin-II type-1 receptors in cerebral and carotid arteries that was associated with 
increased arterial wall thickness after four weeks, but not seven days of hind limb suspension 
(Bao et al., 2007; Gao et al., 2009) suggesting that longer exposure to simulated microgravity 
is needed to induce structural changes in cerebral arteries. Therefore, the results of the 
current study demonstrate that cerebral blood flow and tone were well maintained after 5 
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days of HDBR; however, it is unclear if this result would be consistent after longer durations 
of HDBR.  
 Results of the current study are based on ultrasound assessments of CBFV and CCA 
diameter and velocity. As such, results are subject to errors inherent in each of these 
measures. These include the possibility of measurements being taken at different points along 
the vascular tree, or alterations in the angle of insonation. Care was taken to minimize these 
errors, however they cannot be completely ruled out as contributing factors in the variability 
of results. 
 An additional consideration with the current data is the timing of measures after the 
administration of NG. Efforts were made to ensure that measures were taken at consistent 
time points after the administration of NG, but, due to variability in signal acquisition times, 
measures were taken between 5 and 10 minutes after NG. Previous work has shown that 
CBFV is reduced up to 30min post NG stimulation (Dahl et al., 1989); therefore, it was 
thought that the variability in data collection timing post NG would not affect results. 
 Assessment of cerebrovascular resistance and compliance was done using the RCKL 
model previously presented (Robertson et al., 2008; Zamir et al., 2007). This model requires 
the simultaneous assessment of pressure and flow as input variables. To accommodate this, 
pressure and flow measures were taken from the left and right CCA respectively. Results 
from the model provide outputs reflecting vascular resistance and compliance downstream 
from the point of measurement and include the influences of both changes in intracranial and 
extracranial hemodynamics. No studies have been conducted to determine if differences exist 
between extracranial and intracranial hemodynamic responses to NG. However, the increase 
in compliance seen in the current study match changes expected from previously published 
work which used the calculation of CrCP to determine changes in cerebrovascular tone 
(Moppett et al., 2008) and from the assessment of peripheral vascular responses (Smulyan et 




 This study was the first to use quantitative measures of CCA blood flow along with 
measures of CBFV to assess cerebrovascular responses to NG before and after exposure to 
five days of HDBR. In support of the hypotheses, alterations in MCA velocity wave 
inflection points were seen with NG and were reflected in similar alteration in CCA blood 
flow inflection points. The use of mathematical RCKL modelling showed that NG resulted in 
a decrease in resistance that was linearly related to the pulse amplitude of the velocity trace, 
and an increase in vascular compliance related to the calculated augmentation index, the peak 
of the reflected velocity wave, and the amplitude of the dicrotic notch of the velocity trace. 
No differences in resting cerebrovascular variables or responses to NG were seen with 
HDBR. The use of quantitative measures of CCA blood flow as an indication of cerebral 
blood flow demonstrated that resting cerebrovascular variables and responses to NG are well 





Common carotid artery blood flow as a quantitative 
indicator of cerebral blood flow for the assessment of 







 The use of transcranial Doppler ultrasound for the assessment of cerebral 
hemodynamics is dependent on the diameter of the insonated vessel remaining constant. As 
this may not be the case under all conditions, the purpose of the current study was to use 
measures of common carotid artery (CCA) blood flow to determine potential changes in 
middle cerebral artery (MCA) diameter with nitroglycerin (NG) and acute changes in the 
partial pressure of end tidal carbon dioxide (PETCO2). Data were collected from 12 subjects 
who performed 30s of breath-hold after a normal inspiration and 20s of breath-hold 
following 30s of hyperventilation. Data were also collected from these same subjects before 
and after stimulation with NG. MCA and CCA velocity were continuously recorded 
throughout the test. CCA flow was calculated from diameter measures taken at rest, after the 
30s of hyperventilation, after each of the breath holds, and every 30s after NG for 9 minutes. 
Regression analysis was performed to determine the relationship between MCA velocity and 
CCA flow for both NG and acute changes in PETCO2. No relationship was found between 
CCA flow and CBFV with NG confirming the dilation of the MCA with NG. With changes 
in PETCO2 a significant non-linear relationship was found between MCA velocity and CCA 
flow suggesting the dilation of the MCA with acute changes in PETCO2. Using CCA flow as 
a quantitative measure of cerebral blood flow, a 13% dilation of the MCA was found with 
NG. With alterations in PETCO2, the MCA diameter was found to increase by 8% with 
hypoventilation and decrease by 7% with hyperventilation. The results of this study 
demonstrate that the diameter of the MCA does not remain constant with NG or acute 






 Transcranial Doppler ultrasound (TCD) is frequently used as a method for the non-
invasive estimation of cerebral blood flow. However, TCD is limited in that the diameter of 
the insonated vessel, traditionally the middle cerebral artery (MCA) is not known and 
therefore, cerebral blood flow velocity (CBFV) is measured and not quantitative measures of 
cerebral blood flow. As the diameter of the MCA may not remain constant under all 
conditions, the quantitative assessment of blood flow in vessels supplying the cerebral 
circulation may provide a more complete picture of changes in cerebrovascular 
hemodynamics including calculations of potential changes in MCA diameter. 
 The common carotid artery (CCA) is a readily accessible vessel which provides a 
non-invasive indication of cerebral blood flow. The CCA bifurcates to form the internal 
(ICA) and external (ECA) carotid arteries with approximately 65% of blood flow going to 
the cerebral circulation via the ICA at rest (Sato, Ogoh, Hirasawa, Oue, & Sadamoto, 2011). 
Recently, Sato et al. (Sato et al., 2012) have demonstrated that ECA flow does not change 
with hyper- and hypo-capnia which suggests that the observed changes in ICA flow are 
reflected in CCA flow. Therefore, these results suggest that the CCA provides a quantitative 
assessment of cerebral blood flow with changes in CO2.   
 Nitroglycerin has been frequently used in research settings as a method to elicit 
maximal vasodilation independent of the endothelium (Bleeker et al., 2005; Bonnin et al., 
2001; Platts et al., 2009). With respect to the cerebral circulation, studies have consistently 
shown a reduction in CBFV with NG (Bishop et al., 1986; Poeppel et al., 2007; Ulrich et al., 
1995; Dahl et al., 1992; Muller et al., 1995; Dahl et al., 1994). However, this reduction has 
been shown to result from dilation of the MCA (Hansen et al., 2007) with no changes in 
cerebral blood flow (Borisenko & Vlasenko, 1992; White et al., 2000). In addition to the 
assumption of no change in cerebral blood flow with NG, the MCA diameter change can also 
be calculated using CCA flow as a quantitative indication of cerebral blood flow.  
 In a recent study, Willie et al. (Willie et al., 2012) showed that with change in the 
arterial partial pressure of carbon dioxide (PaCO2), CBFV measures underestimated the 
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change in cerebral blood flow as measured by internal carotid artery blood flow, thus 
suggesting the potential dilation or constriction of the MCA. This is in contrast to other work 
that has suggested that the diameter of the MCA remains constant with changes in PaCO2 
(Giller et al., 1993; Serrador et al., 2000; Valdueza et al., 1997). Willie et al. (Willie et al., 
2012) utilized 15 minute step changes in PaCO2 to assess CBFV and ICA blood flow 
responses which could influence the CBFV responses to hyper- and hypo-capnia. Therefore, 
it is unclear if similar changes in MCA diameter would be observed over a shorter time 
frame, or if the observed changes are due to the duration of the CO2 stimulus.  
 The purpose of this study was to assess CBFV responses along with quantitative 
measures of CCA blood flow to determine potential MCA diameter changes with NG and 
acute changes in PaCO2. It was hypothesized that no relationship would exist between CCA 
blood flow and CBFV with NG indicating the dilation of the MCA. With changes in PaCO2, 
it was hypothesized that a non-linear relationship would be seen between CBFV and CCA 
blood flow indicating changes in MCA diameter with acute changes in PaCO2. 
7.3 Methods 
 Twelve individuals were tested (six men) with a mean age of 26±4 years (mean ± 
SD). All experimental procedures were approved by the University of Waterloo, Office of 
Research Ethics, and protocol conducted in accordance with the declaration of Helsinki. All 
participants signed informed consent and were aware of their right to withdraw from the 
study at any time without prejudice.  
 Participants were requested to abstain from consuming caffeine for 12 hours and food 
for two hours before the start of the testing session. All testing took place with participants at 
supine rest. Variations in ventilation were used to manipulate end tidal CO2 (PETCO2) 
thought to reflect alterations in PaCO2. Two bouts of hypoventilation and two bouts of 
hyperventilation, each separated by 1.5 minutes of rest, were performed by the participants. 
Hypoventilation consisted of 30s of breath hold in which subjects were instructed to start the 
breath hold at the end of a normal inspiration. For hyperventilation testing, subjects were 
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instructed to increase tidal volume and slightly increase breathing frequency to achieve a low 
level of hyperventilation. This breathing pattern was maintained for 30s immediately after 
which subjects performed a 20s breath hold which was initiated at the end of an inspiration. 
Expired CO2 was measured (Colin, Pilot, San Antonio, TX) from a nasal cannula. Values 
were recorded as percent CO2 and later converted to mmHg based on ambient temperature 
and barometric pressure.  
 Subjects always performed the NG testing following the manipulations in PETCO2. 
Previous work has shown the effects of NG stimulation on CBFV persisting for, on average, 
30 minutes after stimulation (Dahl et al., 1989). Therefore, the testing was done in this order 
to avoid any confounding effects on NG on the CO2 testing. For the NG testing, two minutes 
of supine rest were recorded for baseline measures after which 0.4mg of NG was 
administered sublingually (Nitrolingual ®). Data were recorded continuously for 10 minutes 
after NG stimulation. 
7.3.1 Cardiovascular Variables 
 Heart rate (HR) was determined using a standard three lead electrocardiogram and 
arterial blood pressure continuously recorded using finger photoplethysmography 
(Finometer, Finapres Medical, Amsterdam). TCD was used for the assessment of CBFV with 
a 2MHz Doppler ultrasound probe fixed in place using a head band over the temporal 
window allowing for the insonation of the right MCA (Multigon Industries, New York, NY). 
Blood velocity was assessed in the ipsilateral common carotid artery using a 4MHz Doppler 
probe with a fixed 45° angle (Multigon Industries, New York, NY). It was assumed that the 
common carotid artery was parallel to the skin surface and, therefore, velocity measures were 
corrected for a 45° angle of insonation. The beat-by-beat means of the outer envelopes of the 
MCA and CCA velocity signals were determined for analysis. 
 Echo Doppler ultrasound imaging (MicroMaxx, SonoSite Inc, USA) of the left CCA 
was conducted for the measurement of CCA diameter which was used with the measures of 
CCA velocity for the calculation of blood flow. For diameter measurement, an M-mode 
tracing of the left CCA was obtained approximately 2cm away from the carotid bifurcation 
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and diameter measured from the recorded M-mode tracing using edge detection software. 
Systolic (maximum) and diastolic (minimum) diameters were determined from the M-mode 
tracing and CCA diameter calculated as: Diameter = (1/3)*Systolic + (2/3)*Diastolic. 
Diameter measures were determined at the start and end of each bout of hyper- and 
hypoventilation, the beginning of breath hold following hyperventilation, at baseline before 
NG, and ever 30s for 9 minutes following NG administration.  
7.3.2 Data Analysis 
 The protocol consisted of each subject performing two trials of hyperventilation and 
hypoventilation; however, due to probe movement during hyperventilation, two subjects only 
had a single hyperventilation trial. Therefore, 24 hypoventilation trials and 22 
hyperventilation trials were used to assess the relationship between CCA blood flow and 
CBFV. Mean arterial pressure (MAP) was determined as the mean over a cardiac cycle. 
Similarly, CCA blood velocity and CBFV were determined as the mean of the outer envelope 
of the Doppler spectrum over a cardiac cycle. Vascular resistance of the CCA was calculated 
as CCAVR = MAP / CCA flow. Similarly, an index of cerebrovascular resistance was 
calculated at CVRi = MAP / CBFV. 
 Resting values were determined as 10s averages taken before each bout of hyper- and 
hypo-ventilation. Similarly, peak responses were determined as 5s averages after breath hold, 
or at the end of hyperventilation. Resting PETCO2 values were determined and compared to 
peak responses defined as the average of the last three end tidal values of the 
hyperventilation, and the first end tidal value after breath hold.  
 With respect to the NG responses, a 30s average was taken during the resting baseline 
period and compared to values four minutes after the administration of NG. For these data, 
two different methods of assessing changes in MCA diameter were used. First, as previously 
suggested (Borisenko & Vlasenko, 1992; White et al., 2000) cerebral blood flow was 
assumed to remain constant with the administration of NG and the percent change in MCA 
diameter was calculated as previously described (Dahl et al., 1989; Borisenko & Vlasenko, 
1992) using the following equation: 
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(Equation 1)        
     
     
        
Where CBFV1 is the resting baseline value and CBFV2 is the value four minutes after NG 
stimulation. The second method assumed that changes in cerebral blood flow might have 
occurred with NG and CCA blood flow was used as a surrogate of cerebral blood flow to 
calculate the theoretical change in MCA diameter as: 
(Equation 2)        
    
     
 
     
    
        
Where, again, CBFV1 and CCA1 are baseline averages of cerebral blood velocity and 
common carotid artery blood flow respectively, and CBFV2 and CCA2 are values four 
minutes after NG stimulation.  
 Beat-by-beat data was linearly interpolated to second-by-second values and averaged 
across both trials for each subject. Hypo- and hyperventilation data was combined and linear 
regressions analysis was performed on these data for each subject to determine the 
relationship between CCA flow and CBFV with changes in PETCO2 (SigmaPlot 11.0, Systat 
Software Inc., Chicago, IL) Data for NG testing were averaged over 30s periods and linear 
regressions performed for each subject using the 30s averages to test for a relationship 
between CCA flow and CBFV using linear regression. 
 Beat-by-beat data for hyper- and hypoventilation were linearly interpolated to second-
by-second values and averaged across both trials for each subject. Hypo- and 
hyperventilation data was combined and regressions analysis was performed on these data for 
each subject to determine the relationship between CCA flow and CBFV with changes in 
PETCO2 (SigmaPlot 11.0, Systat Software Inc., Chicago, IL). Two different curves (linear and 
a four component sigmoid curve) were used to fit the CCA flow and CBFV relationship with 
the resulting fits compared using an F ratio. For this test, the residual sum of squares (RSS) 
for each curve was compared to determine the F ratio as: 
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(Equation 3)    
                     
        
 
For this equation, RSS1 and RSS2 are the residual sums of squares for the linear and sigmoid 
curves with DF1 and DF2 degrees of freedom respectively.  
 General hemodynamic responses to changes in CO2 and NG were assessed using a 
one-way repeated measures analysis of variance (SigmaStat 3.5, Systat Software Inc., 
Chicago, IL). For all test, statistical significance was set at p<0.05.  
7.4 Results 
 Cardiovascular responses to changes in PETCO2 and NG, presented in Table 7.1, 
indicated that HR was not changed with either hypo- or hyperventilation. Conversely, MAP 
was seen to increase with hypoventilation and decrease with hyperventilation. Hemodynamic 
responses in Table 7.2 showed that hypoventilation elicited approximately a 32% increase in 
CBFV and a 14% increase in CCA flow where hyperventilation served to decrease CBFV 
and CCA by 31% and 16% respectively and NG decreased CBFV by 13% with no change in 
CCA flow. No changes were seen with CCAVR but CVRi was increased 27% with 
hyperventilation and decreased 19% with hypoventilation.  
 Results from the assessment of CBFV and CCA blood flow responses, presented in 
Figure 7.1, showed a reduction in CBFV but no change in CCA blood flow. Linear 
regression analysis of the CBFV and CCA flow relationship with NG showed weak, but 
significant relationship (P<0.05) for 4 of the 12 subjects with an average R
2
 value of 
0.299±0.107. For the remaining 8 subjects, no significant relationships were seen between 
CBFV and CCA flow (P>0.05) with an average R
2
 of 0.038±0.056. The results from NG 
stimulation suggest that, as expected the MCA dilated with NG producing a reduction in 
CBFV with no change in cerebral blood flow as seen by the lack of change in CCA flow and 
the lack of linear relationships between CBFV and CCA flow. The calculation of MCA 








































Figure 7.1:CCA and MCA response to NG 
Responses to NG of CCA flow (black circles) and CBFV (grey circles) (mean ± SD). Statistical 
analysis was conducted on values at 4 and 9 minutes (Table 7.2) showing no changes in CCA flow, 
but a decrease in CBFV. 
 With alterations in PETCO2, all 12 subjects showed a significant linear relationship 
with an average R
2
 value of 0.795±0.196. Although all subjects showed significant linear 
relationships between CBFV and CCA flow with hyper- and hypo-ventilation, inspection of 
the resulting residuals (Figure 7.2 A) suggested a non-linear relationship. Therefore, non-
linear regression analysis using a four parameter sigmoid curve was conducted showing 
significant relationships for all subjects with an average R
2
 of 0.825±0.167. For each 
individual, the linear and non-linear curve fits were compared using the F ratio. Results 
found that the nonlinear curve provided a better fit for the data for 9 of the 12 individuals 
(P<0.05) with strong trends for 2 of the remaining 3 (P=0.075 and P=0.077). A representative 
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data set is presented in Figure 7.2, which shows the linear regression model (Figure 7.2 A) 
and the sigmoid regression model (Figure 7.2 B) suggesting a better fit with the non-linear 
regression. Using CCA flow as a surrogate measure of cerebral blood flow, the calculated 
MCA diameter changes using Equation 2 were -6.8±2.7% and 7.8±7.2% for hyper- and 
hypoventilation respectively. 
 








Baseline 37.02±3.06 62.60±10.78 93.16±7.38 
Hypoventilation 42.92±2.81* 65.88±20.48 98.31±8.28* 
Hyperventilation 23.07±4.96* 65.74±13.08 81.77±8.80* 
Nitro 37.54±4.00 60.38±7.88 90.98±5.80 
 Values show the mean ± SD with values that are statistically different from baseline denoted 
by * (P<0.05). 
 










Baseline 486.93±99.79 62.52±13.02 0.199±0.044 1.57±0.44 
Hypoventilation 553.77±113.43* 82.74±20.12* 0.184±0.035 1.27±0.39* 
Hyperventilation 397.11±116.23* 43.05±9.04* 0.223±0.070 1.99±0.57* 
Nitro 514.20±114.02 54.13±12.52* 0.184±0.036 1.79±0.55* 
 Values show the mean ± SD with values that are statistically different from baseline denoted 




















































































Figure 7.2:Linear verses non-linear curve fit 
Representative regression results (black dots) with data from hyper- and hypo-ventilation. Linear 
regression results (Panel A) were statistically significant (P<0.0001) with an R
2
 value of 0.952. Non-
linear regression results of the same data (Panel B) were also statistically significant (P<0.0001) 
with a larger R
2
 value of 0.988. Calculation of the F ratio of this data showed that the non-linear 




 This study provided the opportunity to study simultaneously the responses of cerebral 
blood flow velocity in the middle cerebral artery and blood flow in the common carotid 
artery with alterations in PETCO2 and NG stimulation. In support of the hypotheses, the 
results of this study found a sigmoid relationship between CCA blood flow and CBFV with 
change in PETCO2, and no relationship between CCA blood flow and CBFV with NG 
stimulation suggesting, in both instances, changes in the diameter of the MCA. This is the 
first study to show a non-linear relationship between CBFV and CCA blood flow with acute 
changes in PETCO2 suggesting a change in the diameter of the MCA.  
7.5.1 MCA and NG 
 Consistent with the hypothesis, no relationship was seen between CBFV and CCA 
flow with NG stimulation, as CCA flow was not changed, which suggested dilation of the 
MCA with NG. This result is consistent with previously reported data that showed reductions 
in MCA velocity with no changes in cerebral blood flow (Dahl et al., 1989; Dahl et al., 1990; 
Borisenko & Vlasenko, 1992; White et al., 2000). Previous work by Dahl et al. (Dahl et al., 
1989) using regional blood flow calculated that a diameter increase of the MCA of 15% was 
necessary to account for the reduction in CBFV with no change in cerebral blood flow. More 
recently, a study by Hansen et al (Hansen et al., 2007) used MRI to directly measure the 
diameter of the MCA after NG stimulation finding diameter increases of 10-14%. The 
current study, using CCA blood flow to calculate the changes in MCA diameter, found a 
13% dilation of the vessel which is consistent with the previous studies.  
7.5.2 MCA and PETCO2 
 The literature has been split on whether the MCA changes diameter with alterations 
in PaCO2. Several studies have suggested that the diameter remains constant as a strong 
relationship has been seen between cerebral blood flow and CBFV with acetazolamide 
testing (Dahl et al., 1992; Muller et al., 1995; Ulrich et al., 1995), hypercapnia (Bishop et al., 
1986; Muller et al., 1995; Poeppel et al., 2007), and hypocapnia (Poeppel et al., 2007). In 
addition, MRI studies have also suggested no change in the diameter of the MCA with 
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acetazolamide testing (Schreiber et al., 2000) and changes in PETCO2 (Serrador et al., 2000; 
Valdueza et al., 1997). However, limitations in the measurement methods may have 
contributed to this lack of observable change.  
 One of the most cited papers suggesting that the diameter of the MCA remains 
constant with manipulations in PETCO2 is that of Serrador et al. (Serrador et al., 2000). In this 
study, the diameter of the MCA was measured under manipulations of PETCO2 and with the 
application of lower body negative pressure; however, questions remain as to the ability of 
this study to detect small changes in MCA diameter. In this study, it was reported that the 
pixel resolution of images was 0.47mm (Serrador et al., 2000). With a reported average MCA 
diameter of 2.5mm (Serrador et al., 2000), the pixel resolution would equate to 
approximately 19% of the diameter of the vessel. Even assuming that the employed 
measurement techniques were able to improve this resolution, it is still unlikely that they 
were able to accurately detect changes in the MCA diameter less than 0.25mm, or 10% of the 
resting MCA diameter. This does have implications for TCD studies a 10% change in 
diameter with velocity remaining constant would equate to a 21% change in cerebral blood 
flow. Similarly, if cerebral blood flow is constant, a 10% change in diameter could offset a 
17% change in velocity.  
 Several studies have suggested that the diameter of the MCA does not remain 
constant with manipulation in PETCO2. Work by Valdueza et al. (Valdueza et al., 1999) 
quantified cerebral blood flow by using simultaneous Doppler measures of MCA and 
sphenoperietal sinus blood velocity. Through comparison of arterial and venous blood 
velocity, it was concluded that increases in PETCO2 can result in change in MCA diameter. In 
a separate study, Dahl et al. (Dahl et al., 1994) found no correlation between changes in 
cerebral blood flow and CBFV with acetazolamide, again, suggesting a change in MCA 
diameter. Although MCA diameter was not directly assessed, work by Poeppel et al. 
(Poeppel et al., 2007) showed variations in changes in regional cerebral blood flow and 
CBFV also suggesting changes in MCA diameter to account for this difference. Finally, in a 
study by Eicke et al. (Eicke et al., 1999), similar to the current study, CBFV was compared to 
CCA blood flow showing a linear relationship between the two variables with changes in 
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PETCO2. However, when CCA flow was used to calculated percent changes in MCA 
diameter, a 6% increase and a 4.5% decrease were found with increased and decreased 
PETCO2 respectively. Most recently, Willie et al. (Willie et al., 2012) showed that CBFV 
measures underestimated changes in cerebral blood flow with 15 minute step increases and 
decreases in PaCO2. However, the current study is the first to suggest that changes in MCA 
diameter can occur within 30s of breath hold or hyperventilation. 
7.5.3 Limitations 
 The most noteworthy limitation of this study was the use of blood flow in the 
common carotid artery as a surrogate for cerebral blood flow. Blood flow in the MCA is 
supplied by the ICA which is in turn supplied by the CCA. However, the CCA also provides 
blood flow through the ECA. It is possible that changes in flow distribution between the ICA 
and ECA may have accounted for some of the variation in result. However, the recent study 
by Sato et al. (Sato et al., 2012) showed that ECA blood flow was not changed with variation 
in PaCO2. Therefore, it is believed that the observed changes in CCA flow in the current 
study were indicative of changes in cerebral blood flow. 
7.6 Conclusion 
 Consistent with the hypotheses, this study was able to demonstrate a strong 
relationship between CCA blood flow and CBFV with changes in PETCO2 and no 
relationship between these variables with NG stimulation suggesting dilation of the MCA. In 
addition, this was the first study to show that the relationship between CCA blood flow and 
CBFV with acute changes in PETCO2 was non-linear thereby suggesting changes in MCA 
diameter. This study highlights the need to quantitative assessments of cerebral blood flow, 






Cerebral blood velocity responses to changes in CO2 and 







 Transcranial Doppler ultrasound has been used to assess cerebral blood velocity 
(CBFV) in the middle cerebral artery (MCA) with characteristics of the within beat velocity 
profile being used as a potential method for determining cerebrovascular tone. However, 
changes in MCA diameter and cerebral blood flow may distort these measures. Therefore, 
the purpose of this study was to simultaneously assess MCA velocity and common carotid 
artery (CCA) velocity to determine potential changes in cerebrovascular tone with changes in 
the partial pressure of end tidal carbon dioxide (PETCO2). Data were collected from 12 
individuals who performed 30s of hyperventilation and 30s of breath-hold to manipulate 
PETCO2. Arterial pressure, MCA velocity, and CCA velocity were continuously measured 
throughout the test. Velocity waves were assessed to determine key inflection point which 
allowed for the calculation of the Doppler resistance indices (RI=(systolic-diastolic)/systolic 
and PI=(systolic-diastolic)/mean), the augmentation index (AI=(reflected peak-
diastolic)/(systolic-diastolic) x 100%), and critical closing pressure. The Doppler resistance 
indices calculated for the MCA and CCA both showed an increase and decrease with hyper- 
and hypoventilation respectively. However, only the MCA showed variation in other velocity 
wave inflection points, the calculation of AI, and the calculation of CrCP suggesting that 
alterations in the cerebral circulation are not reflected in the CCA velocity wave. Assessment 
of the augmentation index suggested an increase and decrease in cerebrovascular compliance 
with hyper- and hypoventilation respectively. In contrast the calculation of CrCP suggested a 
reduction in cerebrovascular tension with hypoventilation and an increase with 
hyperventilation. These results suggest that in the cerebral circulation, vascular tension 
changes independently from cerebrovascular compliance with changes in PETCO2 and 
highlight that cerebrovascular tone is comprised of multiple factors that may be 






 Assessment of the within beat characteristics of the middle cerebral artery (MCA) 
blood velocity trace provides a potential method for the determination of cerebrovascular 
tone. It has been suggested that both the augmentation index (AI) (Robertson et al., 2008) 
and critical closing pressure (Panerai, 2003) reflect changes in cerebrovascular tone. 
However, little work has been done to systematically relate changes in the MCA velocity 
trace to quantitative measures of cerebral blood flow or other within beat characteristic with 
changes in cerebral blood flow.  
 Studies have looked at changes in cerebral blood velocity waveforms in a number of 
conditions including hypercapnia (Robertson et al., 2008) and stimulation with nitroglycerin 
(Lockhart et al., 2006). Previous work has shown and increase in the augmentation index, 
calculated from the MCA velocity wave profile, with aging (Kurji et al., 2006) and 
hypercapnia (Robertson et al., 2008) suggesting a reduction in pulse wave transit time with 
an early return of the reflected wave potentially due to an increase in vascular tone and 
reduction in vascular compliance. Conversely, work with critical closing pressure (CrCP) has 
shown a decrease in CrCP with hypercapnia (Ainslie et al., 2008; Panerai, 2003; Panerai et 
al., 1999) suggesting a decrease in vascular tone and increase in vascular compliance. The 
quantitative assessment of cerebral blood flow may help to explain the discrepancy between 
CrCP and AI interpretations of cerebrovascular tone with changes in CO2.  
 The common carotid artery (CCA) may provide a readily accessible artery for the 
assessment of cerebral blood flow and potential assessment of cerebrovascular tone. Previous 
work has dilation and constriction of the MCA with changes in the partial pressure of end 
tidal carbon dioxide (PETCO2) using CCA blood flow as a surrogate for cerebral blood flow 
(Chapter 7). Assessment of within beat characteristics of the MCA and CCA velocity waves 
has suggested that alterations in MCA waveform shape with nitroglycerin are reflected in 
similar alterations in the CCA waveform (Chapter 6). To date, no work has looked at the 
simultaneous assessment of MCA velocity waveforms and CCA velocity waves to determine 
if CCA measure can be used to describe changes in cerebrovascular properties and 
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potentially explain the apparently contradictory results between changes in the MCA velocity 
wave profile and the calculation of CrCP with changes in PETCO2. 
 In this study, it was hypothesized that the MCA velocity wave would show changes 
in key inflection points with alterations in PETCO2 and that these changes would be reflected 
in the CCA flow waveform. Therefore, the purpose of this study was to characterize changes 
in the MCA and CCA velocity waves in hope that the assessment of the CCA velocity wave 
would help to explain the apparent conflicting cerebrovascular tone results between the 
calculation of the augmentation index and critical closing pressure.  
8.3 Methods 
 Data for this study were acquired during the same study as Chapter 7. Therefore, the 
experimental protocol was as previously described (Chapter 7) with the additional data 
analysis as follows. 
8.3.1 Data Analysis 
 The protocol consisted of each subject performing two trials of hyperventilation and 
hypoventilation; however, due to probe movement during hyperventilation, two subjects only 
had a single hyperventilation trial. Therefore, 24 hypoventilation trials and 22 
hyperventilation trials were used to assess the relationship between CCA blood flow and 
CBFV. Mean arterial pressure (MAP) was determined as the mean over a cardiac cycle. 
Similarly, CCA blood velocity and CBFV were determined as the mean of the outer envelope 
of the Doppler spectrum over a cardiac cycle. Vascular resistance of the CCA was calculated 
as CCAVR = MAP / CCA flow. Similarly, an index of cerebrovascular resistance was 
calculated at CVRi = MAP / CBFV.  
 For the assessment of velocity wave characteristics of both the MCA and CCA, ten 
consecutive cardiac cycles were averaged to produce a representative wave for each resting 
period before hyper- and hypo-ventilation and at each peak response point for hyper- and 
hypoventilation. The representative waves were then assessed for key inflection points shown 
in Figure 8.1. All inflection points were assessed with respect to end diastolic velocity, T1, as 
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P1-T1, T2-T1, P2-T1, T3-T1, and P3-T1 where T represents at trough and P represents a 
peak inflection point of the wave to provide an indication of the shape of the waveform. As 
previously described (Robertson et al., 2008; Kurji et al., 2006), the peaks P1 and P2 of the 
velocity wave were used with the end diastolic value T1 for the calculation of an 
augmentation index as AI = (P2-T1) / (P1-T1) x 100%. The Doppler resistance indices, RI 
and PI, were calculated as RI = (P1-T1) / P1, and PI = (P1-T1) / Vmean, where Vmean was 
the mean velocity calculated from the average CCA or MCA blood velocity wave. 
 For each of the ten cardiac cycles used to generate the representative waveform, CrCP 
was calculated using a two point method of mean arterial pressure CBFV and diastolic 
pressure and velocity as previously described (Panerai et al., 2011). Briefly, the slope of the 
relationship between CBFV and MAP was calculated as a = (CBFVmean – CBFVdia) / 
(MAP – DBP). RAP was then calculated as RAP = 1 / a and CrCP calculated as CrCP = 
MAP – (CBFVmean / a). Using this same, method an index of CrCP was also calculated 
using the CCA velocity wave. 
 Inflection point and CrCP changes with PETCO2 were assessed using a one-way 





























Figure 8.1: Representative average MCA velocity wave 
The figure depicts 10 beats of MCA velocity (grey lines) that were averaged to produce the 
representative wave (black line). The velocity wave was then assessed for key inflection points; end 
diastolic velocity (T1), the systolic peak (P1), the following trough (T2), reflected peak (P2), dicrotic 
notch (T3), and the following peak (P3). Changes in waveform shape with alterations in CO2 were 
then determined by comparing inflection points to the end diastolic, T1, value. 
8.4 Results 
 Average velocity waveforms for a representative subject are shown from the MCA 
(Figure 8.2 A and B) and the CCA (Figure 8.2 C and D) during baseline rest, 
hypoventilation, and hyperventilation. Changes in PETCO2 produced changes in mean 
velocity and end diastolic velocity. Therefore, to assess changes in the waveform shape, key 
 
 145 
inflection points were assessed with respect to the end diastolic velocity (T1). Results from 
the assessment of the inflection points, presented in Table 8.1, show significant changes in all 
inflection points of the MCA with respect to T1 during changes in PETCO2. In contrast to the 
MCA results, only the peak CCA velocity point was significantly increased with 
hyperventilation and no other differences were found with any of the other inflection points 
or the calculation of the augmentation index. 
 For both the CCA and MCA the Doppler resistance indices (RI and PI), AI, CrCP, 
and RAP are presented in Table 8.2. Both CCA and MCA RI and PI were increased with 
hyperventilation and reduced with breath hold. The MCA AI was significantly increased with 
hypoventilation decreased with hyperventilation but no changes were seen in CCA AI. MCA 
CrCP was increased with hyperventilation and reduced with hypoventilation but again, no 
changes were seen in CrCP calculated with the CCA velocity wave. RAP was not changed 























































































Figure 8.2: Representative MCA and CCA waves 
Representative data from one individual for average MCA (panel A and B) and CCA (panel C and D) 
velocity waves at rest (solid black line), hypoventilation (dashed dotted line), and hyperventilation 
(dashed line). Key points are identified as dots on the corresponding waves in panels A and C. Panels 
B and D show the same velocity waves from panels A and C normalized to end diastolic velocity so 






Table 8.1: Velocity wave inflection points with changes in PETCO2 
  P1-T1 (cm/s) T2-T1 (cm/s) P2-T1 (cm/s) T3-T1 (cm/s) P3-T1 (cm/s) 
MCA Baseline 54.12±15.08 34.57±9.29 35.57±7.12 20.30±6.41 28.00±6.47 
 Hypoventilation 51.92±16.50 41.60±11.96* 44.18±12.16* 26.01±8.45* 32.71±8.57* 
 Hyperventilation 64.21±20.15* 29.36±10.60* 28.40±9.51* 11.02±5.78* 25.33±5.35 
CCA Baseline 42.82±11.11 15.77±8.43 15.23±6.87 0.72±3.99 11.40±2.61 
 Hypoventilation 36.31±10.11 14.80±6.64 15.26±4.93 1.48±3.36 10.60±2.56 
 Hyperventilation 58.64±16.40* 18.13±15.89 16.62±12.39 -2.89±7.70 13.75±6.47 
 Values show the mean ± SD for differences between inflection points and the end diastolic 
value (T1). Values that are statistically different from baseline are denoted by * (P<0.05). 
 
 









MCA Baseline 69.56±14.57 0.575±0.061 0.887±0.187 30.4±8.2 1.11±0.36 
 Hypoventilation 88.50±19.49* 0.477±0.063* 0.644±0.163* 23.0±8.4* 1.00±0.30 
 Hyperventilation 46.70±16.55* 0.733±0.068* 1.520±0.346* 39.2±6.7* 1.08±0.37 
CCA Baseline 36.49±15.84 0.838±0.052 2.586±0.632 49.6±10.9 2.70±0.92 
 Hypoventilation 43.96±14.95 0.754±0.069* 1.864±0.684* 44.0±12.4 3.00±0.82 
 Hyperventilation 26.97±16.18 0.938±0.045* 3.780±0.801* 54.4±6.7 2.02±0.77 
 Values show the mean ± SD with values that are statistically different from baseline denoted 





 A different view of the changes in waveform shape is presented in Figure 8.3. In this 
figure, the average wave for all subjects is presented for hyperventilation (red) and 
hypoventilation (blue) (Figure 8.3 A and B). Assuming the resting average wave represents 
0cm/s, the middle panels show the differences between the resting wave and the 
hyperventilation and hypoventilation waves. Finally, the bottom panels show the same 
differences accounting for the pressure wave. From this it can be seen that changes in the 
velocity waves are dependent on the phase of the cardiac cycle. In addition, it can be seen 
that the majority of change for the CCA occurred during the systolic phase (P1-T1) where the 
MCA showed change throughout the cardiac cycle. When the pressure wave shape was taken 
into consideration, it can be seen that the majority of change in the MCA velocity wave 
occurred during the systolic portion of the cardiac cycle (Figure 8.3 E and F). 
 To further examine the influence of the pressure wave on the velocity wave, the 
relationship between the averaged, normalized velocity waves were plotted against the 
averaged, normalized pressure waves (Figure 8.4). From these plots it can be seen that with 
hypoventilation Figure 8.4 C), the relationship between MCA velocity and pressure was 
closer, compared to the relationship with hyperventilation (Figure 8.4 E) which showed a 
large ‘loop’ portion corresponding to the systolic portion of the waves. Conversely, there 












































































































































Figure 8.3: Changes in velocity waves 
Averages velocity waves (solid) ± SD (dotted) for the raw waveform (A and B) for hyper- (red) and 
hypoventilation (blue), differences from baseline velocity waves (C and D), and differences from 

































































































































Figure 8.4: MCA and CCA velocity waves versus the arterial pressure wave 
Relationships between MCA velocity waves (A, C, and E) and CCA velocity waves (B, D, and F) with 
the arterial pressure wave at rest (A and B), with hypoventilation (C and D), and with 




 The purpose of the current study was to utilize quantitative measures of CCA blood 
flow to describe changes in cerebrovascular hemodynamics with changes in PETCO2. 
Therefore, CCA blood flow was assessed simultaneously with CBFV during hyper- and 
hypoventilation. In contrast to the hypotheses, the observed changes in MCA velocity 
waveform morphology were not seen in the CCA velocity wave. More in depth examination 
of the MCA velocity wave compared to the CCA velocity wave and the arterial pressure 
wave suggested that alterations in the systolic portion of the velocity wave may be 
influencing the interpretation of changes in vascular tone with hyper- and hypoventilation. 
8.5.1 Velocity and Flow Wave Inflection Points 
 Previous work has examined the CBFV wave profile under varying conditions 
(Robertson et al., 2008; Kurji et al., 2006; Albina et al., 2004; Lockhart et al., 2006). 
However this is the first that has attempted to associate observed changes in CBFV velocity 
wave inflection points with similar alterations in the CCA flow wave. To accomplish this, 
five inflection points were assessed (three peaks and two troughs) with respect to end 
diastolic velocity or flow. Significant alterations were seen for all points in of the MCA 
velocity trace, but contrary to the hypothesis, only the systolic peak of the CCA flow wave 
showed a similar increase with hyperventilation which contributed to alterations in the 
Doppler resistance indices. 
 The calculation of the Doppler resistance indices, RI and PI rely on the observation 
that changes in downstream vascular resistance serve to change the pulse amplitude of the 
velocity trace (Gosling et al., 1991). Therefore, an increase in the pulse amplitude of the 
velocity, or flow, trace with respect to systolic value (RI) or the mean of the wave (PI) is 
thought to reflect an increase in downstream vascular resistance. In this study, hypo- and 
hyperventilation produced a respective decrease an increase in RI and PI for both the MCA 
velocity wave and the CCA velocity wave suggesting that changes in downstream vascular 
resistance serve to produce similar changes in the pulse amplitudes of both the MCA velocity 
and CCA flow waveform. However, when only the P1-T1 variable was assessed, differences 
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in the CCA velocity wave were only different with hyperventilation suggesting that the 
Doppler resistance indices are dependent on more than just the pulse amplitude of the 
velocity wave. 
 Contrary to the hypothesis, and observed results with nitroglycerin (Chapter 6), 
assessment of the other waveform inflection points only showed variation in the MCA trace 
and not the CCA trace. This was especially evident when the velocity traces were assessed 
over the cardiac cycle with respect to the resting baseline traces (Figure 8.3 C and D). 
Vertical lines on this figure represent the troughs of the inflection points and serve to divide 
the velocity trace into three distinct sections where the first section represents the systolic 
component, the second section influenced by the reflected wave, and the third section 
indicating the diastolic decay portion after the dicrotic notch. From this figure it can be seen 
that changes in the velocity wave trace change to different extents throughout the cardiac 
cycle where the MCA tended to show differences throughout the cardiac cycle, the CCA only 
showed change in the systolic component. The differences in these responses are reflected in 
the lack of change in the CCA velocity wave inflection points. 
 Several factors could account for the variation in responses between the MCA and 
CCA velocity traces. Most notably is the fact that the MCA is much further down the arterial 
tree than the CCA. Some studies have been conducted which have examined flow wave 
shape at different points of the carotid vascular tree finding large variations in waveform 
morphology at different measurement points (Gwilliam et al., 2009; Schubert et al., 2011). 
Therefore, it is possible that changes MCA velocity waveform morphology due to small 
variations in vascular tone are not translated up the vascular tree to the CCA.  
 Possible changes in MCA diameter with hyper- and hypo-ventilation may also have 
contributed to the observed changes in velocity waveform morphology. Previous work has 
suggested the possibility of changes in MCA diameter (Chapter 7). However, the CCA 
diameter was only significantly changed with hyperventilation (Chapter 7); therefore, it is 
possible that the variation in MCA diameter and lack of change in CCA diameter could have 
contributed to the differences in responses.  
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8.5.2 Augmentation Index and CrCP 
 Similar to data reported by Robertson et al. (Robertson et al., 2008), this study 
showed that hypoventilation resulted in an increase in the calculated augmentation index of 
the MCA. The current study also demonstrated that the reverse is also true in that 
hyperventilation resulted in a reduction of the augmentation index. The augmentation index 
represents an increase in the ratio of P2-T1 to P1-T1 or rather an increase in the ratio of the 
second peak, thought to represent a reflected wave, to the systolic peak (Robertson et al., 
2008; Kurji et al., 2006). Based on observations from arterial pressure waves (Nichols et al., 
2008), it is thought that the augmentation index of the cerebral blood velocity traces 
represents constructive interference of a reflected wave such that an increase in the 
augmentation index would represent a faster return of the reflected velocity wave and thus an 
increase in vascular tone (Robertson et al., 2008; Kurji et al., 2006). Work with the CCA 
flow wave and pressure has shown that the augmentation index calculated from the flow 
wave was similar to that calculated with the pressure wave (Hirata et al., 2006) which lends 
support to the concept that changes in the augmentation index of the MCA velocity wave is 
reflective of changes in cerebrovascular tone. However, the observed augmentation index 
results are in contrast to the observed CrCP results. 
 Consistent with previous reports, this study found an increase in CrCP with 
hyperventilation and a reduction in CrCP with hypoventilation (Ainslie et al., 2008; Panerai 
et al., 1999; Panerai, 2003). Thought to be directly related to vascular wall tension (Panerai, 
2003), these changes in CrCP suggest that hyper- and hypoventilation result in decreased and 
increased vascular tension respectively. The observed changes in vascular tension are 
consistent with the metabolic influences of changes in CO2, such that an increase in CO2 
results in a relaxation of vascular smooth muscle and a reduction in vascular wall tension. 
However, the results of the current study suggest that cerebrovascular compliance is 
changing independent of the changes in vascular tone. 
 If blood flow circulation was a purely resistive system, the arterial pressure wave 
would equal the flow wave (Zamir, 2005). In the current study, differences in the pressure-
flow relationship were seen with both hyper- and hypoventilation (Figure 8.3 E and Figure 
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8.4 A, C, and E) suggesting alterations in vascular compliance. One research group, which 
has attempted to quantify cerebrovascular compliance with hypercapnia has shown 
conflicting results with animal data demonstrating an increase in compliance (Czosnyka et 
al., 2012) where human data suggested a reduction (Carrera et al., 2011; Kasprowicz et al., 
2012). Previous work with sublingual NG has shown that the calculation of AI was 
negatively related to vascular compliance (Chapter 6). Therefore, considering the AI result of 
the current study, it would appear that vascular compliance is changing independently of 
cerebrovascular tension as determined by the calculation of CrCP. 
8.5.3 Limitations 
 The current study utilized hyperventilation and breath-holds to manipulate PETCO2. 
The results showed that this experimental manipulation was successful in altering PETCO2; 
however, the magnitude of change was not controlled. Therefore, some of the variability seen 
in the current work could be a reflection of individual differences in the degree of 
hyperventilation, or the ability to perform the 30s breath-hold.  
 The calculation method used for critical closing pressure may also have influenced 
the results. This study used a two point method using mean and diastolic values of CBFV and 
ABP as this method has been shown to provide good repeatability (Panerai et al., 2011). It 
has been noted that the calculation of CrCP using the linear relationship between CBFV and 
ABP only provides an estimate of the true CrCP and does not account for changes in 
cerebrovascular compliance (Panerai, 2003). Therefore, it is possible that some of the CrCP 
results reflecting cerebral arterial wall tension may be distorted by the changes in 
cerebrovascular compliance.  
8.6 Conclusions 
 The current study assessed simultaneous recordings of MCA and CCA blood velocity 
with changes in PETCO2 for the assessment of cerebrovascular tone. In support of the 
hypothesis, significant changes in the MCA velocity trace were seen with hyper- and hypo-
ventilation; however, in contrast to the hypothesis, these variations were not reflected in the 
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CCA velocity trace. Further examination of the velocity waves showed that where the CCA 
velocity wave is only altered in the systolic portion of the cardiac cycle, the MCA wave 
shows variation throughout which may be reflective of changes in cerebrovascular 
compliance with changes in PETCO2. The calculation of the augmentation index of the MCA 
velocity wave suggested an increase and decrease in cerebrovascular compliance with hyper- 
and hypoventilation respectively. These results contrasted with the calculation of CrCP 
which suggested an increase and decrease in cerebrovascular tension with hyper- and 
hypoventilation. Therefore, the results of this study suggest that in the cerebral circulation 
cerebrovascular compliance, and cerebral arterial tension change independently with 









 In the presented studies, the general purpose was to examine cerebrovascular 
properties under varying conditions with particular emphasis on the within beat variation of 
the cerebral blood velocity trace. It was hypothesized that information about the 
cerebrovasculature, including changes in vascular tone, could be learned from examining 
within beat variation that would not otherwise be considered with just traditional measures of 
mean CBFV or CVRi. To test this general hypothesis, CBFV and CBFV Doppler waveform 
morphology were assessed after long duration spaceflight, in response to orthostasis before 
and after exposure to 5 days HDBR, in response to changes in PETCO2, and in response to 
sublingual NG.  
9.1 Spaceflight 
 Exposure to microgravity and simulated microgravity provide interesting models for 
the examination of cerebral blood flow control as these situations may promote remodelling 
of the cerebrovasculature without the confounding influences of systemic pathological 
conditions including, but not limited to cardiovascular disease, diabetes, and hypertension. 
Recently, two studies have been published noting vision alterations associated with structural 
changes of the eye in astronauts after long duration spaceflight which have been attributed to 
increased intracranial pressure during flight (Kramer et al., 2012; Mader et al., 2011). To 
date, it is still unknown to what extent intracranial pressure is increased in astronauts and 
what affect this has on the cerebrovasculature. 
 Much of what is known with respect to cerebrovascular adaptations to microgravity 
comes from animal work which has shown significant remodelling of the cerebrovasculature. 
Cerebral arteries of rats after HLU have shown vascular smooth muscle hypertrophy 
(Wilkerson et al., 1999; Lin et al., 2009; Zhang et al., 2001; Wilkerson et al., 2002) with a 
smaller luminal cross-sectional area (Wilkerson et al., 1999) and increased myogenic tone 
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(Wilkerson et al., 2005; Geary et al., 1998; Lin et al., 2009) thought to be related to the nitric 
oxide (Prisby et al., 2006; Lin et al., 2009; Wilkerson et al., 2005) or renin-angiotension 
system (Bao et al., 2007). Functionally, these alterations have been associated with 
reductions in cerebral blood flow (Wilkerson et al., 2002; Wilkerson et al., 2005). In human 
studies, no changes have been seen in resting CBFV or CVRi suggesting a lack of changes in 
human cerebrovasculature (Blaber et al., 2011; Iwasaki et al., 2007; Tobal et al., 2001). 
However, CBFV is only representative of cerebral blood flow if the diameter of the insonated 
vessel is not changing. To date, no studies have been conducted in humans to assess whether 
the MCA diameter changes after exposure to real or simulated microgravity. However, the 
results of animal models suggest that there is remodelling of the cerebrovasculature with 
spaceflight.  
 The results of Chapter 2 also showed no differences in resting CBFV after 
spaceflight. However, it is possible that this lack of change was the result of reduced cerebral 
blood flow through a smaller vessel which was suggested in the results of Chapter 3. The 
study presented in Chapter 3 looked to examine potential changes in CBFV Doppler 
waveform morphology with spaceflight, where Chapter 2 was primarily focused on potential 
changes in the functional regulation of cerebral blood flow. Contrary to the hypothesis, the 
key inflection points of the CBFV wave were not different pre to post spaceflight likely due 
to large variability in individual responses. Conversely, results from the calculation of CrCP 
after spaceflight showed an increase in CrCP which suggests an increase in cerebrovascular 
tone, a reduction in MCA resting diameter, or a combination of these two alterations. 
Although it cannot be confirmed with the measurements made in the current studies, it would 
appear that cerebrovascular remodelling did occur with long duration spaceflight which 
could contribute to the observed functional changes in cerebral blood flow regulation. 
 The main findings of Chapter 2 showed that cerebrovascular autoregulation and 
cerebrovascular CO2 reactivity were both blunted after long duration spaceflight. This is in 
contrast to results of short duration spaceflight presented by Iwasaki et al. (Iwasaki et al., 
2007) which showed no change, or even slight improvements in cerebrovascular 
autoregulation and potentially work by Blaber et al. (Blaber et al., 2011) that demonstrated 
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impairments in cerebrovascular autoregulation only in those astronauts that exhibited post 
flight orthostatic intolerance; however orthostatic tolerance was not assessed in the current 
study. It is possible that the variations in cerebrovascular results after spaceflight are due to 
individual differences in adaptation responses. In the current study, although the direction of 
change in cerebrovascular autoregulation and cerebrovascular CO2 reactivity responses were 
similar, the magnitudes of the responses were very different. Similarly, the recent studies of 
vision changes with long duration spaceflight show a large amount of individual variation 
(Kramer et al., 2012; Mader et al., 2011). However, results do suggest that to varying 
degrees, idiopathic intracranial hypertension associated with long duration spaceflight results 
in cerebrovascular adaptations for all individuals.  
9.2 Orthostasis 
 Reductions in orthostatic tolerance have frequently been seen after spaceflight 
(Buckey et al., 1996; Waters et al., 2002) and with simulated microgravity exposure (Arbeille 
et al., 2008; Zhang et al., 1997). As syncope ultimately results from cerebral hypoperfusion, 
it follows that alterations in the cerebrovasculature may contribute to changes in orthostatic 
tolerance. The studies presented in Chapter 4 and Chapter 5 both examined the 
cerebrovascular responses to sustained orthostasis and the progression towards syncope 
before and after exposure to five days of HDBR. Both studies, to some extent looked at the 
within beat variation in the MCA velocity trace to further understand the cerebrovascular 
responses to orthostasis. 
 It has been frequently documented that transition to an upright results in reductions in 
BPMCA, CBFV, and PETCO2 (Immink et al., 2006; O'Leary et al., 2007; Cencetti et al., 1997; 
Serrador et al., 2006) and a progressive reduction in PETCO2 with prolonged head up tilt 
(O'Leary et al., 2007; Razumovsky et al., 2003; Howden, Lightfoot, Brown, & Swaine, 2004; 
Cencetti et al., 1997). With the progression towards syncope, several studies have observed 
paradoxical increases in cerebrovascular resistance before syncope (Serrador et al., 2006; 
Bondar et al., 1995; Levine et al., 1994) which could be due to the reduction in arterial CO2 
(Serrador et al., 2006; Blaber et al., 2001). The results in Chapter 4 support the hypothesis of 
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a reduction in PETCO2 being significantly related to the reduction in CBFV and the increase 
in CVRi with the progression towards syncope independent of changes in BPMCA. In 
addition, this chapter also demonstrated a progressive increase in CrCP with the progression 
towards syncope which suggests that changes in cerebrovascular tone contribute to the 
reduction in cerebral blood flow. The calculation of CrCP in this chapter utilized a two point 
method of mean and diastolic BPMCA and CBFV; however, similar results were showed by 
Carey et al. (Carey et al., 2001) who used the linear regression method which is dependent on 
the shape of the entire velocity and pressure waveforms. Therefore, it is conceivable that this 
change in cerebrovascular tone with the progression towards syncope contributed to the 
collapse of small blood vessels within the brain thus leading to a reduction in cerebral blood 
flow and the development of syncope.  
 The calculation of CrCP is dependent on the relationship between BPMCA and CBFV 
and is affected to by the shape of the cerebral blood velocity waveform. The work presented 
in Chapter 5 in part attempted to expand on the CrCP results by examining the MCA velocity 
waveform with the progression towards syncope. Originally intended as an extension of a 
previously published study with the same subjects in which the temporal artery Doppler 
waveform morphology was examined with approaching syncope (Arbeille et al., 2012), 
Chapter 5 examined both the temporal artery and the MCA velocity waves with the 
progression towards syncope in an attempt to relate these changes to potential alterations in 
cerebrovascular autoregulation in those individuals with marked orthostatic intolerance after 
HDBR. Previous work examining the MCA velocity trace has shown a deepening of the 
dicrotic notch portion of the MCA velocity trace (Albina et al., 2004) which was also found 
in the current study. However, contrary to the hypothesis, although there was a reduction in 
orthostatic tolerance, there were no observed changes in cerebrovascular autoregulation, 
changes in temporal artery or MCA velocity profiles, or the ratio of temporal artery velocity 
to CBFV with HDBR. These results suggest that although changes in the MCA velocity trace 
occur with the progression towards syncope, this response is well maintained and is not 
related to the development of orthostatic intolerance after five days of HDBR.  
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 Due to the CrCP results presented in Chapter 4, it is likely that the observed reduction 
in the dicrotic notch point of the MCA velocity wave presented in Chapter 5 was due to 
alterations in cerebrovascular tone. However, other physiological changes with the 
progression towards syncope may have also contributed to changes in MCA waveform 
morphology including alterations in vascular resistance, changes in cerebral blood flow, and 
alterations in MCA diameter. Therefore, later chapters of this thesis have used quantitative 
measures of cerebral blood flow and mathematical modeling in attempt to explain the 
physiological relevance of the observed changes in MCA velocity waveform morphology. 
9.3 RCKL Modelling 
 Mathematical modeling, applied to the cerebral circulation, may provide an indication 
of cerebrovascular properties that can be used to assess the observed changes in velocity 
waveform morphology. Previously described by Zamir et al. (Zamir et al., 2007) to describe 
changes in the peripheral circulation, the RCKL model uses a modified Windkessel model 
placing vascular resistance (R) and vascular compliance (C) in parallel with viscoelastic (K) 
resistance and inertance (L) in series with C. In a pilot study, the RCKL model was used with 
CCA blood flow and pressure recordings to detect changes in cerebrovascular properties with 
aging (Robertson et al., 2008). The results of this thesis further examined the feasibility of 
using CCA measures and the RCKL model for detecting change in cerebrovascular variables 
and determining the relationship to alteration in MCA velocity wave inflection points. 
 Preliminary work with the RCKL model presented in Appendix A showed good 
repeatability of the RCKL outputs. Although the CV values were greater than 20% for each 
of R, C, K, and L a power analysis determined that a change of one half the within-subject 
standard deviation would require a sample size of only 11 individuals. Therefore, it is likely 
that observed changes in the RKCL results presented in Chapter 6 are due to changes in 
vascular properties and not the error of the measurement. Of additional consideration with 
respect to the use of the RCKL model was the calculation of flow values for the common 
carotid artery. With the ultrasound assessment of CCA blood flow, studies have commonly 
used a single measure of CCA diameter for the calculation of flow (Sato et al., 2011; Eicke et 
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al., 1999; Arbeille et al., 2001). However, as the CCA is a very pulsatile artery, it was unclear 
what effect a single diameter measure versus continuous diameter measures would have on 
the calculation of CCA flow within a cardiac cycle and therefore the results of RCKL 
modelling. The results presented in Appendix B show that although the use of continuous 
diameter measures of CCA flow affect the shape of the resultant CCA flow wave and the 
corresponding responses to NG, the use of continuous diameter measures did not affect the 
results of the RCKL model. Therefore, considering the results of Appendix A and Appendix 
B, the RCKL model was used to determine cerebrovascular responses to HDBR and NG.  
 Use of the RCKL model with NG and HDBR presented in Chapter 6 showed that R 
was decreased and C was increased after NG and there was no effect of HDBR on any of the 
RCKL results. The lack of change in NG response after five days of HDBR was expected as 
previous work, presented in Appendix C, looking at women after 56 days of HDBR also 
found no change in the cerebrovascular responses to NG (Zuj et al., 2012b). In addition, the 
results from this chapter also found no differences in CCA diameter, or calculated MCA 
diameter after HDBR or in the dilation response to NG which further supports the results 
from Chapter 4 and Chapter 5 which all indicate that cerebrovascular hemodynamics are not 
changed after only 5 days of HDBR.  
 In Chapter 6, RCKL results were then compared to observed changes in the MCA 
velocity wave. This analysis revealed that both before and after NG the augmentation index 
of the MCA velocity, the reflected peak (P2), and the amplitude of the dicrotic notch (T3) 
were all related to the value of C from the RKCL model. Previous work has suggested that 
the augmentation index of the MCA velocity wave corresponds to cerebrovascular 
compliance such that an increase in the index is associated with a reduction in vascular 
compliance (Robertson et al., 2008; Kurji et al., 2006). The work presented in chapter 6 
confirmed that the augmentation index is related to cerebrovascular compliance as 
determined through the use of the RCKL model. This work suggests that the determination of 
the amplitude of the dicrotic notch and the calculation of the augmentation index may be 
used as indicators of cerebrovascular compliance potentially providing another index that can 
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be determined from the MCA velocity trace for the assessment of cerebrovascular 
hemodynamics.  
 The use of NG for the assessment of changes in cerebrovascular properties presents a 
situation where there is a dilation of the middle cerebral artery with no changes in cerebral 
blood flow. However, changes in PETCO2 as seen in previous chapters of this thesis have 
been known to result in changes in cerebral blood flow. Therefore, the last section examined 
the relationship between CCA blood flow and MCA blood velocity with acute changes in 
PETCO2.  
9.4 Cerebrovascular tone, tension, and compliance 
 The use of transcranial Doppler ultrasound for the assessment of cerebral blood flow 
relies on the assumption that the MCA does not change diameter. However, the MCA is not a 
static vessels and has been shown to dilate with NG (Hansen et al., 2007). Recent work has 
also suggested changes in MCA diameter with 15min step changes in PaCO2 (Willie et al., 
2012). Therefore, Chapter 7 looked at assessing potential changes in MCA diameter with NG 
and acute changes in PETCO2 using measures of CCA flow. Results from both Chapter 6 and 
Chapter 7 both confirm that assessment of CCA blood flow with NG provides a calculated 
dilation of the MCA that is consistent with what was observed in the study by Hansen et al. 
(Hansen et al., 2007). In addition the results of Chapter 7 also showed that with acute 
changes in PETCO2 there are changes in cerebral blood flow and calculated MCA diameter 
that may have implications for alterations in cerebrovascular tone. 
 Throughout this thesis, and in the literature, the term “cerebrovascular tone” has been 
used as a nebulous concept incorporating the influences of changes in active and elastic 
cerebrovascular tension, cerebrovascular compliance, and to some extent potential changes in 
the luminal diameter of cerebral vessels. However, results from the assessment of MCA and 
CCA wave properties with acute changes in PETCO2 suggest that this concept of tone with 
respect to velocity wave morphology and the calculation of critical closing pressure may not 
be appropriate for describing the cerebral circulation. While it can be said that 
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cerebrovascular tone influences the morphology of the MCA velocity trace, it would appear 
that some waveform assessments, particularly the augmentation index and CrCP, would be 
better used to describe changes in cerebrovascular compliance and tension.  
 Results from Chapter 8 demonstrated that with an increase in PETCO2, there is an 
increase in the augmentation index suggesting an increase in cerebrovascular tone, and a 
decrease in CrCP suggesting a reduction in cerebrovascular tone with the opposite true for a 
reduction in PETCO2. However, results from Chapter 6 suggested that AI was reflective of 
cerebrovascular compliance consistent with the interpretation from previously published 
work (Robertson et al., 2008; Kurji et al., 2006) where the descriptions of CrCP have 
emphasized that CrCP is reflective of cerebrovascular tension (Burton, 1951; Panerai, 2003). 
Therefore, with changes in PETCO2 it appears that the tension and compliance of the 
cerebrovasculature are changing independently potentially due to the changes in cerebral 
blood flow within the confined space of the skull. These results suggest the need for further 
clarification in the concept of cerebrovascular tone with relationships to MCA velocity 
waveform morphology and the calculation of CrCP.  
9.5 Summary and future directions 
 The results presented in this thesis represent initial work with respect to the analysis 
of MCA velocity wave morphology for the assessment of cerebrovascular hemodynamics. 
Results have demonstrated the malleability of the MCA velocity waveform and have 
suggested that assessment of various components of velocity wave including the overall 
pulse amplitude, the amplitude of the reflected peak, and the amplitude of the dicrotic notch 
reflect variation in cerebrovascular tone. However, additional analysis has demonstrated that 
care must be taken in the interpretation of cerebrovascular tone as different vascular 
properties affecting cerebral blood flow generally included in the concept of ‘tone’ may be 
changing independently.  
 Results from this thesis have also highlighted the need for quantitative assessments of 
cerebral blood flow. TCD provides a relatively simple and reproducible method for the 
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assessment of cerebral blood flow velocity. However, results presented have demonstrated 
that the MCA is not a static vessel and diameter changes may be confounding interpretation 
of CBFV results with respect to cerebral blood flow. Studies that have used MRI to visually 
assess the MCA diameter have been limited by the resolution of the technology available and 
may not have been able to detect small variations in MCA diameter (Valdueza et al., 1997; 
Schreiber et al., 2000; Serrador et al., 2000). Therefore, additional work is required to assess 
potential changes in MCA diameter using the improved imaging systems that are available. 
 Future studies are needed to further explore the relationships between cerebral blood 
velocity wave characteristics and cerebrovascular hemodynamics. Mathematical modelling 
using the RCKL model may provide additional insight into the physiological meaning of 
velocity wave characteristics. The RKCL model was used to describe the changes in the 
MCA velocity wave with NG finding relations between output variables and waveform 
characteristics (Chapter 6); however, it is unclear if these relationships would be consistent 
with changes in PETCO2 or under other conditions. Therefore, additional work is required to 
expand the use of the RCKL model for the assessment of cerebrovascular hemodynamics and 
for the interpretation of changes in MCA velocity wave morphology in various situations. 
 One of the major limitations of work presented in this study was the use of the CCA 
for quantitative assessments of cerebral blood flow. In ideal situations, analysis of ICA blood 
flow and waveform morphology may provide a better indication of cerebrovascular 
responses. However, the use of the ICA may be limited by the anatomical situation of the 
vessel preventing the non-invasive assessment of pressure. Therefore, the CCA was used in 
the presented studies as this vessel provided an easily imaged vessel with the potential for 
simultaneous non-invasive measures of pressure. Some studies assessing the CCA have 
suggested that the changes in CCA diameter over the cardiac cycle are reflective of CCA 
pressure (Sugawara, Niki, Furuhata, Ohnishi, & Suzuki, 2000; Niki et al., 2002; Hirata et al., 
2006). Therefore, if future studies determine that a similar relationship between diameter and 
pressure exists for the ICA, the continuous assessment of ICA diameter and flow may 
provide a better indication of changes in cerebrovascular hemodynamics. 
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 Of final consideration is the length of HDBR utilized for the studies presented in 
Chapter 4, Chapter 5, and Chapter 6. HDBR may be used as an Earth based analogue of 
microgravity exposure; however, the lack of changes found in the current studies are likely 
due to the HDBR only lasting 5 days. This prevents comparison to the long duration 
spaceflight study presented in Chapter 2 and Chapter 3 and even comparison to other 
spaceflight studies which have involved 1-2 weeks of flight (Blaber et al., 2011; Iwasaki et 
al., 2007; Waters et al., 2002). Therefore, studies are required with longer duration HDBR 
periods to determine potential influences of microgravity on human cerebrovascular structure 
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 The cerebral circulation presents the unique challenge of being contained within the 
skull and, therefore, prevents non-invasive, direct assessment of cerebral circulation in 
humans. To address this issue, the use of mathematical modeling may help to provide further 
information about cerebrovascular properties. It is well known that blood flow is affected by 
downstream vascular conditions. The simplification of the Poiseuille equation to relate flow 
to resistance and the pressure gradient is one example of this. However, it has been noted that 
if blood flow was a purely resistive system, the blood flow and pressure waves would be 
identical (Zamir, 2005). As may not be the case in the cerebral circulation, additional 
variables, such as vascular compliance, must be taken into consideration. In 2007, Zamir et 
al. (Zamir et al., 2007) presented a model for the assessment of peripheral hemodynamic 
properties. Based on a modified Windkessel model, the presented model (RCKL) placed 
resistance (R) and capacitance (C) in parallel with viscoelastic resistance (K) and inertance 
(L) in series with C. Theses researchers showed that the model was very effective in 
assessing properties of peripheral circulation; however, it is still unknown if the RCKL 
model can be applied to assess the cerebral circulation. 
 The RCKL model required the simultaneous input of pressure and blood flow 
measures to calculate the outputs of R, C, K, and L. With respect to the cerebral circulation, 
non-invasive measures of both pressure and flow can be made using the common carotid 
artery (CCA). Preliminary work using the RCKL model and CCA measures of pressure and 
blood flow has shown that RCKL is able to demonstrate large changes in cerebrovascular 
properties associated with age (Robertson et al., 2008). However, it is unclear how sensitive 
this model is for detecting changes in cerebral vascular properties, or what the variability is 
within the measure. Therefore, this study is intended as pilot work to determine the 




 Data were collected on five participants recruited for this pilot work. Participants 
were asked to come into the lab on three separate days with efforts being made to ensure that 
each participant was in a similar physiological state for each testing day; that is, participants 
were asked to come into the lab at the same time of day each of the three days and will have 
eaten similar meals during the day and performed similar amounts of physical activity. All 
data were collected with the participants resting in a supine position.  
 The use of RCKL requires the simultaneous assessment of pressure and flow in the 
conduit artery of interest. To accomplish this task in humans, two non-invasive methods were 
employed. Pressure was determined via tonometry with the use of a Millar pressure 
transducer. Briefly, a trained experimenter manually held the probe in place over the artery of 
interest and applied pressure so that the probe was firmly against the artery but not altering 
blood flow in the artery. At this point, the pressure waveforms recorded by the Millar probe 
can be considered representative of arterial pressure. The experimenter aimed to maintain a 
constant pressure on the probe throughout the testing. The absolute pressure values recorded 
by the Millar probe are dependent on the hold-down pressure applied by the experimenter; 
therefore, the Millar pressure tracing were normalized to recorded diastolic arterial pressure 
readings. Arterial blood pressure (ABP) was determined continuously through the use of 
finger photoplesthysmography (Finometer, Finapres Medical, Amsterdam). A three lead 
ECG was used for the assessment of heart rate. 
 Blood velocity in the common carotid artery was determined using Doppler 
ultrasound (Multigon Industries, New York, NY). A 4MHz, pulsed wave, Doppler ultrasound 
probe was used to assess continuous velocity in the common carotid artery (CCA). The outer 
envelope of the Doppler spectrum was recorded for analysis. Echo Doppler ultrasound 
(MicroMaxx, Sonosite Inc.) was used to determine the diastolic diameter of the common 
carotid artery. This diameter was then used to calculate arterial cross sectional area which 
was used to convert the Doppler blood velocity trace to blood flow.  
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 Data collection started after the participant had been resting supine for five minutes. 
Data were collected so that three distinct sections of usable data, at least ten cardiac cycles in 
length, were recorded. Usable data were defined as 10 consecutive cardiac cycles where both 
the velocity and pressure tracing showed consistent waveforms with minimal variation in 
baseline (hold-down pressure of Millar probe) or spikes in the ultrasound signal. This data 
collection was repeated on each of the three days that the participant was in the lab. 
Therefore, each participant had three RCKL measures on each day of testing for a total of 
nine measures. 
A.2.1 Data Analysis 
 RCKL modeling was used to assess cerebrovascular hemodynamic properties for 
each of the nine trials (three on each day). For each trial, mean values of CCA flow, CCA 
arterial blood pressure, R, C, K, and L were determined. A one way repeated measures 
analysis of variance was conducted to determine the residual mean square error 
representative of within-subject variance. Measurement error was determined through the 
calculation of within-subject standard deviation (SW) which is equivalent to the square root 
of within-subject variance (Bland & Douglas, 1996a). Repeatability was then calculated at 
2.77 x SW (Bland & Douglas, 1996a). The coefficient of variation (CV), expressed as a 
percentage, was also calculated as the ratio of SW and overall mean (Bland & Douglas, 
1996b). 
A.3 Results 
 Data were successfully collected for each individual on each testing day. Mean data 
for CCA flow, CCA arterial pressure, R, C, K, and L are presented in Table A.1. No 
differences were seen between data trials for either mean CCA blood flow, or mean CCA 
arterial pressure. Results from the repeated measures analysis of variance also showed no 
difference between data sections for R, C, K, or L (P>0.05). Results for the calculation of 
repeatability and CV are shown in Table A.2. 
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T1 0.537 ± 0.175 0.0127 ± 0.0065 0.0412 ± 0.012 7.73E-6 ± 5.22E-6 183.7 ± 72.7 88.6 ± 6.97 
T2 0.529 ± 0.176 0.0140 ± 0.0066 0.0605 ± 0.031 7.44E-6 ± 3.30E-6 185.4 ± 77.5 87.4 ± 9.40 
T3 0.506 ± 0.188 0.0162 ± 0.0089 0.0514 ± 0.035 7.32E-6 ± 5.98 E-6 193.9 ± 85.2 86.1 ± 7.98 
T4 0.434 ± 0.0949 0.0142 ± 0.0066 0.0353 ± 0.014 7.57E-6 ± 2.05E-6 204.7 ± 64.1 84.5 ± 7.04 
T5 0.430 ± 0.0868 0.0148 ± 0.0069 0.0294 ± 0.009 6.44E-6 ± 4.62E-6 203.4 ± 55.1 84.2 ± 7.99 
T6 0.459 ± 0.0403 0.0126 ± 0.0051 0.0357 ± 0.019 5.25E-6 ± 4.12E-6 191.5 ± 34.0 87.2 ± 12.0 
T7 0.414 ± 0.0699 0.0162 ± 0.0047 0.0242 ± 0.008 5.10E-6 ± 4.18E-6 208.7 ± 52.7 84.7 ± 16.0 
T8 0.434 ± 0.066 0.0132 ± 0.0029 0.0303 ± 0.016 5.99E-6 ± 3.79E-6 202.8 ± 49.1 86.8 ± 17.5 
T9 0.451 ± 0.0716 0.0143 ± 0.0046 0.0418 ± 0.009 6.31E-6 ± 3.39E-6 203.9 ± 56.9 89.2 ± 16.7 
 Values show the mean ± SD for each data section. Results of the repeated measures analysis of variance showed no differences between 
the data trials for any variable. 
 
 171 
Table A.2: Repeatability and CV values for RCKL outputs 
Variable Repeatability CV 
R 0.235mmHg/mL/min 18.2% 
C 0.00923mL/mmHg 23.4% 




 Table shows results of repeatability analysis with values for repeatability and 
the coefficient of variation. 
A.4 Discussion 
 RCKL modelling has previously been used to describe changes in the peripheral 
vasculature (Zamir et al., 2007). The major finding of the current work was that RCKL 
modelling of the cerebral circulation produced repeatable outputs, suggesting that observed 
changes in model outputs are the result of alteration in the cerebrovasculature and that this 
model can be applied to provide a greater understanding of cerebrovascular hemodynamics. 
 The assessment of repeatability involves determining the degree of within-subject 
variation. This was determined through the calculation of repeatability and CV. In general, 
the smaller the values for repeatability and CV the better the repeatability of the measure. 
The current study showed values for CV that at first assessment seemed large. Therefore, 
sample size calculations were conducted to determine how these repeatability numbers 
translated to practical application. Calculations were conducted to determine the minimum 
sample size required to detect a change of half of the repeatability with a standard deviation 
equal to SW, power of 0.8, and an alpha level of 0.05. To detect a change in R, a sample size 
of 10 was required, where only 9 were required for C, K, and L. These results suggest that 
despite larger than desired values for CV, only a relatively small sample sizes are required to 




 In this study, hemodynamic data collected from the common carotid artery were 
thought to reflect changes in cerebral blood flow. However, the CCA supplies both the 
intracranial circulation via the internal carotid artery and the extracranial circulation via the 
external carotid artery. The use of RCKL modeling provides indications of total downstream 
vascular condition. Therefore, the use of the CCA for RCKL modelling is influenced by both 
the cerebral and extracranial circulation. Future studies need to be conducted to determine 
potential differences between intracranial and extracranial responses and how these responses 
relate to RCKL outputs. 
 As the data acquisition of common carotid artery pressure and flow are to be done 
simultaneously, this required pressure to be collected on one side of the neck and flow to be 
determined on the opposite side. The left and right common carotid arteries do possess 
slightly different characteristics; however, pilot work conducted in the Neurovascular 
Research Laboratory at Western University, has shown no differences in RCKL measure 
when pressure was collected on the right side with flow on the left versus pressure collected 
on the left side and flow on the right (data not shown). For consistency purposes, Millar 
pressure data were always collected from the left CCA and velocity and flow measures from 
the right CCA. 
 Doppler ultrasound was used for the assessment of CCA velocity; however, the use of 
this method does not allow for the determination of the exact angle of insonation. It is 
believed that this did not pose an issue for this work, as each individual was acting as his/her 
own control, and the structure of the common carotid artery was not expected to change over 
a 3 day period. This assumption may serve to increase variability between subjects; however, 
this testing was intended to assess repeatability within subjects and the assumption of a 
constant angle of insonation was believed to be appropriate.  
 In the current work, only the end diastolic diameter value was used for the calculation 
of flow. However, there is a large variation in CCA diameter throughout the cardiac cycle. 
Currently it is unclear how the use of continuous diameter for the calculation of flow will 
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influence results for RCKL modelling and future work will have to address this 
consideration. 
 The current study was designed solely to test the repeatability of RCKL outputs using 
CCA pressure and flow measures as model inputs. As such, it is not possible to tell from the 
current data set what variables might have contributed to the variability of RCKL outputs. 
Previous work has suggested alterations in vascular tone with changes in carbon dioxide 
(Ogoh et al., 2010; Panerai et al., 2010; Panerai, 2003). It is possible that spontaneous 
fluctuations in CO2 contributed to the variability seen in this study. Future work is required to 
determine potential variables that contribute to within subject variation of RCKL outputs. 
A.5 Conclusion 
 The current work presented repeatability data for RCKL modelling using flow and 
pressure inputs measured in the common carotid artery. Although values calculated for CV 
seem large, the sample size required to detect a minimum change of half the repeatability was 
small suggesting good repeatability of the measures. In summary, the results of this work 






Appendix B  
The impact of continuous common carotid artery 
diameter measures on the calculation of flow and flow 







 The use of Doppler ultrasound for the assessment of blood flow has traditionally 
utilized single diameter measures for the calculation of vessel cross sectional area and 
resulting flow. In many cases the end diastolic diameter is used or a mean diameter is 
calculated as Davg = ((1/3) x Dsys) + ((2/3) x Ddia). However, in addition to differences 
between systolic (Dsys) and diastolic (Ddia) diameter, throughout the cardiac cycle the 
diameter of blood vessels change with alterations in pressure and are potentially dependent 
on vascular compliance and viscoelastic resistance. This is particularly evident when 
studying the common carotid artery (CCA) as changes in vessel diameter are relatively large 
and can be easily seen in real time B-mode ultrasound video. The use of continuous diameter 
measurements will have an influence on the calculation of mean blood flow, but could also 
have a profound influence in results when the variation in flow is assessed within a cardiac 
cycle, particularly in situations where CCA vascular tone is changing.  
 Nitroglycerin (NG) is commonly used in clinical settings as a method to reduce the 
work of the heart through venodilation and potentially through dilation of coronary blood 
vessels (Abrams, 1996). In research settings NG is often used to determine maximal nitric 
oxide (NO) dependent dilation of conduit arteries independent of the endothelium (Bleeker et 
al., 2005; Bonnin et al., 2001; Guazzi et al., 2004). However, NG also influences vascular 
tone as previous work has shown an increase in peripheral vascular compliance (Smulyan et 
al., 1986; Bank & Kaiser, 1998) and a reduction in cerebrovascular tone (Moppett et al., 
2008) with NG. It is conceivable that the CCA also responds in a similar fashion thus altering 
the diameter profile throughout a cardiac cycle and potentialy calculations of flow and 
vascular resistance. 
 Previous work has utilized mathematical modeling for the determination of 
downstream vascular properties. The RCKL model, based on a modified Winkessel model, 
placed resistance (R) and compliance (C) in parallel with viscoelastic resistance (K) and 
inertance (L) in series with C and has been used to assess changes in the peripheral 
vasculature (Zamir et al., 2007) and the cerebrovasculature with aging (Robertson et al., 
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2008). However, these studies only utilized single diameter measures for the calculation of 
flow. Therefore the purpose of the current study was to continuously assess the diameter for 
the CCA at rest and after NG stimulation to determine if alterations exist in the CCA flow 
profile that affect calculations of flow, vascular resistance, and RCKL model outputs. 
 This study looked at the calculation of CCA blood flow and resistance with a single 
diastolic diameter measure of the CCA and with continuous assessment of CCA diameter 
both before and after NG stimulation. In addition RCKL model outputs were also assessed 
with the two calculated CCA flow waves. It was hypothesized the different methods for 
calculating CCA blood flow would result in statistically different absolute values, but would 
not affect the calculated responses to NG. However, it was also hypothesized that the use of 
continuous CCA diameter for the RCKL model would produce significantly different 
compliance and viscoelastic resistance results to those utilizing single diameter measures for 
the calculation of flow both at rest and with NG stimulation. 
B.2 Methods 
 Data for this project were collected as a part of the STBR-2010 project with general 
methods and instrumentation presented in Chapter 6.  
B.2.1 Data Analysis 
 The assessment of CCA diameter was conducted using video analysis, wall detection 
software. This software was designed to use a threshold detection technique for the 
identification of vessel walls providing a diameter measure for each frame of video collected. 
Video was recorded at 25 frames per second which allowed for the detection of diastolic 
(Ddia) diameter points with a diameter measure calculated for each frame of video. 
Continuous diameter measures (Dcont) values were spline interpolated to 100Hz to match 
CCA velocity which was also calculated at 100Hz. The outer envelope of the CCA Doppler 
velocity trace was used as an indication of CCA blood velocity and combined with diameter 
measures for the calculation of CCA flow. Therefore, two different values for flow were 
determined using Ddia and Dcont.  
 
 177 
 Differences in the CCA flow waves with the different calculation methods were 
assessed by looking at key inflection points as shown in Figure B.1 and assessed with respect 
to the end diastolic velocity value, T1, as P1-T1, T2-T1, P2-T1, T3-T1, and P3-T1. Similar to 
previously described (Robertson et al., 2008; Kurji et al., 2006), the peaks P1 and P2 of the 
velocity wave were used with the end diastolic value T1 for the calculation of an 
augmentation index as AI = (P2-T1) / (P1-T1) x 100%. 
 Mean flow was determined as the mean of each calculated flow wave over a cardiac 
cycle. Vascular resistance (VR) was determined as mean arterial pressure divided by mean 
flow. In addition, the two Doppler resistance indices were calculated from the CCA flow 
waves as RI = (CCAsys-CCAdia)/CCAsys and PI = (CCAsys-CCAdia)/CCAmean. 
 RCKL modeling was conducted as previously presented by Zamir et al. (Zamir et al., 
2007). Briefly, simultaneous flow and pressure measures of the CCA were used as model 
inputs both before and after NG stimulation for the calculation of downstream R, C, K, and 
L.  
B.2.2 Statistical Analysis 
 Values presented show the mean ± SD. Data were assessed using a two-way repeated 
measures analysis of variance (SigmaStat 3.5, Systat Software Inc., Chicago, IL) for the main 
effects of NG stimulation and flow calculation method as well as any potential interactions 



























Figure B.1: Representative CCA flow wave 
CCA flow waveform with key inflection points marked as T1, P1, T2, P2, T3, and P3. 
B.3 Results 
 Representative tracings are shown in Figure B.2 for CCA pressure (Figure B.2 A), 
CCA diameter (Figure B.2 B), and CCA flow calculated using the continuous diameter 
measure (Figure B.2 C). Calculated CCA blood flow (Figure B.3 A) and vascular resistance 
(Figure B.3 B) showed the main effect of measure indicating that the absolute value of CCA 
blow flow and VR were dependent on the diameter measure used. Statistical analysis also 
found main effect of NG with CCAVR being reduced with NG administration. With respect to 
the Doppler resistance indices, RI (Figure B.3 C) and PI (Figure B.3 D) both showed 
interaction effects between the use of Ddia or Dcont and NG stimulation. Post hoc testing 
showed that with Ddia, PI was greater after NG stimulation (P=0.037) and there was a strong 
trend for an increase in RI (P=0.051). Conversely, when Dcont was used for the calculation 






























































Figure B.2: Individual raw data 
Raw data from one individual with CCA pressure (A), diameter (B) and CCA flow calculated with the 
continuous diameter measure (C). 
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 Representative CCA flow waves are show in Figure B.4 for baseline rest (Figure B.4 
A) and after NG stimulation (Figure B.4 B) with waves normalized to an end diastolic value 
of 0mL/min. From this figure it can be seen that the diameter measure used for the 
calculation of CCA blood flow influences the shape of the resultant flow wave. Statistically 
significant results were found for each of the flow wave inflection points assessed (Figure 
B.5). Significant interactions were found for T2-T1 (Figure B.5 B), P2-T1 (Figure B.5 C), 
and T3-T1 (Figure B.5 D). Post hoc analysis showed that values calculated with Dcont were 
different from Ddia with a greater response to NG for flow waves calculated with Dcont. P1-
T1 (Figure B.5 A) also showed a main effect of measure with only Dcont values showing a 
significant increase with NG. However, the interaction did not reach statistical significance 
potentially due to large individual variability in the direction of NG responses. P3-T1 (Figure 
B.5 E) showed a significant effect of the measurement method, but no effects of NG. 
Analysis of AI showed significant differences between Dcont and Ddia values and a 
significant reduction with NG; however there was no interaction between these variables. 
 RCKL modelling results showed differences in the values for R (Figure B.6 A), C 
(Figure B.6 B), and L (Figure B.6 D) dependent on the diameter measure used for the 
calculation of flow. The calculated value of K (Figure B.6 C) was not dependent on the 
diameter measure used. Only C showed a significant change with NG stimulation; however, 







































































Figure B.3: Calculated CCA flow and vascular resistance 
Results for calculated CCA flow (panel A), vascular resistance (panel B), RI (panel C), and PI (panel 
D) calculated with Ddia (black bars) and Dcont (white bars). All values are mean ± SD with P values 
on the graphs showing the main effects of the two-way repeated measures ANOVA. Values that are 









































Figure B.4: Representative CCA flow waves 
Representative CCA flow waveforms for one individual at rest (panel A) and after NG (panel B). 
























































































Figure B.5: Wave inflection point results 
Flow wave inflection point results (mean ± SD) for Ddia (black bars) and Dcont (white bars). P 
values on the graphs showing the main effects of the two-way repeated measures ANOVA. Values 

























































































Figure B.6: RCKL results 
Results from the RCKL modeling analysis using flow waves calculated with Ddia (black bars) and 
Dcont (white bars). All values are mean ± SD with P values on the graphs showing the main effects of 
the two-way repeated measures ANOVA. Values that are statistically different with NG compared to 






 The current study utilized two different assessments of CCA diameter for the 
calculation of CCA flow to determine how each diameter measure affected the resultant CCA 
flow waveform and responses to NG. In support of the hypothesis, the results showed 
differences in calculated flow and resistance values with the different diameter measures; 
however, responses to NG were similar for each diameter measure used. Also in support of 
the hypotheses, assessment of the CCA flow waveform morphology showed significant 
differences with the different diameter measures and showed greater responses to NG when 
continuous diameter measures were used compared to single measures. The different 
calculated flow waves also resulted in differences in the RCKL model results; however, in 
contrast to the hypothesis, no differences in RCKL model results with NG were seen. 
 Studies using the ultrasound assessment of CCA blood flow have frequently used a 
single diameter measure for the calculation of flow (Sato et al., 2011; Eicke et al., 1999; 
Arbeille et al., 2001). The results of the current study support this method for determining 
changes in mean CCA flow, but also demonstrate that continuous measure of vessel diameter 
are needed when changes are assessed within a cardiac cycle. Some work has been conducted 
with continuous diameter assessments of the CCA (Hirata et al., 2006; Niki et al., 2002; 
Hirata et al., 2006) and brachial artery (Green, Cheetham, Reed, Dembo, & O'Driscoll, 2002) 
but these studies did not attempt to show the difference between a flow wave calculate with a 
single diameter measure versus that with the continuous diameter measures.  
 Surprisingly, no differences in the RCKL outputs were seen between the two flow 
calculations. The RCKL model generates a modelled flow wave from the measured pressure 
wave with changes in R, C, K, and L so that the modelled flow wave matches measured flow 
wave. Analysis of the flow wave inflection points found that the use of continuous diameter 
measures altered the shape of the flow wave; therefore, alterations in the RCKL outputs were 
expected. As this was not the case, it is possible that the RCKL model, which is a simplified 
estimate of downstream hemodynamic conditions, was not sensitive enough to be affected by 




 In the current study, ultrasound video was collected and used for analysis which 
provided a diameter measure for each frame of video. Therefore, diameter measures were 
collected at 25Hz for comparison to a velocity trace assessed at 100Hz. Diameter measures 
were spline interpolated to match the velocity collection frequency; however this 
interpolation may introduce an additional error into the calculation of flow using continuous 
diameter. As ultrasound technology continues to progress, it is possible that collecting 
diameter measures at a higher collection frequency will show more variation in the diameter 
wave thus further contributing to alteration in the calculated flow waveform. 
B.5 Conclusion 
 The current study showed that different methods of CCA diameter measures have a 
significant effect on the resultant calculated CCA flow, vascular resistance, and RCKL model 
output. However, contrary to the hypothesis, the different diameter measure did not affect the 
responses of these variables. Conversely, in support of the hypothesis, several flow 
waveform inflection points and the calculation of RI and PI showed significant interactions. 
These results suggest that when using ultrasound assessments of CCA flow and resistance, as 
long as the diameter used is consistent, minimal differences will be seen. However, in cases 
where the morphology of the waveform within a cardiac cycle is important, a continuous 





Appendix C  
Responses of women to sublingual nitroglycerin before 
and after 56 days of 6° head down bed rest 
 
This chapter was published as: 
Zuj KA, Arbeille Edgell H, Shoemaker JK, Custaud MA, Arbeille Ph, and Hughson RL (2012). 
Responses of women to sublingual nitroglycerin before and after 56 days of 6° head down bed 





 This study tested the hypothesis that cardiovascular effects of sublingual nitroglycerin 
(NG) would be exaggerated after 56 days of 6° head down bed rest (HDBR) in women, and 
that an aerobic and resistive exercise countermeasure (EX, n=8) would reduce the effect 
compared to HDBR without exercise (CON, n=7). Middle cerebral artery maximal blood 
flow velocity (CBFV), cardiac stroke volume (SV), and superficial femoral artery blood flow 
(Doppler ultrasound) were recorded at baseline rest and for five minutes following 0.3 mg 
sublingual NG. Post-HDBR, NG caused greater increases in heart rate (HR) in CON 
compared to EX (+24.9±7.7, and +18.8±6.6bpm respectively, P<0.0001). The increase in HR 
combined with reductions in SV to maintain cardiac output. Systolic, mean and pulse 
pressures were reduced 5-10mmHg by NG, but total peripheral resistance was only slightly 
reduced at 3min after NG. Reductions in CBFV of -12.5±3.8cm/s were seen after NG, but a 
reduction in the Doppler resistance index suggested dilation of the middle cerebral artery 
with no differences after HDBR. The femoral artery dilated with NG and blood flow was 
reduced ~50% with the appearance of large negative waves suggesting marked increase in 
downstream resistance, but there were no effects of HDBR. In general, responses of women 
to NG were not altered by HDBR; the greater increase in HR in CON but not EX was 
probably a consequence of cardiovascular deconditioning. These results contrast with the 
hypothesis and a previous investigation of men after HDBR by revealing no change in 





 The vasodilatory actions of nitric oxide (NO) work in conjunction with sympathetic 
vasoconstrictor activity and other vasoactive hormones in the regulation of blood pressure 
and blood flow (Delp & Laughlin, 1998; Mombouli & Vanhoutte, 1999). Acute alterations in 
NO effects on blood vessels have been noted under conditions that simulate spaceflight in 
animals (Prisby et al., 2006; Wilkerson et al., 2005; Sangha, Vaziri, Ding, & Purdy, 2000; 
Vaziri, Ding, Sangha, & Purdy, 2000) and humans (Rudnick et al., 2004; Bleeker et al., 
2005; Platts et al., 2009; Bonnin et al., 2001; Salanova, Schiffl, Püttmann, Schoser, & 
Blottner, 2008). These results suggest that alterations in hemodynamic responses with 
exposure to real or simulated microgravity may be due to changes in NO mediated 
mechanisms. 
 Animal models of simulated microgravity have shown elevated nitric oxide synthase 
(NOS) activity increasing NO production that could dilate peripheral vessels and reduce 
vascular responsiveness to norepinephrine (Sangha et al., 2000; Vaziri et al., 2000). In 
contrast, cerebral arteries of hind limb suspended rats show reduced eNOS protein 
(Wilkerson et al., 2005) and reduced middle cerebral artery endothelial dependent dilation 
(Prisby et al., 2006). These results from animal studies point towards potential regional 
differences in hemodynamic responses to NO after simulated microgravity; a topic which has 
not been studied in humans. 
 Focusing on isolated regions, studies involving humans suggest changes in the NO 
system after simulated microgravity. Expression of NOS isoforms in leg skeletal muscle was 
altered in men following 90 days of head down bed rest (HDBR) (Rudnick et al., 2004) and 
in the women reported in the current study after 60 days of HDBR (Salanova et al., 2008). In 
peripheral vascular beds, a trend has been observed for greater flow mediated dilation (FMD) 
responses after HDBR (Bleeker et al., 2005; Platts et al., 2009) thought to be mediated by 
NO mechanisms (Green, 2005). However, different responses have been observed with 
respect to the dilatory effects of sublingual nitroglycerin (NG) where two studies have shown 
no effect (Bonnin et al., 2001; Platts et al., 2009) compared to enhanced dilation after 52 days 
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of horizontal bed rest (Bleeker et al., 2005). It has been speculated that changes in NO 
mediated mechanisms of blood flow regulation might contribute to orthostatic intolerance 
observed after spaceflight and spaceflight simulation (Bonnin et al., 2001; Guazzi et al., 
2004). A greater heart rate response to NG has been reported after seven days of HDBR 
(Bonnin et al., 2001) but little information is available on the systemic and regional responses 
to this NO donor. 
 The current experiments were conducted within the WISE-2005 spaceflight analogue 
study which involved women who completed 56 days of continuous 6° HDBR with or 
without exercise countermeasures. We hypothesized that 56 days of HDBR would exaggerate 
cardiovascular responses to NG reflecting poorer orthostatic tolerance following HDBR and 
that the aerobic and resistive exercise countermeasure would attenuate these effects. 
C.3 Methods 
C.3.1 WISE-2005 
 The Women’s International Simulation for Space Exploration (WISE) was an 
international collaborative study between the Centre National d’Etudes Spatiales (CNES), 
European Space Agency (ESA), Canadian Space Agency (CSA), and the National 
Aeronautics and Space Administration (NASA). This study reports on fifteen healthy women 
between the ages of 25 and 40 years of age who completed 60 days of continuous 6° HDBR 
with the experiments for this study completed on day 56 of HDBR. The research was 
conducted in Toulouse, France, at the MEDES Space Medicine Research Facility of CNES 
and approved by the Comité Consultatif de Protections des Personnes dans la Recherche 
Biomédicale, Midi-Pyrénées (France), Committee for the Protection of Human Subjects at 
Johnson Space Center, and local ethics committees including the Office of Research Ethics, 
University of Waterloo. All study protocols were in accordance with the declaration of 
Helsinki. Each subject signed an informed consent form and was aware of her right to 
withdraw from the study without prejudice. 
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C.3.2 Countermeasures and Exercise Schedule 
 Subjects were randomly assigned to either the control (CON), or exercise (EX) group 
after first stratifying them according to maximal oxygen uptake. Participants were 
recreationally active with an average height of 164.3±6.2cm and weight of 58.2±5.0kg. 
Maximal oxygen uptake data have been previously presented (Schneider, Lee, Macias, 
Watenpaugh, & Hargens, 2009; Guinet et al., 2009) with averages of 38.9±6.8mL/min/kg 
and 37.9±4.0mL/min/kg for CON and EX respectively. One participant in the CON group 
did not complete the NG testing post-HDBR and was excluded from all analysis. The CON 
group (n=7) did not receive any countermeasure during the 56 days of bed rest, while the 
subjects in the EX group (n=8) performed two types of exercise. Three to four times per 
week, the EX group exercised for 40 minutes between 40-80% of their peak oxygen uptakes 
on a treadmill inside a lower body negative pressure (LBNP) chamber with LBNP applied to 
provide a ground reaction force of 1-1.2 body weight (Cao et al., 2005). Treadmill exercise 
was followed by 10 minutes of static LBNP. Every third day of the bed rest period, the EX 
group completed flywheel resistance exercise (Rittweger et al., 2005).  
C.3.3 Physiological Measures 
 Heart rate (HR) was determined using a standard three lead electrocardiogram. Finger 
photophlethysomography (Finometer, Finapres Medical, Amsterdam) was used for the 
determination of arterial pressure. Mean arterial pressure (MAP), systolic pressure (SBP), 
diastolic pressure (DBP), and pulse pressure (PP) were determined from the recorded 
pressure wave forms. Data were recorded on a PowerLab (ADInstruments, Colorado Springs, 
USA) data collection system. 
 Aortic blood velocity was determined using a 2MHz probe oriented to determine the 
velocity of blood at the aortic root (Multigon, New York, NY). Ultrasound imaging (Acuson 
128XP, Paris, France) was used to assess the cross-sectional area of the aortic root which was 
then combined with velocity measures to determine cardiac stroke volume (SV). Cardiac 
output (Q) was determined as the product of SV and HR. Total peripheral resistance (TPR) 
was calculated as TPR = MAP / Q. 
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 Superficial femoral artery blood velocity was determined using a 4MHz pulsed 
Doppler probe (CardioLab, ESA-CNES device, France). Echo Doppler ultrasound (Acuson 
128XP, Paris, France) was used to provide images of the superficial femoral artery for the 
determination of vessel cross-sectional area and the calculation of femoral blood flow. Blood 
flow data were normalized to 100mL of lower limb lean tissue calculated from magnetic 
resonance imaging (S. Trappe and T. Trappe, personal communication). Femoral vascular 
conductance (FC) was calculated as FC = femoral flow / MAP. Vascular conductance was 
calculated for this study as the calculation of vascular resistance (MAP / flow) had a skewed 
distribution with some extremely high values as, in some individuals, femoral blood flow 
was reduced to near zero with NG stimulation. 
 Echo Doppler imaging of the portal vein (Acuson 128XP, Paris, France) was used for 
the assessment of portal vein cross sectional area. Due to technical issues, the data from only 
eight of the subjects was analyzed for pre-HDBR responses. 
 Transcranial Doppler ultrasound was performed for the assessment of cerebral blood 
flow velocity (CBFV). A 2MHz pulsed Doppler probe (CardioLab, ESA-CNES device, 
France) was positioned over the temporal window allowing for the insonation of the middle 
cerebral artery (MCA). Throughout the test, the probe was held in place using a head band. 
The outer envelope of the Doppler spectrum was recorded and CBFV was determined as the 
mean of the outer envelope over a cardiac cycle. Two indexes of cerebral vascular resistance, 
CVRi and RI, were calculated from the waveform. CVRi was determined from CVRi = MAP 
/ CBFV, whereas RI was calculated from RI = (CBFVsys – CBFVdia) / CBFVsys where 
CBFVsys and CBFVdia are the maximum and minimum points of the wave respectively 
during a cardiac cycle. 
C.3.4 Testing Protocol 
 Data were collected seven days before the start of HDBR (pre-HDBR) and on the 
56th day of the bed rest period (post-HDBR), approximately 24 hours after a treadmill in 
LBNP exercise session for the EX group. All measures were made in a supine posture. 
Physiological measures were recorded continuously for two minute baseline period and five 
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minutes after the sublingual administration of 0.3mg of nitroglycerin (Natispray, Proctor & 
Gamble Pharmaceuticals, France). Imaging of the portal vein was performed at baseline, two, 
and four minutes after NG stimulation for 8 of the 15 participants, pre-HDBR. Diameter 
measures of the superficial femoral artery were taken at baseline and five minutes after NG. 
C.3.5 Statistical Analysis 
 The analysis of HDBR responses used a three-way repeated measures analysis of 
variance with the main effects for this analysis being HDBR (pre, post), countermeasure 
group (EX n=8, CON n=7), and time after drug. Responses to NG were determined every 
minute after NG and compared to baseline values before NG stimulation. SAS 9.1.3 analysis 
software was used for all statistical analysis with significance set at p<0.05. Values in the 
text are expressed as mean ± SD. 
C.4 Results 
C.4.1 Pre-HDBR Response to NG 
 No differences were seen for any measured variable between EX and CON pre-
HDBR (filled symbols in figures). MAP was slightly reduced the first minute, decreased 
significantly (-4.9±3.0mmHg, Figure C.1 A) for the second minute, and remained lower for 
the remainder of the test. A decrease in SBP (-5.5±4.5mmHg, Figure C.1 B) combined with a 
slight increase in DBP to produce a decrease in PP (-5.8±4.9mmHg, Figure C.1 C). SBP 
recovered back towards baseline after four minutes, but the small, significant increase in 
DBP (1.7±3.4mmHg, Figure C.1 D) served to maintain the decrease in PP. 
 HR pre-HDBR increased significantly in the first minute after NG (4.2±4.2bpm, 
Figure C.2 A) then increased further at two minutes (11.8±3.9bpm) and remained elevated. 
SV decreased significantly by the second minute and Q was elevated only at the third minute 
(Figure C.2 B and D respectively). TPR was reduced at the third minute in response to NG 
(Figure C.2 C). The average baseline diameter of the portal vein was 10.9±1.7mm. Diameter 
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increased at two minutes to 11.9±1.9mm and remained dilated after four minutes with an 
average value of 12.0±1.7mm (n=8, p<0.05). 
 CBFV decreased over the first two minutes of NG (-9.0±2.3cm/s, Figure C.3 A) then 
remained lower throughout the observation period. Two calculated resistance indices 
revealed opposite effects. CVRi increased at two minutes (0.30±0.15mmHg/cm/s, Figure C.3 
B) then remained elevated until the end of the test. However, the Doppler resistance index, 
RI, remained constant for the first two minutes and decreased significantly at three minutes 
after NG stimulation (-0.025±0.042, Figure C.3 C). 
 Femoral blood flow was reduced by 49.1±22.1mL/min/100mL tissue (Figure C.4 A, 
p<0.05). This resulted primarily though a large reduction in downstream vascular 
conductance (Figure C.4 B, p<0.05) as the diameter of the superficial femoral artery 
increased after NG (11.7±6.6% and 15.9±10.2% for EX and CON respectively, Figure C.4 C, 
p<0.05). The pattern of the blood velocity waveform (Figure C.5) changed dramatically 


























































































Figure C.1: Arterial pressure responses to NG 
Responses of MAP (A), SBP (B), PP (C) and DBP (D) to 0.3mg sublingual nitroglycerin (NG) 
administered at time = 0. Pre- (solid symbols) and post-HDBR (open symbols) for exercise (EX, ●) 
and control (CON, ▲) groups. The assessment of NG effects are shown as differences from time = 0 
(*, p<0.05). Group x HDBR interactions showed significant reductions in MAP, SBP, and PP in CON 
post-HDBR compared to pre-HDBR (#, p<0.05). HDBR x NG interactions were found for both SBP 





























































































Figure C.2: HR, SV, TPR, and Q responses to NG 
Responses of HR (A), SV (B), TPR (C), and Q (D) to NG administered at time = 0 before and after 
HDBR (symbols as in Figure C.1). The assessment of NG effects are shown as differences from time 
= 0 (*, p<0.05). A significant 3 ways interaction (HDBR x Group x NG) was found for HR (p<0.05) 
indicating a greater response to NG in CON post-HDBR (CON n=7, EX n=8). No HDBR effects were 

































































Figure C.3: Cerebrovascular responses to 
NG 
Responses of CBFV (A), CVRi (B), and RI (C) 
to NG administered at time = 0 before and 
after HDBR (symbols as in Figure C.1). The 
assessment of NG effects are shown as 
differences from time = 0 (*, p<0.05). No 
HDBR effects were found with either CBFV or 
CVRi; however, post-HDBR, RI was 

































































































Figure C.4: Femoral artery responses to NG 
Responses of superficial femoral artery flow 
(A), conductance (B), and diameter (C) in 
response to NG pre-HDBR (solid bars) and 
post-HDBR (hatched bars) for EX (grey) and 
CON (white). All variables showed a 
significant effect of NG (*, p<0.05). No HDBR 
effects were found for femoral flow, 
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Figure C.5: Representative femoral blood flow trace 
Representative tracings of the waveforms for a single subject of femoral blood flow (product of 
measured instantaneous velocity and vessel cross-sectional area) at baseline (A) and after NG 
stimulation (B). Mean flow, shown by dashed horizontal lines, was greater at baseline (56.1 mL/min) 
than after NG (30.1 mL/min) primarily due to a large increase in negative flow. 
C.4.2 Effects of HDBR 
 After HDBR, resting MAP, SBP, and PP were lower in the CON group with no 
change in the EX group (Figure C.1). A significant HDBR x NG interaction effect (p<0.05) 
was detected for SBP and PP whereby both variables decreased more in post-HDBR 
compared to pre-HDBR. 
 The HR responses to NG after HDBR were characterized by a significant three-way 
interaction of HDBR x Group x NG effect (Figure C.2). Further analysis of this interaction 
showed that baseline HR, measured before NG stimulation, was elevated in CON but not in 
the EX group. In response to NG, both groups had greater HR increases post-HDBR. Peak 
increases in HR pre-HDBR (13.7±5.8 bpm and 13.0±5.2 bpm for EX and CON respectively) 
were significantly less than post-HDBR with a smaller HDBR increase for EX than CON 
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(18.8±6.6 bpm and 24.9±7.7 bpm for EX and CON respectively, Figure C.2). There were no 
HDBR effects for SV (Figure C.2 B), Q (Figure C.2 D), or TPR (Figure C.2 C). 
 After HDBR, CBFV and CVRi responses to NG were not statistically different from 
pre-HDBR (Figure C.3). There was a significant reduction in RI post-HDBR in both the EX 
and CON groups (HDBR main effect), but there was no difference in the response to NG. 
Baseline femoral blood flow, conductance, and diameter were not significantly different 
post-HDBR and the responses to NG including the change in diameter (13.9±13.6% and 
18.6±17.2% for EX and CON respectively) were also not changed (Figure C.4). 
C.5 Discussion 
 Sublingual nitroglycerin was used in the current study to investigate the overall 
cardiovascular response to an exogenous source of NO and to determine if the responses 
were altered after 56 days of HDBR. The pre-HDBR responses to NG were consistent with 
previous research with an increase in heart rate (Bonnin et al., 2001), reduction in cardiac 
stroke volume (Soma, Angelsen, Aakhus, & Skjaerpe, 2000), and lower arterial systolic, 
mean, and pulse pressure (Soma et al., 2000; Smulyan et al., 1986; Lai, Koyanagi, Shaw, & 
Takeshita, 1998). A novel observation was the almost 50% reduction in femoral blood flow 
that reflected a marked reduction in downstream vascular conductance as demonstrated by 
the large reverse (negative) component, shown in Figure C.5, of the Doppler ultrasound trace 
(Arbeille et al., 1995). Mean cerebral blood flow velocity was reduced in response to NG, but 
the reductions in the Doppler resistance index suggested that brain blood flow might have 
increased or at least remained constant as observed previously using other imaging 
techniques (Borisenko & Vlasenko, 1992; Dahl et al., 1989; Dahl et al., 1990; White et al., 
2000). 
 This is the first study to explore the potential effects of an exercise countermeasure on 
the hemodynamic responses to NG in women after HDBR. Consistent with our hypothesis 
and in agreement with a shorter duration HDBR study of men (Bonnin et al., 2001), there 
was a greater increase in HR with NG stimulation that was attenuated by the exercise 
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countermeasure. Conversely, post-HDBR there was a greater reduction in both systolic blood 
pressure and arterial pulse pressure that was not affected by the exercise countermeasure. No 
effects of HDBR were seen for any of the cerebrovascular indicators examined in this study. 
Similarly, there were no differences in femoral artery dilation responses to NG which was 
consistent with results from two studies (Bonnin et al., 2001; Platts et al., 2009) but 
contrasted with the results from the Berlin Bed Rest Study in men (Bleeker et al., 2005). 
Overall, these data revealed only small changes in the cardiovascular responses to NG after 
HDBR which tend to contrast with previously reported data from both human males and 
rodent models. 
C.5.1 Overall Responses to Nitroglycerin 
 This study provided a comprehensive view of the cardiovascular response of young, 
healthy, women to sublingual NG both before and after 56 days of HDBR. Previous work has 
focused on regional responses to NG in men. NG is an NO donor acting primarily on 
vascular smooth muscle (Chung & Fung, 1990; Ignarro et al., 1981), but potentially affecting 
the endothelium (Munzel, 2001). The major clinical application of NG has been to alleviate 
the effects of angina by reducing the preload on the heart through venodilation and by the 
direct action of dilating coronary arteries (Abrams, 1996). In research settings, NG is used 
extensively in the study of vasodilatory properties of conduit arteries as a method for eliciting 
maximal vasodilation independent of the endothelium (Bleeker et al., 2005; Bonnin et al., 
2001; Guazzi et al., 2004). In the current study, NG was used to determine hemodynamic 
responses to NO both before and after HDBR. 
 There was evidence in the current study from the decline in SV that the cardiac 
preload was reduced by NG. The decline in SV was consistent with data from hypertensive 
men (Soma et al., 2000) but in contrast to that study Q was elevated at three minutes, 
potentially as a function of the increase in HR resulting from baroreflex compensation for the 
decline in SBP and MAP. The different responses could reflect a sex difference in the effect 
of NG or could simply reflect the contrast between hypertensive patients and the healthy 
subjects of the current study. 
 
 202 
 The peripheral vascular responses to NG suggested the dilation of conduit arteries but 
also a marked peripheral vasoconstriction as seen by the dilation of the superficial femoral 
artery, but reduction in superficial femoral blood flow. In spite of this local effect, the overall 
change in TPR was very small only significantly reduced at three minutes when Q was 
elevated suggesting that other vascular beds, possibly the splanchnic (see below) had 
directionally opposite changes in vascular resistance than the peripheral vasculature. Similar 
increases in vascular resistance in the limbs has been previously reported in studies 
examining blood flow control in the dog (Bogaert, Herman, & De Schaepdryver, 1970; 
O'Hara, Ono, Oguro, & Hashimoto, 1981), and is probably resultant from an initial elevation 
in muscle sympathetic nerve activity with NG (Nordin, Fagius, & Waldenlind, 1997). To the 
best of our knowledge, this is the first study to demonstrate a marked reduction in femoral 
vascular conductance in response to NG in women.  
 The overall maintenance of TPR with clear indications of increased local 
vasoconstriction in the legs suggests that other vascular beds must have had reduction in 
resistance. The increase in portal vein diameter was expected due to the venodilator actions 
of NG (Abrams, 1996). Given a positive relationship between portal vein diameter and blood 
flow (Arbeille, Besnard, Kerbeci, & Mohty, 2005) it is possible that portal vein flow 
increased with NG as found previously in humans (Reiss et al., 1994) and pigs (Morse & 
Rutlen, 1994) potentially do to a reduction in splanchnic vascular resistance thereby 
offsetting the observed increase in peripheral vascular resistance and allowing for the 
maintenance of TPR; however, an incomplete data set with no measures of velocity suggests 
caution in interpreting the impact on portal vein blood flow.  
 There were marked reductions in CBFV after sublingual NG. While it is often 
assumed that the cross-sectional area of the middle cerebral artery does not change during an 
experimental manipulation and that observed changes in velocity are proportional to changes 
in volume flow. This does not appear to be correct under the current conditions as MRI 
angiography has confirmed the dilation of the MCA with NG (Hansen et al., 2007). This 
study provides further support for the dilation of the MCA with NG in that the Doppler 
resistance index (RI) indicated a reduction in resistance in contrast to the calculated CVRi 
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which increased. The reduced RI coincident with lower MAP after NG might suggest 
relatively unchanged cerebral blood flow which is consistent with observations from PET 
scanning techniques following NG stimulation (Borisenko & Vlasenko, 1992; White et al., 
2000). 
C.5.2 Effects of NG after HDBR 
 Long duration HDBR as used in the current study is associated with a general 
cardiovascular deconditioning (Pavy-Le Traon et al., 2002). The current study was designed 
with an exercise countermeasure (EX) intervention to contrast with the control (CON) group 
that simply rested in bed throughout the entire 56 days. The EX group showed preservation 
of baseline values of HR and SV in the post-HDBR baseline condition while there was a 
significant increase in HR in the CON group. Post-HDBR, SV for the CON group was 
reduced by 16% compared to pre-HDBR values but this was not significant as technical 
problems limited the sample size. However, other data sets for different experiments 
conducted on these same women found significant reductions in SV in the CON group 
(Edgell et al., 2007; Guinet et al., 2009) as well as evidence of reduced left ventricular 
volume and mass in the CON group and a significant increase in mass for the EX group 
(Dorfman et al., 2007). In combination with these results, reductions in total blood volume of 
-9% for CON and -4% for EX (Guinet et al., 2009) probably contributed to the elevation in 
HR required to maintain cardiac output in the CON group as observed in this study. 
 There were no differences in the diameter of the superficial femoral artery, blood 
flow, or vascular conductance as a function of HDBR. Also, there were no changes in the 
response to sublingual NG in either the CON or the EX groups with HDBR. Previous 
research with men found reduction in leg artery diameter after 52 days horizontal bed rest 
(Bleeker et al., 2005) and after 60 days HDBR with or without resistance or vibration 
exercise countermeasures (van Duijnhoven et al., 2010). It is possible that the women in the 
current study were not as physically active prior to HDBR as the men so there was less 
difference between pre- and post-HDBR values, but technical difficulties reduced the sample 
size to 5 so the negative findings in the women should be viewed with caution. In the current 
 
 204 
study, the EX group showed no differences in pre- and post-HDBR baseline diameter values 
suggesting that the exercise countermeasures, which included treadmill running, were 
sufficient to maintain vascular properties, while resistance or vibration exercise in men was 
not sufficient to maintain femoral artery diameter (van Duijnhoven et al., 2010).  
 The findings of no difference in response to NG after HDBR in the women of the 
current study contrast with data from the study of men in horizontal bed rest (Bleeker et al., 
2005), but are similar to the findings for the tibial (Platts et al., 2009) and brachial (Bonnin et 
al., 2001) arteries of men after HDBR. In another investigation of the same subjects in the 
current study, Demiot et al (Demiot et al., 2007) showed that microvascular dilation of skin 
vessels to sodium nitroprusside was not affected by HDBR suggesting that peripheral 
vascular responses to NO from donor molecules was not altered by HDBR in women. 
Although there are no data for potential changes in the nitric oxide synthase (NOS) 
expression of the conduit arteries studied in the current study, muscle biopsy samples from 
these same women revealed that the exercise countermeasures were associated with an 
increased number of capillaries and greater total endothelial NOS (Salanova et al., 2008). No 
changes in the relative density of endothelial NOS were reported but sarcolemmal-associated 
NOS1 was reduced in the CON and increased in the EX women. 
 No HDBR effect was observed for CBFV or CVRi for either baseline values or in 
responses to NG, but there was a significant baseline reduction in RI post-HDBR. The 
interpretation of the differences between CVRi and RI response to NG could suggest a 
dilation of the MCA, but interpretation of HDBR effects remain uncertain. Unchanged CBFV 
has been previously reported with HDBR and spaceflight (Zhang et al., 1997; Arbeille et al., 
2001; Pavy-Le Traon et al., 2002) and has been taken to reflect no changes in cerebral blood 
flow as indicated by measures of common carotid artery flow in cosmonauts (Arbeille et al., 
2001). However, the common carotid artery supplies both cerebral and extracranial vascular 
beds and therefore, might not reflect changes in cerebral blood flow. Animal models of 
microgravity exposure have shown vascular smooth muscle hypertrophy of cerebral blood 
vessels (Wilkerson et al., 1999; Lin et al., 2009; Zhang et al., 2001; Wilkerson et al., 2002) 
and a smaller luminal cross-sectional area (Wilkerson et al., 1999) that is associated with 
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reduced cerebral blood flow (Wilkerson et al., 2002; Wilkerson et al., 2005). The different 
cerebrovascular response to head-down position between animals and humans might be due 
to the application of quantitative methods in animals compared to indirect indicators of brain 
blood flow in humans. These differences could potentially be resolved by application of 
quantitative ultrasound techniques to assess blood flow through the internal carotid artery.  
C.5.3 Limitations 
 The WISE bed rest study was conducted as a large, multi-investigator study of the 
effects of long duration HDBR and the potential benefits of exercise countermeasures. 
Technical issues related to the acquisition of the Doppler signals for cardiac stroke volume 
and leg blood flow reduced the sample size and it was impossible to repeat the 
measurements. Therefore, while the statistical analysis did not find significant bed rest on 
effects on cardiac SV and femoral artery blood flow it is possible that the main effects would 
have been found with a larger sample size. 
C.6 Conclusion 
 In response to NG, post-HDBR there was an augmented HR response, especially in 
the CON group. The HR responses likely serve to offset reductions in SV as Q was 
maintained. Cerebral blood velocity decreased with NG but this was most likely the result of 
dilation of the middle cerebral artery. A novel finding was, contrary to previous work in men, 
no changes were seen resting superficial femoral diameter post-HDBR and no differences 
were seen in the femoral vascular response to NG which included a large reduction in 
femoral vascular conductance. These data indicate that the primary impact of HDBR on the 
women of this study was on cardiovascular deconditioning and that there were no changes in 
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